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Dedication
“The fairest thing we can experience is the mysterious. It is the fundamental
emotion which stands at the cradle of true science. He who knows it not, and can no
longer wonder, no longer feel amazement, is as good as dead. We all had this priceless
talent when we were young. But as time goes by, many of us lose it. The true scientist
never loses the faculty of amazement. It is the essence of his being.” -Hans Seyle

This dissertation is dedicated to my parents, Don and Astrid Finnell. Their
guidance, understanding, unconditional love, and sacrifice have afforded me a number of
opportunities throughout my life that helped me become the woman I am today and
ultimately sparked my interest in science.

This work is also dedicated to my loving husband Noah Harris. Our relationship
has helped me maintain a healthy work-life balance and kept me going even on the worst
of days when everything had failed. It was during these times that I was thankful to know
that I could always expect a warm welcoming smile and a hug when I returned home.
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Abstract
Social stress is a significant risk factor for the emergence of psychiatric disorders
including depression and anxiety. While there are a number of commercially available
therapeutic options for the treatment of these disorders, these treatments require weeks of
continuous use to produce behavioral efficacy. It has also been suggested that these
traditional therapies are only marginally effective in producing complete remission,
suggesting that our understanding as it pertains to the mechanisms underlying stressinduced behavioral dysfunction is still in its infancy. In the last few years, inflammation
has become a major focus in the field of stress and depression as clinical and pre-clinical
models have shown that stress results in an enhancement of inflammation in the periphery
and the brain. While the field of stress-induced inflammation is rapidly growing, there is
still a vast amount that remains unknown. Therefore, the primary goal of the work
described in this dissertation was to elucidate mechanisms underlying stress-induced
depressive like behaviors as it pertains to inflammation. Using the resident-intruder
paradigm of social defeat, the following studies demonstrate that repeated stress exposure
results not only in the enhancement of inflammation but also sensitizes inflammatory
responses in the periphery and the brain. While these inflammatory responses are largely
indiscriminate as evidenced by enhancement of both pro- and anti-inflammatory cytokines,
expression profiles in the brain demonstrated significant regional specificity. Strikingly,
these inflammatory responses differed greatly between animals that demonstrated
resilience or susceptibility to the behavioral consequences of stress. Rats that exhibited
vii

active coping defensive behaviors during the stress exposure demonstrated resilience to the
behavioral and inflammatory effects of social defeat. In contrast, rats demonstrating
passive coping behaviors during the stress exposure and subsequent susceptibility to the
depressogenic effects of social defeat exhibited robust neuroinflammation within the locus
coeruleus (LC). Peripheral administration of resveratrol, a natural anti-inflammatory, seven
days prior to and during the 5-day social defeat period was able to dose dependently inhibit
these behavioral and inflammatory effects in susceptible rats. Importantly, only the highest
dose which achieved complete inhibition of stress-induced inflammation was associated
with complete inhibition of depressive-like behaviors. A follow-up study demonstrated that
stress-induced inflammatory effects in the periphery and the brain were directly dependent
upon norepinephrine (NE) derived from the LC. In the periphery LC-derived NE was found
to potentiate and sensitize stress-induced inflammation as evidenced by enhanced cytokine
concentrations in the plasma. While the effects of LC derived NE in the plasma were clear,
the effects of LC-NE on the brain were highly dependent upon the brain region analyzed.
For example, loss of NE in the central amygdala (CeA) in response to stress or
pharmacological NE lesion of the LC, resulted in a significant enhancement of
inflammation within this region. In contrast, inflammatory responses in the dorsal raphe
were largely independent of LC-NE. Inflammation in the brain is known to result in
significant shift in neuronal function and with respect to the CeA has been shown to engage
signaling cascades associated with tyrosine receptor kinase (Trk)B, which has been
suggested to underlie the emergence of anxiety-like behaviors and cardiovascular
abnormalities. To elucidate the specific involvement of this receptor in stress-induced
behavioral and cardiovascular responses, a small molecule TrkB inhibitor was injected
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directly into the CeA 30-minutes prior to social defeat on days 1, 3, and 5. Notably, CeA
TrkB signaling was directly associated with the expression of defensive behaviors and
cardiovascular reactivity during defeat. These effects were associated with enhanced TrkB
phosphorylation and were accompanied by preferential activation of the extracellular
signal-regulated kinase (ERK) pathway. Surprisingly, these effects in cellular signaling
occurred independently of the TrkB ligand brain derived neurotrophic factor (BDNF).
While CeA TrkB signaling was critical for the expression of behavior and cardiovascular
responses during stress, behaviors and cardiovascular measurements obtained after stress
exposure were largely independent of the CeA and TrkB. Taken together, the studies
outlined in this particular document function to (1) directly implicate inflammatory
processes in the emergence of stress-induced behavioral dysfunction, (2) suggest that these
responses are driven by LC derived NE, and (3) begin to probe inflammatory sensitive
mechanisms that may be involved in the expression of adverse behaviors.
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Preface
My passion for this research comes from my own experiences struggling with the
consequences of social stress. During my childhood and teen years, I experienced severe
bullying from both classmates and teachers. These experiences left me feeling so worthless
and depressed that I completely isolated myself, skipped school to avoid further torment,
and even progressed to suicidal ideation. It took years to build back my self-confidence,
my ability to trust and be vulnerable with others, and learn active coping strategies to battle
the negative preconceptions that were drilled into me by these people who acted with the
cruelest of intentions. The saddest part about this story is that I am not alone. There are a
striking number of people who struggle with similar feelings, thoughts, and experiences.
Sadly, the rates of mood disorders have been steadily increasing over the last few decades
and I predict that these rates will only continue to increase especially with the continued
popularity of social media and reported rise in cyberbullying.
I began my journey to recovery during graduate school when, with the love and
support of my parents and husband, I finally found the courage to seek help. Luckily, I was
able to find relief with a combination of cognitive behavioral therapy and use of traditional
antidepressants. However, not everyone is as lucky and some never truly feel relief. In
many cases this is linked to a lack of effective medication. Post-traumatic stress disorder
(PTSD) is a classic example of this phenomenon. PTSD patients are often prescribed
antidepressants which do not function to alleviate their symptoms thereby contributing to
the disproportionally high suicide rate associated with this disorder. It is also important to
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note that traditional antidepressants can also fail to produce remission in certain
populations of depressed patients. Taken together these data suggest that our understanding
of the neurobiological mechanisms that underlie stress-induced psychosocial disorders is
still in its infancy. Therefore, the research described herein is focused on elucidating the
discrete mechanisms that may be involved in the emergence of stress-induced psychiatric
disorders with the hopes that it may be used as the foundation for future studies that could
lead to the development of novel therapeutics.
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Chapter 1
General Introduction
1.1 Social Stress and the development of depression and anxiety
“I am feeling overwhelmed.” “I need a vacation.” “I am stressed out.” Phrases such
as these are common in today’s society. However, our modern understanding of stress is
relatively new. First described in 1940 by Hans Selye (Szabo et al., 2012), stress was used
as a general term indicating a noxious agent capable of producing the general adaptation
syndrome (GAS) (Selye, 1950). According to Selye’s description, GAS was a
physiological syndrome which occurred across three distinct phases and was characterized
by tissue catabolism and activation of secretory granules in the adrenal glands (Selye,
1950). In line with our current understanding of stress physiology, Selye believed that GAS
was the body’s inherent defense mechanism and was largely beneficial, but in excess could
be involved in the development and worsening of disease (Selye, 1950). Since this initial
article, thousands of reports have been published expanding our understanding of stress as
well as the physiological response to stress.
By todays standard, stress is a broad term designed to convey the feeling of
emotional, mental, or physical strain. Unlike the 1940s and 50s where chemical and
physical agents were considered to be the primary source of stress (Selye, 1950), in today’s
society social adversity such as bullying, abuse, divorce, taking care of a terminally ill
loved one, or witnessing traumatic events are considered to be the most common source of
stress (Almeida, 2005). Social standing is well known to influence an individual’s sense of
1

self-worth and esteem (Kraus and Park, 2014). Therefore it is not surprising that social
stressors which not only disrupt social standing but also decrease self-worth and selfesteem (Kemeny et al., 2004; Kesting et al., 2013) are subjectively perceived to be more
impactful than other forms of stress (Almeida, 2005). Generally classified as acute,
episodic, or chronic based its duration, social stress encompasses any situation that may
jeopardize an individual’s relationships or sense of belonging. As with other forms of
stress, acute occurrences of social stress are often associated with feelings of anger (Lupis
et al., 2014), fear (Lupis et al., 2014), and reductions in pleasure (Vors et al., 2018). While
shifts in mood caused by acute social stress exposure are largely transient, exposure to
episodic and chronic social stress is well known to promote the emergence of psychosocial
disorders such as depression and anxiety (Almeida, 2005).
According to the World Health Organization (WHO), depression and anxiety are
the most prevalent mental health disorders affecting a respective 322 and 264 million
people worldwide (Organization, 2017). These disorders are long lasting and are estimated
to have a lifetime prevalence of 20.6% (Hasin et al., 2018) and 6.8% (Kessler et al., 2005).
Strikingly, it has been suggested that the magnitude of disability caused by these disorders
is as great if not greater than several common physical medical conditions. Specifically, it
has been reported that depressed patients spend a greater number of illness-related days in
bed and have lower physical functioning compared to patients suffering from a physical
disorder such as hypertension, diabetes, and arthritis (Wells et al., 1989). In addition to
affecting physical ability, these disorders also have the potential to significantly disrupt an
individual’s daily life. For example, adults with depression and anxiety are more likely to
be absent from work and exhibit poor or reduced work performance (Lerner et al., 2010;
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Plaisier et al., 2010). In addition, these disorders are anecdotally associated with
disruptions in social relationships due to self-induced social withdrawal and isolation
(Kenneth and Burgess, 2001; Matthews et al., 2016).
Currently, there are a number of treatment options for patients suffering from these
disorders. However, remission rates for traditional anti-depressant therapies, such as
selective serotonin reuptake inhibitors (SSRIs), selective noradrenergic re-uptake
inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), and tricyclic anti-depressants
(TCAs), are approximately 40% (Machado et al., 2006; Rush et al., 2006; Trivedi et al.,
2006). Similar (20-40%) remission rates have also been reported in patients with posttraumatic stress disorder (PTSD) (Berger et al., 2009) and general anxiety disorder
(Bandelow et al., 2013) where the primary pharmacological treatments are traditional antidepressants and anxiolytics. These primary therapeutics were created based on the
monoamine hypothesis of mood disorders. This hypothesis states that mood disorders such
as depression and anxiety are caused by deficiencies in serotonin (5-hydroxytryptamine, 5HT), NE (NE), and dopamine (DA) (Delgado, 2000). However, recent research has
suggested that stress-induced alterations of monoamines may be a secondary occurrence.
This suggestion largely stems from findings that these anti-depressants produce immediate
enhancement of neurotransmitter concentrations in the synaptic cleft but require weeks of
continuous use to relieve behavioral symptoms (Liu et al., 2017). Taken together, these
data suggest that our understanding of the mechanisms that underlie the emergence of these
mood disorders is still in its infancy.
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1.2 Behavioral coping mechanisms and stress susceptibility
Virtually everyone will experience social stress in their lives. However, only a
small portion of the population go on to develop psychosocial disorders, suggesting that
there is significant individual variability in the vulnerability to susceptibility to stress. In
humans, it has been suggested that stress susceptibility and resiliency are largely driven by
an individual’s coping style (Henry and Stephens, 1977). While there are a number of
different methods for coping with stress, these activities and behaviors are broadly
categorized as either active or passive (Henry and Stephens, 1977). As originally described
by Walter Cannon (Cannon, 1929), active coping applied to behaviors that were directly
associated with fight or flight responses. In contrast, passive coping behaviors were
originally characterized by low levels of aggression and heightened immobility (Engel and
Schmale, 1972). These original reports were focused on the behavioral responses during
stress. However, more recent reports have broadened both of these classifications, as we
now know that coping responses not only include the primary but also secondary appraisal
and behavioral responses to the stress. By today’s standard active coping also includes
seeking support, engaging in problem solving, as well as adopting positive attitudes and
maintenance of humor (Christen et al., 1986; Cairns et al., 2014). While passive coping
includes behaviors such as avoidance, withdrawal, excessively seeking reassurance
(Cambron et al., 2009; Cairns et al., 2014), and rumination (Nicolai et al., 2013).
It is important to note that adoption of either passive or active coping strategies is
a dynamic process (Orzechowska et al., 2013) and is highly dependent upon the stress type
and severity (Lazarus and Folkman, 1987). However, it is generally understood that people
who more readily adopt passive coping strategies are more susceptible to the behavioral
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consequences of stress exposure (Lazarus and Folkman, 1987; Cambron et al., 2009; Cairns
et al., 2014). Conversely, those who more readily adopt active coping strategies tend to
exhibit resilience to the behavioral consequences of stress (Cairns et al., 2014). In addition
to mediating the behavioral response to stress, an individual’s coping style can also impact
the physiological response to stress. For example, it has been demonstrated that heart rate
and blood pressure are enhanced to a greater extent in individuals exhibiting active coping
during a rapid response task compared to individuals that readily gave up in this task (Light,
1981).
Similar effects have also been reported with regard to the primary stress hormone
cortisol. In 2017 Sladek et al conducted a study in which diurnal cortisol levels were
tracked across 3 days in 122 adolescent girls (Sladek et al., 2017). In addition to obtaining
cortisol samples, the girls were asked to complete a standard coping survey. Sladek et al
determined that during instances of low interpersonal stress, coping responses played an
integral role in diurnal cortisol levels. Specifically, individuals that self-reported the use of
passive coping strategies exhibited overall greater diurnal cortisol levels compared to
individuals who reported using active coping strategies. Interestingly, diurnal cortisol
levels did not differ between active and passive coping individuals in instances of high
interpersonal stress. However, passive coping during these high stress experiences was
associated with the highest baseline (waking) concentrations of cortisol compared to all
other stress and coping groups (Sladek et al., 2017). The authors of this particular study
concluded that these findings suggested that the release of stress hormones in individuals
prone to passive coping strategies is more reactive than individuals prone to active coping
(Sladek et al., 2017).

5

These findings regarding the release of cortisol in active versus passive coping
humans are of particular importance as enhanced concentrations cortisol are reported in
patients with depression (Murphy, 1991) and anxiety (Mantella et al., 2008). Cortisol, the
terminal hormone released after activation of the hypothalamic-pituitary-adrenal axis
(HPA), exerts broad influence over nearly every major organ system during a stress
response. Whether it is mobilization of glucose, modifying fat and protein metabolism in
the central nervous system (CNS), enhancing sensitivity of the cardiovascular system to
catecholamines, or reducing histamine secretion (Stephens and Wand, 2012), this hormone
is a critical mediator in what is commonly known as the fight or flight response. Typically,
the release of cortisol is well regulated by a number of negative feedback mechanisms.
However, in instances of chronic stress these feedback mechanisms can become
dysregulated resulting in an overall increase in resting levels and facilitation and delayed
shut-off of stress-induced cortisol secretion (Herman et al., 2016). Based on the broad
physiological effects of cortisol, it has been suggested that these dysregulations may
underlie the emergence of mood disorders. However, much of what we know regarding
hypercortisolemia have come from studies analyzing patients that were already suffering
from these disorders (Ozbolt and Nemeroff, 2013). Therefore, it is unclear if
hypercortisolemia is causal to the development of these disorders or a biproduct of
dysregulation in other converging systems. Regardless of the specific mechanism driving
the emergence of depression and anxiety, the findings from Sladek et al. in combination
with the known relationship between cortisol and mood disorders, suggests that the
physiological reactivity associated with passive coping may predispose these individuals
to develop mood disorders.
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1.3 Modeling social stress and coping in rodents
Much of what is known today with regard to stress, stress physiology, and resulting
behavioral dysfunction has come from studying these processes in animals. While there are
a number of ways to model stress in rodents, social stress is primarily studied using the
resident-intruder paradigm of social defeat. Originally developed by Claus Miczek
(Miczek, 1979), the resident-intruder paradigm involves placing a male, termed the
“intruder”, into the home cage of a larger more aggressive male termed the “resident”. Rats
(Flannelly and Thor, 1976), mice (Kikusui, 2013), and prairie voles (Gobrogge and Wang,
2011) are extremely territorial in nature and will readily defend their territory from
intruders. In the context of the resident-intruder paradigm, this results in the resident
repeatedly attacking the intruder, until the intruder exhibits a supine posture signaling
behavioral submission or until physical separation by the experimenter. Notably, these
rodent species are highly social and readily establish stable social hierarchies (Hoshaw et
al., 2006; van den Berg et al., 2014; Sadino and Donaldson, 2018).
Similar to findings in primates (Michopoulos et al., 2012), this long-term and
repeated subordination in rodents has been shown to produce detrimental effects in the
overall health of the animal. Specifically, these acute episodes (minutes to hours) of social
defeat have been shown to result in significant enhancement of the HPA axis (Bhatnagar
et al., 2006), robust activation of the sympathetic nervous system (Sgoifo et al., 1996),
increases in blood pressure and heart rate (Meehan et al., 1995), enhanced susceptibility to
cardiac arrhythmias (Tornatzky and Miczek, 1993, 1994), and enhanced inflammation in
the periphery (Niraula et al., 2019) and the brain (Gao et al., 2019). In addition to producing
robust physiological effects, social defeat readily induces depressive- and anxiety-like
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behavioral states. This is most commonly evidenced by reductions in social interaction
(Trainor et al., 2011; Greenberg et al., 2013; Andoh et al., 2019; Aubry et al., 2019; Jiang
et al., 2019; Zhang et al., 2019), reductions of sucrose preference (Bowens et al., 2012;
Carrier and Kabbaj, 2012; Spierling et al., 2017; Deng et al., 2018; Jiang et al., 2019),
increases in behavioral despair (Bowens et al., 2012; Carrier and Kabbaj, 2012; Deng et
al., 2018; Jiang et al., 2019), and avoidance of high risk areas (Heinrichs et al., 1992;
Kinsey et al., 2008; Andoh et al., 2019; Aubry et al., 2019). Notably, stress responsivity
and susceptibility in rodents can be highly variable depending on the duration and intensity
of social defeat.
In many cases these variable behavioral and physiological responses have been
attributed to the emergence of individual differences in the susceptibility to social defeat.
Similar to humans, ethologically relevant stress coping behaviors have been described in
birds (Verbeek et al., 1994), fish (Mather and Anderson, 1993; van Raaij et al., 1996),
rodents (Korte et al., 1992; Fokkema et al., 1995; Gomez-Lazaro et al., 2011; Chaijale et
al., 2013; Reyes et al., 2015; Wood et al., 2015), pigs (Hessing et al., 1994; Ruis et al.,
2000), cattle (Hopster, 1998), and non-human primates (Von Holst, 1986; Suomi, 1991).
These coping behaviors and the resulting behavioral and physiological effects have been
best characterized in rodents with the use of social defeat. Several labs have found that
quantification of behavior during defeat, such as immobility (De Miguel et al., 2011;
Gomez-Lazaro et al., 2011), social and non-social exploration (De Miguel et al., 2011;
Gomez-Lazaro et al., 2011), fleeing (De Miguel et al., 2011), duration spent in upright
defensive postures (Wood et al., 2012; Wood et al., 2015), and latency to submit (De
Miguel et al., 2011; Wood et al., 2012; Reyes et al., 2015; Wood et al., 2015), can be
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effectively utilized to statistically separate socially defeated rodents into susceptible and
resilient subpopulations. Specifically, rodents characterized as passive coping exhibit high
levels of immobility (De Miguel et al., 2011; Gomez-Lazaro et al., 2011), low social and
non-social exploration (De Miguel et al., 2011; Gomez-Lazaro et al., 2011), short durations
of upright defensive postures (Wood et al., 2012; Wood et al., 2015), and short latencies to
submit to the attacking resident (De Miguel et al., 2011; Wood et al., 2012; Reyes et al.,
2015; Wood et al., 2015). Adoption of these behaviors during defeat are associated with
the emergence of depressive-like behaviors following the cessation of defeat (Wood et al.,
2010; Gomez-Lazaro et al., 2011; Perez-Tejada et al., 2013).
In contrast, active coping rodents that exhibit resiliency to the behavioral
consequences of social defeat demonstrate short bouts of immobility (De Miguel et al.,
2011; Gomez-Lazaro et al., 2011), enhanced exploratory behaviors (De Miguel et al., 2011;
Gomez-Lazaro et al., 2011), long durations of upright defensive postures (Wood et al.,
2012; Wood et al., 2015), and generally resist defeat (Wood et al., 2010; De Miguel et al.,
2011; Reyes et al., 2015; Wood et al., 2015). In addition to affecting long-term behavioral
outcomes, physiological responses during stress also differ between active and passive
coping rodents. For example, plasma corticosterone (CORT), the rodent analogue of
human cortisol, is enhanced to a greater extent during social defeat in passive coping
rodents compared to their active coping counterparts (Korte et al., 1992; Wood et al., 2010;
De Miguel et al., 2011; Perez-Tejada et al., 2013). Passive coping during social defeat has
also been associated with enhanced plasma epinephrine (Korte et al., 1992), blunted NE
(Korte et al., 1992; Perez-Tejada et al., 2013), and enhanced cardiac reactivity as evidenced
by increased heart rate variability (Wood et al., 2012).
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However, determination of susceptibility and resiliency can also be determined
using behavioral responses prior to and following social defeat. Other labs have
successfully demonstrated that susceptibility and resiliency can also be determined by
analyzing post-hoc social behavior and behavioral responses to novel nonsocial stressors.
Social interaction is one popular method for post-hoc determination of susceptible and
resilient subpopulations. Studies using this method have shown that social interaction
following social defeat is bimodally distributed (Krishnan et al., 2007). Animals that
demonstrate social avoidance as evidenced by low interactions with a conspecific target
mouse are classified as susceptible (Krishnan et al., 2007; Hodes et al., 2014). In contrast,
animals that are classified as resilient demonstrate similar interaction profiles with that of
non-stress controls (Krishnan et al., 2007; Hodes et al., 2014). Interestingly, it has also
been shown that it is possible to predict resilient and susceptible subpopulations prior to
social defeat exposures. This has been accomplished by placing the rodent in a novel
environment (Calvo et al., 2011; Duclot et al., 2011; Hollis et al., 2011; Duclot and Kabbaj,
2013). Animals that readily explore this novel environment are termed high responders
while those that demonstrate reduced locomotor activity and do not explore this
environment are termed low responders (Calvo et al., 2011; Duclot et al., 2011; Hollis et
al., 2011; Duclot and Kabbaj, 2013). Rats and mice are naturally neophobic (Meddock and
Osborn, 1968; Stryjek and Modlinska, 2016) and it is thought that the behavioral responses
during exposure to a novel environment is indicative of an animals trait anxiety (Steimer,
2011). Based on these data it stands to reason that animals that exhibit low exploratory
behaviors would be more susceptible compared with rodents that readily explore. However,
findings using the high/low responders has been equivocal with some studies reporting
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high responder groups as displaying resilience (Calvo et al., 2011) while others have
reported resilience in low responder groups (Duclot et al., 2011; Hollis et al., 2011; Duclot
and Kabbaj, 2013). These differences are likely due to variances in protocol, however these
conflicting reports highlight the necessity for the inclusion of post-stress behavioral assays
to verify resilient and susceptible phenotypes.
While there are a number of methods for determining individual differences as they
pertain social defeat and each has inherent advantages and disadvantages, studies powered
to visualize these individual differences are critical to truly understand the neurobiological
mechanisms that underlie the emergence of stress-induced behavioral dysfunction in
susceptible phenotypes.

1.4 Stress, mood disorders, and the brain
Up until this point, there has not been significant discussion regarding the effects
of stress in the brain. However, the brain is exquisitely sensitive to stress and demonstrates
rapid and long-lasting adaptation to these challenges. While these stress-induced
adaptations are wide spread and highly region specific, studies in animals and humans have
shown that there are a few key brain regions that are consistently dysregulated. This
includes the prefrontal cortex (PFC), hippocampus, amygdala, locus coeruleus (LC), and
dorsal raphe (DR) (Bremner, 2006; Bremner, 2007; Lucassen et al., 2014).

The PFC has been studied for the better part of a century. Interest in this brain region was
initially sparked in 1848 with the land mark case of Phineas Gage (Steegmann, 1962; Stuss
and Knight, 2013). Gage, who was working as a railroad construction foreman, survived a
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freak accident in which a rail road spike was driven completely through the left portion of
his frontal lobe (Steegmann, 1962; Stuss and Knight, 2013). Initially it was his survival
that astounded doctors. However, that soon changed as his friends and loved ones noted
dramatic shifts in Gages personality (Steegmann, 1962; Stuss and Knight, 2013). Prior to
the accident Gage was considered to be hard-working, responsible, and generally amiable
(Steegmann, 1962; Stuss and Knight, 2013). Following the accident, he demonstrated
indifference, impatience, obstinance, and would easily become enraged (Steegmann, 1962;
Stuss and Knight, 2013). These observations were the first lines of anecdotal evidence to
suggest that the structures found within the frontal lobe were critical for what we consider
to be the manifestation of personality. Since then our understanding of the function,
structure, and connectivity of the PFC has significantly broadened.
Functionally speaking, the PFC is critical for executive function. This includes
complex processes such as sustained attention, planning, flexibility, initiating and
executing complex behaviors, and active problem solving (Siddiqui et al., 2008). It has also
been shown to play a significant role in memory (Fletcher et al., 1998; Luria, 2012),
language (Siddiqui et al., 2008), gaze control (Luria, 2012), and contributes to intelligence
(McFie and Thompson, 1972; Drewe, 1974). Notably, exposure to stress differentially
affects these executive functions. Specifically, meta-analysis of 51 studies assessing a total
of 2,486 participants has shown that stress significantly impairs working memory and
cognitive flexibility while other control functions, such as inhibition, remain largely intact
(Shields et al., 2016). Impairments in these executive functions have also been denoted in
patients with depression (Channon and Green, 1999; Ajilchi and Nejati, 2017) and anxiety
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(Ajilchi and Nejati, 2017) suggesting that these conditions are likely associated with
abnormalities in PFC functionality.
Several studies have begun to shed light on the functional changes that occur in the
PFC using functional magnetic resonance imaging (fMRI) and positron emission
tomography (PET). These studies have shown that exposure to acute stress results in an
overall increase in the activity of the PFC (Tillfors et al., 2002; Sinha et al., 2016). This
acute stress-induced PFC activity was shown to be significantly reduced in passive coping
individuals who self-reported emotional eating, alcohol consumption, and argumentative
tendencies exhibited lower PFC activity during stress (Sinha et al., 2016). Although human
studies determining functional changes in the PFC following chronic stress are lacking,
studies in depressed patients has shown that there is a dynamic dysregulation within
specific subdivision of the PFC. Specifically depressed patients exhibit abnormally high
resting activity of the medial PFC (Drevets et al., 1992; Biver et al., 1994; Mayberg et al.,
2005; Greicius et al., 2007) and concurrent reductions of activity in the dorsolateral PFC
(Baxter et al., 1989; Biver et al., 1994; Galynker et al., 1998). These alterations in resting
PFC activity have also been reported during tasks assessing working memory and
planning/cognitive flexibility. In line with previous findings, a study conducted by
Fitzgerald et al. determined that depressed patients exhibited widespread enhancement of
PFC activity during completion of both of these tasks which well exceeded that of healthy
controls (Fitzgerald et al., 2008).
Similar PFC activity patterns have also been reported in animal studies using social
defeat (Kumar et al., 2014). Currently there are several different hypotheses regarding the
mechanism by which social defeat stress may cause this PFC dysregulation. Most directly,
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it has been shown that social defeat results in glutamate-induced internalization of
membrane bound GluR1 and GluR2 (Yashiro and Seki, 2017). Both GluR1 and 2 are
subunits of the excitatory AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid) receptor and are critical for the induction of long term potentiation (LTP) (Zamanillo
et al., 1999; Jensen et al., 2003) and the maintenance of basal excitatory tone (Shi et al.,
2001; Kolleker et al., 2003; Lee et al., 2004). It has been suggested that defeat-induced
internalization of these subunits may represent a compensatory mechanism to normalize
otherwise aberrant increases of excitatory tone within the PFC (Yashiro and Seki, 2017).
This is particularly relevant to humans where post-mortem PFC tissue analyses indicated
accumulation of glutamate (Hashimoto et al., 2007).
Glutamate is known to work in concert with several other neurotransmitter systems
and growth factors including BDNF (Martin and Finsterwald, 2011). BDNF is well known
for its role in promoting the growth and survival of neurons. Notably, BDNF has been
suggested to exert these functions through the modification of both pre- and post-synaptic
terminals that enhance the overall sensitivity of neurons to excitatory amino acid
neurotransmitter glutamate (Martin and Finsterwald, 2011). It is through these indirect
actions that BDNF is suggested to contribute to LTP and the strengthening of specific
neural pathways (Martin and Finsterwald, 2011). While findings in rodents using social
defeat are largely equivocal, with some groups indicating enhanced expression of BDNF
transcripts (Mallei et al., 2018) and others reporting direct reductions of BDNF protein
(Dong et al., 2018), post-mortem studies in humans have shown that BDNF is reduced
within the PFC of patients with major depression (Dwivedi et al., 2003). Structurally, this
has been associated with reductions in neuronal size, density, and loss of dendritic spines
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(Rajkowska, 2000; Kang et al., 2012), suggesting that these structural abnormalities may
result in loss or reductions of PFC function.
The Hippocampus, a bilateral temporal lobe structure, is traditionally known for its role
in mediating the formation and maintenance of short-term and long-term memories (Bird
and Burgess, 2008). However, it has been suggested that the hippocampus may also play
an intricate role in cognitive flexibility and social behavior. It has been well documented
that disruptions in the hippocampus can lead to amnesia and produce disturbances in
declarative memory (Cohen and Squire, 1980; Squire, 1992; Cohen and Eichenbaum,
1993; Gabrieli, 1998; Eichenbaum and Cohen, 2004), that is memory of people, places,
and things. However, a component of these declarative memories are also the interactions
between these elements, one’s own personal awareness, and the overall social context
(Cohen and Eichenbaum, 1993; Eichenbaum and Cohen, 2004; Yonelinas, 2013). This
relational information has also been shown to be disrupted in patients with hippocampal
dysfunction (Cohen and Eichenbaum, 1993; Eichenbaum and Cohen, 2004; Yonelinas,
2013), suggesting that the hippocampus is not only critical for the formation of new
memories, but also for encoding the relationship between the individual components that
comprise a memory. In addition to the formation of memories, the hippocampus has also
been implicated in recall, reconstruction, and re-encoding of memories (Rubin et al., 2014).
It is thought that this flexibility in memory is a key component in successful spatial
navigation, exploration of novel environments, imagination, creativity, decision making,
development of social relationships, and empathy (Rubin et al., 2014). With respect to
social relationships and empathy, hippocampal dysfunction has been associated with
difficulties in forming new and maintaining old social bonds (Duff et al., 2008; Davidson

15

et al., 2012; Warren et al., 2012) and a general loss of empathy (Beadle et al., 2013).
Depression is also marked by breakdown of social bonds (Shahar, 2001), impairments in
empathy (Wilbertz et al., 2010), and alterations in declarative memory (Matt et al., 1992;
Burt et al., 1995; Ramponi et al., 2004; Köhler et al., 2015). Generally, these impairments
in depressed patients are associated with reductions in the activity (Milne et al., 2012) and
volume (Videbech and Ravnkilde, 2004) of the hippocampus.
Strikingly, hippocampal loss as it pertains to depression has been reported to persist
for decades after remission (Sheline et al., 1996; Bremner et al., 2000). However, studies
in humans have suggested that these effects may be reversible in humans (Starkman et al.,
1999). Notably, this persistent hippocampal atrophy in depressed patients has also been
suggested to potentiate the emergence of age related cognitive decline (Sawyer et al.,
2012). There are a number of neuronal mechanisms that have been suggested to contribute
to these effects. Under normal healthy conditions, BDNF is quite prominent in the
hippocampus and serves to facilitate LTP and remodeling of pre and post-synaptic
terminals (Leal et al., 2017). These molecular effects have been suggested to underlie
processes such as short and long-term memory formation (Alonso et al., 2002). In response
to stress, several studies in rodents have demonstrated that BDNF is largely reduced in the
hippocampus (Lee and Kim, 2010). Notably, his reduction of BDNF in the hippocampus
has also been reported in humans (Dwivedi et al., 2003) suggesting that this mechanism is
largely conserved across species. Although it is currently unclear if stress-induced loss of
BDNF is the initiating factor involved in hippocampal atrophy, it has been suggested that
the loss of BDNF enhances the vulnerability of neurons to processes such as excitotoxicity
(Campbell and Macqueen, 2004).
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The Amygdala has long been recognized to be a key brain region involved in the
acquisition and processing of fear. The role of the amygdala in fear and emotional
processing has been studied over the past 6 decades. Disease states induced experimentally
(Klüver-Bucy syndrome) and those occurring naturally (Urbach-Wiethe disease) were key
in the initial characterization of amygdala function. For example, the classic case study of
patient S.M. demonstrated that bilateral calcification of the amygdala completely disrupted
the intrinsic feeling of fear. Notably, these lesions were also associated with an inability to
recognize fearful emotions in others. Beyond the immediate role of the amygdala in the
expression of fear, this region has also been suggested to play a key role in mediating
discrete social behaviors including subjective assessments of trustworthiness (Purves et al.,
2012).
The amygdala can be anatomically separated into a number of different sub nuclei.
Of the suggested 13 subnuclei, the central, basal, and lateral divisions of the amygdala are
the most clearly defined and best characterized. In general, it is thought that the basal and
lateral divisions serve as the major input for emotionally salient information. In contrast
the central division is considered to be the major output and is thought to be directly
responsible for the expression of fear related behaviors and somatic responses (Ressler,
2010). This, however, is a very simplistic view of the connectivity and function of the
amygdala. In addition to mediating behavioral and somatic responses to fear, the amygdala
has also been implicated in the emergence of coping responses during stress (Fadok et al.,
2017). Stress is associated with a robust activation of the amygdala (Roozendaal et al.,
1997; Bryant et al., 2008; Roozendaal et al., 2009; Pitman et al., 2012). In terms of acute
stress exposure, these responses are thought to be largely adaptive. However, in response
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to chronic stress and stress-induced disease states such as depression and anxiety, these
adaptations result in persistent enhancements of amygalar activation even in the absence
of a perceived threat (Liberzon and Sripada, 2008; Yang et al., 2010).
There are a number of different mechanisms by which stress has been suggested to
enhance amygdala activation. These putative mechanisms are the subject of investigation
in chapter 5 of this document.

The LC is the major source of NE to the entire neuroaxis. As such the LC has been directly
implicated in the emergence of depression (Wong et al., 2000) and anxiety (Southwick et
al., 1997). Under normal resting conditions, the LC functions to regulate arousal, attention,
and autonomic function (Samuels and Szabadi, 2008). These processes are directly
associated with tonic LC neuronal activity. Studies in cynomolgus monkeys have
demonstrated that an alert wakeful state is associated with moderate and irregular activity
of the LC (Rajkowski et al., 1994). In contrast, prolonged pauses in LC activation are
associated with drowsiness and loss of attention (Rajkowski et al., 1994). Stress has been
shown to temporarily shift LC activity from this tonic firing pattern to a high frequency
phasic firing pattern (Rajkowski et al., 1994). This shift in LC firing has been suggested to
play a key role in the emergence of the sympathetic fight or flight response. While this
process is adaptive in the short term, several studies have suggested that chronic exposure
to stress and disease states such as depression and anxiety are related to an increase in the
tonic firing of the LC (Atzori et al., 2016).
While this seems contradictory as depression has been associated with overall
reductions in NE, it has been suggested that this enhancement of LC firing is likely
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accompanied by depletion of NE in LC projections (Atzori et al., 2016). In addition to the
idea of depletion, it has been suggested that stress may enhance the activity of sirtuin-1
(Sirt-1). Sirt-1 is a histone deacetylase. As such, this particular protein has been shown to
indirectly regulate neuronal function by increasing the transcription of a number of targets.
Of relevance to NE and mood disorders, Sirt-1 has been shown to promote the activation
of monoamine oxidases (MAO) through deacetylation of the transcription factor nescient
helix-loop-helix 2. MAOs are well known for their role in the degradation of NE and 5HT. Moreover, their involvement in the pathogenesis of mood disorders has been well
established and has led to the emergence of a class of anti-depressant therapeutics that
specifically target MAOs (Fujita and Yamashita, 2018).

The DR, like the LC, is a long-standing target for the study of mood disorders. The DR, a
largely heterogeneous cell population, is a predominant site for 5-HT synthesis in the brain.
With both ascending and descending projections, the DR has been implicated in practically
every type of behavior including those corresponding to appetite, arousal, emotion, and
cognition (Frazer and Hensler, 1999). Similar to findings with the LC, the DR demonstrates
slow tonic activity that is directly associated with arousal and wakefulness (Jacobs and
Fornal, 1993). In contrast, stimuli such as stress which provoke arousal are accompanied
by a stark increase in DR firing rates (Jacobs and Fornal, 1993). Under states of chronic
stress, the 5-HT system becomes dysregulated and is often associated with reductions in 5HT neurotransmission (Mahar et al., 2014). In many instances this reduction in 5-HT is
associated with enhanced activity of presynaptic serotonin transporters that function to
remove 5-HT from the synaptic cleft (Mahar et al., 2014). SSRIs are thought to improve
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mood disorders by directly inhibiting these presynaptic receptors thereby increasing the
amount of 5-HT available for neurotransmission. Another putative mechanism by which
stress has been shown to reduce 5-HT is through the induction of indoleamine 2,3dioxygenase (IDO). IDO is the rate limiting enzyme that converts tryptophan to kynurenine
(Greenhill, 2018). Since the amino acid tryptophan is also the primary precursor for the
synthesis of serotonin, enhanced activation of IDO effectively reduces 5-HT synthesis by
creating direct competition for this critical precursor.

1.5 The implication of inflammation in mood disorders
From the previous discussion, it is clear that there are a number of mechanisms that
are suggested to contribute to the onset of social stress-induced mood disorders. One
relatively new area of research in the field of depression, anxiety, and stress is
inflammation. Inflammation is generally thought to be associated with physical illness,
infection, and disease. However, stress is well known to activate the inflammatory system.
In terms of acute stress responsivity, activation of the inflammatory system is considered
to be adaptive by promoting wound healing through the recruitment of leukocytes
(Dhabhar, 1998; Viswanathan and Dhabhar, 2005) and enhancing both adaptive (antigenspecific) and innate (non-specific) immune responsivity (Dhabhar and McEwen, 1996;
Dhabhar, 1998; Dhabhar and McEwen, 1999; Dhabhar et al., 2000; Viswanathan and
Dhabhar, 2005). Typically, these inflammatory responses return to resting levels after the
cessation of stress. But in situations of chronic stress, the immune system can become
dysregulated (Glaser and Kiecolt-Glaser, 2005) and has been suggested to contribute to the
development of mood disorders including depression and PTSD.
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The putative involvement of the inflammatory system in mood related disorders
was first described in 1927 by Julius Wagner-Jauregg, who went on to win the Nobel Prize
for this seminal discovery. Since its initial discovery, several hundreds of papers have been
published on the topic (Loftis et al., 2010). This vast body of literature has demonstrated
that depressed individuals exhibit increases in the number of inflammatory competent cells
in the plasma (Zorrilla et al., 2001), decreased lymphocyte proliferation (Zorrilla et al.,
2001), and decreased adaptive (antigen-specific) immune reactivity (Irwin et al., 1998).
Additionally, these patients often exhibit increases in resting plasma concentrations of
interleukin (IL)-1 (Anisman et al., 1999), IL-6 (Zorrilla et al., 2001), IL-12 (Zorrilla et al.,
2001), tumor necrosis factor (TNF)-a (Anisman et al., 1999), and C reactive protein (CRP)
(Lanquillon et al., 2000; McDade et al., 2006; Miller et al., 2008) the acute phase protein
that follows IL-6 secretion. Notably, these inflammatory effects are not isolated to the
periphery. Increases in the concentration of IL-1b (Miller et al., 2019), IL-6 (Sasayama et
al., 2013; Kern et al., 2014b), and IL-8 (Kern et al., 2014b) have also been documented in
the cerebrospinal fluid (CSF) of depressed patients. It could be argued that cytokine
measures in the CSF do not accurately represent inflammatory processes in the brain due
to the significant cross talk that occurs between the plasma and the CSF at the site of the
blood-CSF barrier in the choroid plexus (Engelhardt and Sorokin, 2009). However, a
seminal study published by Setiawan et al. in 2015 demonstrated for the first time that
patients with major depressive disorder exhibit increases in activated microglia, the innate
immune cells of the brain (Setiawan et al., 2015). This study suggests that depression is
indeed associated with increased inflammatory potential in the brain. Importantly, similar
inflammatory profiles have also been described in patients with PTSD (Wang and Young,
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2016), suggesting that disruptions in the inflammatory system are common features of
stress-related mood disorders and is not isolated to depression.
Enhancements of the inflammatory system have also been reported using social
defeat in rodents. In general, it has been shown that defeat-induced depressive-like
behaviors in rodents is not only associated with enhanced release and transcription of
cytokines (Powell et al., 2013) but also results in an increase in the number and reactivity
of peripheral macrophages (Wohleb et al., 2012; Wohleb et al., 2014b). These peripheral
macrophages have the potential to traffic to the brain where they have been suggested to
contribute to neuroinflammation (Wohleb et al., 2012; Wohleb et al., 2014b). Just as coping
during stress has been shown to drive susceptibility to subsequent behavioral deficits,
coping has also been shown to differentially affect stress-induced inflammation. Our group
has specifically shown that adoption of passive coping behaviors during defeat and
resulting depressive-like behaviors were associated with significant increases of IL-1b
within the LC 24 hours after the final social defeat exposure (Wood et al., 2015). Notably,
these effects were absent in rats demonstrating active coping during the defeat exposure
and subsequent behavioral resilience (Wood et al., 2015). This particular study further
demonstrated that the defeat-induced inflammatory profile of the LC was not ubiquitous
throughout the brain and was not specific to IL-1b. In this regard, concentrations of IL-1b
in the DR were significantly reduced following social defeat. Moreover, analysis of
monocyte chemoattractant protein (MCP)-1 in these same tissues indicated that while this
cytokine exhibited similar protein profiles to that of IL-1b in the DR, social defeat did not
alter MCP-1 concentrations in the LC (Wood et al., 2015).
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1.6 Stress-induced inflammation as a putative mechanism in the pathogenesis of
mood disorders
The studies discussed thus far have clearly demonstrated a relationship between
inflammation and depression. However, inflammation is not just a physiological
consequence of stress exposure that correlates with behavioral dysfunction. Over the last
decade, strong evidence has been collected that directly implicates inflammation in the
pathogenesis of depression. Some of the first lines of causal evidence in humans resulted
from clinical studies administering cytokines for the treatment of cancer, viral hepatitis,
and autoimmune disorders (Pinto and Andrade, 2016). The interferon (INF) superfamily
has long been utilized in these studies for their antiviral, antiproliferative, apoptotic, and
immunomodulatory effects (Rizza et al., 2015; Pinto and Andrade, 2016). However, these
treatments are frequently associated with the emergence of depression in approximately
30-70% of patients (Schaefer et al., 2012) and demonstrate peak depression-inducing
effects at approximately 4-16 weeks of treatment (Ehret and Sobieraj, 2014). While it is
difficult to discern whether these depression-inducing effects are due to the administration
of these treatments, as a result of these illnesses, or a combination of both, it has been
demonstrated that anti-inflammatory treatments can exert anti-depressive efficacy.
Specifically, a study conducted by Raison et al in 2013 demonstrated that infliximab, a
TNF-a inhibitor, could produce remission in depressed patients who previously
demonstrated resistance to traditional anti-depressants (Raison et al., 2013). Importantly,
this study determined that this particular subgroup of patients were admitted to the study
with high baseline CRP concentrations in the plasma (Raison et al., 2013). Other groups
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have demonstrated similar findings (Mehta et al., 2013; Kopschina Feltes et al., 2017),
providing clear causal evidence for the involvement of inflammation in depression.
The putative contribution of inflammation in the onset of depressive-like behaviors
has also been demonstrated in rodent studies. For example, a study by Hodes et al.
illustrated that bone marrow transplantation from susceptible rats induced in susceptibility
in otherwise resilient mice (Hodes et al., 2014). Others have demonstrated that behavioral
resilience can be induced by genetic removal and knockdown of the IL-1 receptor (Wohleb
et al., 2014b). Finally, our group has demonstrated that daily infusion of an IL-1 receptor
antagonist 30 minutes prior to the onset of defeat inhibited the emergence of depressivelike behaviors in passive coping rats (Wood et al., 2015).

1.7 The impetus for this work
Extraordinary effort has been exerted by numerous individuals, labs, and research
groups to understand the mechanisms by which stress promotes the emergence of
depressive- and anxiety-like behavioral dysfunction. Moreover, studies in humans and
rodents alike have suggested that targeting the inflammatory system may represent a viable
and yet untapped therapeutic option for the treatment of these disorders. However, there
is still much that we do not know:
1. While stress is known to result in complex dysregulation of the inflammatory
system, what specific cytokines are implicated? How broad are these inflammatory
effects? How do stress-induced inflammatory profiles differ between the periphery
and the brain and how do they differ between brain regions?
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2. Similarly, we know that stress can promote the activation of the inflammatory
system, but it remains unclear which systems contribute to this activation and how
this relates to the aforementioned stress-induced inflammatory profiles.
3. Lastly, it is still unknown how stress-induced inflammation ultimately promotes
depressive- and anxiety-like behaviors. Are these direct effects of cytokine
signaling? Or are these effects due to secondary shifts in distinct neurotransmitter
systems, receptors, and intracellular signaling cascades?
The goal of all of the work described in the following chapters has been designed to answer
these specific questions. By understanding the “what”, “why”, and “how” underlying
stress- and inflammatory-induced behavioral dysfunction, it will be more plausible to
develop

targeted

therapeutics

for

those

pharmacotherapies.
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exhibiting

resistance

to
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Chapter 2
General Methods
While the work described in each of the subsequent chapters has unique aims and
foci, there are several methods that were held constant throughout these studies. The
purpose of this chapter is to outline these specific methods thereby eliminating repetition
of otherwise superfluous information. Any deviations from the core methods detailed here
are noted in the appropriate subsections in the subsequent chapters.

2.1 Care and use of animals
In order to determine the broad consequences associated with social defeat
exposure, the use of freely moving, fully intact animals was required. Based on a previous
study conducted by our group (Wood et al., 2010), a minimum of 8 rats is required in each
stress x coping x treatment group in order to accurately identify individual differences.
Every attempt was made to minimize the number of animals required for the completion
of a particular study. Further, great care was taken to alleviate discomfort and eliminate
pain for all of the procedures conducted in these studies. Aseptic techniques during surgery
were strictly enforced to minimize possible exposure to infection and all surgeries were
conducted under general anesthetic. The analgesic Flunixin (2.5 mg/kg; Henry Schein;
Melville, NY) and dietary support of Bacon Softies (Bio-Serv; Flemington, NJ) and Diet
Gel (Clear H2O; Portland, ME) were administered on the day of surgery and 24 hours
following surgery to minimize discomfort from surgical procedures. The care and use of
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animals in these studies was approved by the University of South Carolina’s IACUC and
were maintained in accordance with the Animal Welfare Act, the DHHS “Guide for the
Care and Use of Laboratory Animals”, and the NIH guidelines for the Care and Use of
Laboratory Animals. Veterinary care was under the direction of a full-time resident
veterinarian boarded by the American College of Laboratory Animal Medicine. Additional
veterinary staff and technicians were also available and provided a complete
comprehensive program of diagnostics, preventive, and clinical medicine at our facilities.
Use of social defeat required 2 distinct rodent populations: “residents” and
“controls”/ “intruders”. Our resident colony consisted of Long-Evans retired breeders
(650-850g; Charles River, Durham NC). Prior to inclusion in the study, each resident was
carefully screened for his aggressive tendencies. Inclusion criteria consisted of (1)
exhibiting an attack latency of less than 60s, (2) total number of attacks ³ 4 within the first
5 minutes of exposure, and (3) effective attacks that did not result in injury. Any rats that
did not meet these criteria or those whose behaviors became unpredictable or overly violent
were excluded from these studies and were subsequently euthanized using CO2. In each of
these cases death was verified via induction of a bilateral pneumothorax. All of the
behavioral, molecular, and cardiovascular analyses conducted in these studies were
collected from our “control”/ “intruder” population which exclusively consisted of male
Sprague Dawley rats (225-250g; Charles River, Durham NC).
Residents, controls, and intruders were maintained on a standard 12-hr (7am-7pm)
light/dark cycle with ad libitum access to water and standard chow. Importantly, these
rodent groups were individually housed. This particular housing method was chosen as
group housing in the context of stress can be subject to social buffering (Kikusui et al.,
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2006). Social buffering is a process by which a familiar conspecific mitigates and in some
cases completely eliminates the behavioral and physiological responses to stress (Kikusui
et al., 2006). As these behavioral and physiological responses to stress are critical in the
studies conducted within, social buffering represents a significant confound in the study of
stress. In addition to concerns regarding the effectiveness of social defeat exposure in our
“control”/ “intruder” group, there were concerns that group housing of “residents” would
not only affect resident behavior but could also lead to significant injury resulting in the
needless loss of animal life.

2.2 Social defeat and control manipulations
The resident-intruder paradigm of social defeat was utilized for the completion of
all of the studies discussed in the following chapters. For these particular studies, the male
Sprague Dawley rats were randomly assigned into “intruder” and “control” groups. Social
defeat and control manipulations for each of these studies were conducted for 30 minutes
on 5 consecutive days. Rats classified as “intruders” were placed into the home cage of a
novel Long-Evans retired breeder. After a short period of investigation, the resident would
initiate a cascade of attacks. Residents and intruders were allowed to physically interact for
a maximum of 15 minutes or until the intruder exhibited a supine submissive posture,
whichever came first. At this point, residents and intruders were separated with a perforated
Plexiglas partition for the remainder of the 30-minute defeat exposure. Notably, this
separation still allows for olfactory, visual, and auditory contact with the resident but does
not allow for physical interaction. Rats classified as “controls” were placed in a novel cage
behind a perforated Plexiglas partition for the entire 30-minute period on each day.
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Importantly, “control” rats were not in the room during the time of social defeat in order to
avoid potential confounds from stress-induced ultrasonic vocalizations and pheromones.
For a more detailed discussion of the resident-intruder paradigm, please refer to Chapter 1:
“Modeling social stress and coping in rodents”.

2.3 Quantification of during defeat behaviors
In order to determine specific drug effects and for the accurate separation of
intruders into active and passive coping subpopulations social defeat exposures on day 1
and 5 were video recorded. These recordings were subsequently analyzed to determine the
duration of time that each intruder spent in upright defensive positions. These data were
hand scored by an experimenter blinded to each rats treatment designation. These
recordings were further utilized to validate notes taken during the defeat exposure
regarding the total number of attacks as well as the amount of time required for the intruder
to exhibit submission (defeat latency).

2.4 Determination of anhedonic-like behaviors
Anhedonia (i.e. reduced enjoyment of otherwise pleasurable stimuli) is a core
feature of depression (Gorwood, 2008) and has been described in a number of other mood
related disorders such as schizophrenia (Andreasen and Olsen, 1982; Blanchard et al.,
2001), substance abuse (Ahmed and Koob, 1998; Volkow et al., 2002), and PTSD (Frewen
et al., 2012). In rodents, the emergence of depressive-like anhedonic behaviors have been
primarily evaluated with the use of the two-bottle sucrose preference test. In this test, rats
are given free access to either 1% sucrose or water. Both bottles are weighed periodically
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and the preference for sucrose is calculated as the volume of 1% sucrose consumed divided
by the total volume of water and 1% sucrose consumed (Grillo et al., 2014; Eagle et al.,
2016). Our group has previously shown that exposure to social defeat results in a significant
reduction of sucrose preference selectively in rats demonstrating a passive coping
phenotype during defeat (Wood et al., 2015). In contrast, controls and active coping rats
demonstrated normal sucrose preference of approximately 90-95% (Wood et al., 2015).
Importantly, sucrose preference represents a relatively non-invasive measure of
depressive-like behavior. This is of particular importance as other widely used measures
of depressive-like behaviors in rodents such as the forced swim test, an acute inescapable
stress, often result in robust activation of the inflammatory system (Altenburg et al., 2002;
Llorens-Martin et al., 2016).
Based on the ease, utility, and non-invasive nature of this behavioral assay,
depressive-like behaviors in the studies described in the subsequent chapters were
determined using the sucrose preference test. Since rats are naturally neophobic to both
novel objects (Ennaceur et al., 2009) and food (Modlinska and Stryjek, 2016; Stryjek and
Modlinska, 2016), successful completion of the sucrose preference test requires some
degree of training. At 9 am, 48 hours prior to testing, a second bottle with filtered water is
placed into the cages of each rat. On the following day at 9 am, the bottles of each rat are
emptied, and filled with a 1% solution of D-sucrose (Fisher Scientific; Waltham, MA) in
filtered water. The inclusion of this two-day training period allows the rats to first become
accustomed to the presence of the second water bottle and secondly to become familiar
with the taste of the 1% sucrose solution. In addition to this pre-test training period, water
deprivation on test day has also been shown to be critical in the overall success of the
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sucrose preference test (Cohen and Burtt, 1979). Our group begins water deprivation at
9am on test day.
Ten hours later at 7 pm, the time of lights out, the sucrose preference test begins.
Labeled bottles containing 1% sucrose and water are weighed, recorded, and placed into
the cages of each rat. At 8 pm, both bottles are briefly removed, weighed, recorded, and
placed back into the appropriate rats cage. Importantly, during this weighing the position
of the water and sucrose bottles are switched to ensure that the exhibited hedonic effects
are not due to a rats innate side bias (Castellano et al., 1987; Andrade et al., 2001). Water
bottles are weighed a final time at 10 pm. Following this final weighing, a single bottle
containing filtered water is placed into the cage of each rat. Great care is taken during each
of these times to minimize the disruption caused by the experimenter. To accomplish this
all work is conducted under red light and noise is kept to a minimum (i.e. no talking, gentle
insertion of water bottles, and movements of cage lids).

2.5 Euthanasia and tissue collection
The timepoint at which tissue was collected varied for each study discussed in the
subsequent chapters. Each chapter has an associated study design which clearly indicates
the day of tissue collection. Although the timepoint varies due to differences in the overall
goals of each study, the methods by which tissues were collected did not differ. On the day
of tissue collection, rats were lightly anesthetized with Isothesia Isoflurane (Henry Schein;
Melville, NY) prior to uniform instantaneous decapitation with a Guillotine. This method
of euthanasia was selected as it is in accordance with the recommendations of the Panel on
Euthanasia, AVMN (JAVMA 188:252, 1986). At this time, hearts, brains, adrenals, spleen,
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and blood were collected. Brains were blocked into anterior and posterior sections, flash
frozen with 2-Methylbutane (Acros Organics, Morris, NJ), and stored at -80oC. Spleens
and adrenals were cleaned of excess fat and tissue, weighed, and discarded. Blood was
centrifuged at 4oC for 15 minutes at a speed of 3200 rpm. The resulting plasma was
collected, transferred to microfuge tubes, and stored at -80oC.

2.6 Collection, verification, and homogenization of the CeA, hippocampus, LC, and
DR tissue
Each of the studies discussed in the subsequent chapters required collection of the
CeA, hippocampus, LC, and/or DR. Similar to tissue collection, the specific brain regions
collected for subsequent analysis varied between the studies discussed hereafter based on
the overall goal of that particular study. However, the methods by which these brain areas
were collected and homogenized did not differ. Across all studies, frozen anterior and/or
posterior brains were sliced using a Leica CM3050 S Research Cryostat. The cryostat was
kept between -15 and -20 oC to facilitate minimal tissue thawing during the slicing process.
Flash frozen brains were transported and temporarily stored on dry ice during the slicing
process. To ensure that brains would not shred during the slicing process, each brain was
removed from the dry ice and placed into the cryostat for approximately 1 minute.
Following this 1-minute temperature equilibration, brains were embedded in O.C.T.
compound (Fisher Scientific; Waltham, MA) to facilitate slicing.
Frozen anterior brains were coronally sliced until reaching the most rostral level of
the CeA (Bregma -1.72 ) and the hippocampus (Bregma -2.92) in accordance with the Rat
Brain Atlas by Paxinos and Watson (Paxinos and Watson, 2007). In a similar fashion,
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posterior brains were sliced until the most caudal level of the LC (Bregma -10.8) and DR
(Bregma -8.40) (Paxinos and Watson, 2007). These specific brain regions were isolated
and removed using a 1 mm wide tissue biopsy punch (Harvard Apparatus; Holliston, MA).
The entirety of the CeA, hippocampus, and LC were obtained using a depth of 1 mm, while
DR acquisition required a 2 mm depth. Punches were placed into a chilled and labeled
Safe-Lock microfuge tube and stored at -80oC. Importantly, punch placement was
histologically verified. To achieve this, 30 µm thick slices were collected and mounted
onto Superfrost Plus Microscope Slides (Fisher Scientific; Waltham, MA) immediately
prior to and following punch acquisition. Slides were then submerged in a solution of
neutral red (Fisher Scientific; Waltham, MA) for 5 minutes. After staining, the slides were
rinsed, and subsequently dehydrated with 1-minute submersions into baths containing
75%, 95%, and 100% ethanol. Dehydrated slides were then fixed using Histo-Clear
(National Diagnostics; Atlanta, GA). Following a 24-hour drying period, slides were cover
slipped and evaluated. Any samples that were deemed inaccurate based on this verification
method were not included for subsequent tissue analysis. Images of the Paxinos and
Watson Brain Atlas used for reference in these studies and examples of pre- and post-punch
slices are depicted in Figure 2.1.

2.7 Tissue Homogenization
All of the analyses conducted in the CeA, hippocampus, LC and DR required
homogenization of the collected tissue punches. Homogenization is a process used to
disrupt tissue and break open cell membranes, resulting in the release of the cellular
contents. There are a number of ways in which homogenization can be completed, however
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these methods can all be classified as either a chemical or physical disruption. A chemical
homogenization process typically includes some kind of detergent or emulsifier which
breaks down the phospholipid bilayer of a cell. In contrast a physical approach, such as use
of a sonicator or mortar and pestle, uses direct physical or mechanical force. Each of these
approaches has their inherent advantages and disadvantages. For example, use of
detergents high in Sodium Dodecyl Sulfate (SDS) can interfere with a number of assays
including a simple Bradford protein assay (Friedenauer and Berlet, 1989). In contrast,
physical disruption has been associated with denaturation and coagulation of proteins (Ye
et al., 2017). In order to avoid some of these issues, many groups, including ours, use a
combination of chemical and physical disruption.
For the purpose of homogenization, collected tissue punches were thawed on ice.
Mechanical disruption was accomplished using Zirconium oxide beads (ZrOB05, 0.5mm
diameter; Next Advance; Troy, NY). Beads were added to the tissue punches as outlined
in Table 2.1. After addition of the beads, a lab made lysis buffer was added to each sample
as outlined in Table 2.1. The lysis buffer contains 137mM sodium chloride, 20mM Tris,
1% Igepal (NP-40), 10% Glycerol, and 1x protease and phosphatase inhibitor cocktail
(Thermo Scientific, Waltham MD). Samples were then placed into a Bullet Blender (Next
Advance, Troy, NY) and physical disruption occurred at 4oC for 3 minutes on a speed of
8. For studies in chapters 3 and 4, samples were immediately transferred to a microfuge
(stored at 4oC) and centrifuged at 14000 rcf for 15 minutes. The resulting supernatant was
carefully removed and transferred to a new labeled microfuge tube. For studies in chapter
5, homogenates were transferred to a new microfuge tube prior to centrifugation in order
to remove the zirconium oxide beads. These samples were then centrifuged as described
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above. The supernatant was again transferred to a new labeled tube and the resulting pellet,
containing the containing the cell membranes, some organelles, and cellular debris, were
resuspended. This small shift in protocol was chosen specifically for chapter 5 as this study
required the analysis of several membrane bound proteins. Membrane bound proteins were
not studied in chapters 3 and 4 and therefore did not require this additional step.
The final step the tissue homogenization protocol is the determination of protein
concentration. This is most commonly completed with the use of a Bradford Assay. The
Bradford assay is a colorimetric analytical procedure in which is based on an absorbance
shift in Coomassie Brilliant Blue dye (Ninfa et al., 2009). The particular kit used by our
group (Pierce BCA Protein Assay Kit, Thermo Scientific; Waltham MA), utilizes a neutral
(green) variant of this dye. The dye readily forms strong non-covalent bonds with carboxyl
groups found within the chemical structure of the amino acids that comprise a protein. It is
the bonding of the dye to amino acids that visually result in a shift in color. Typically,
samples with more protein, and therefore more amino acids, will have a much more
dramatic shift in color and will generally appear darker. In addition to a shift in color, there
is a dramatic shift in absorbance. The unbound dye is well characterized to have exhibit a
maximum absorption of 465 nm. Once it is bound to protein, the maximum absorbance
shifts to 595 nm. It is this dramatic shift in absorbance that allows for the accurate and
precise determination of protein concentrations within a sample.
As previously mentioned, our group uses the neutral (green) variant of this dye. In
order to determine protein concentration, 12 µL of resulting homogenate are added to 48
µL of phosphobuffered azide. These samples are briefly vortexed to ensure proper mixture
and 25 µL of the resulting solution is pipetted onto a 96 well plate in duplicate. 200 µL of
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the proprietary dye solution (Working Reagent, Thermo Scientific, Waltham MA) is then
added to each well and allowed to incubate for 30 minutes at 37oC. After this 30-minute
incubation, absorbance of this plate is read using a Synergy 2 Multi-Mode Plate Reader
(Bio Tek, Winooski VT).

2.8 Bio-Plex
The primary data in chapters 3,4, and 5 were generated using a relatively new assay
that allows for simultaneous detection of multiple different substrates within one sample.
These assays are sold as kits by various companies including Bio-Rad (Bio-Plex) and
Millipore (Milliplex). Whether it is the detection of cytokines (Chapters 3 and 4) or cellular
signaling proteins (Chapter 5), these assays utilize the same general scientific principles
that are similar to a traditional Sandwich ELISA. Sandwich ELISAs have been utilized for
the better part of a century for the detection and quantification of a variety of targets. This
particular assay format captures antigens (target protein) between two antibodies termed
the capture and detection antibodies. Capture antibodies are bound to the bottom of a plate
or a net well. When the sample is added, the target proteins bind to this capture antibody.
A secondary antibody is then applied to each well. This secondary antibody functions to
increase specificity and also has a specialized protein tag. Typically, this protein tag is the
binding site for a fluorescent tag or a color changing enzyme. It is this layered binding that
gives the Sandwich ELISA its characteristic name. The Bio-Plex functions in a very similar
manner. However, instead of having the capture antibody bound to the bottom of the plate,
they are bound to magnetic beads. Each magnetic bead is coated with a specific antibody
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that can be sorted based on fluorescence. It is this specificity and sorting that allows for the
creation of bead mixtures to quantify a number of protein targets within the same sample.
Based on the utility of this assay method, Bio-Plexes were used in each of the
studies discussed hereafter. However, due to variability in the analytes utilized, a brief
discussion is provided in each chapter regarding the specific protein targets included on the
Bio-Plex kits as well as the protein concentration that was loaded for each kit. While some
things varied between studies, the general equipment utilized for the completion of these
studies did not differ. Specifically, all 96-well plates were washed using a Bio-Rad BioPlex Pro II Wash Station (Hercules, CA) and were read using the Bio-Rad Bio-Plex
Luminex SD system (Hercules, CA).

2.9 Statistics
Data collected in each of the studies discussed in chapters 3-5 were statistically
analyzed to determine specific effects of stress and drug manipulation on target outcomes.
Prior to statistical analysis, all data sets described in Chapters 3-5 were analyzed using a
combination of 2x standard deviation and Modified Thompson Tau. The Modified
Thompson Tau test is a particular method of outlier analysis that provides a more specific
approach by incorporating sample size and standard deviation to determine the presence or
absence of outliers. In this way the Modified Thompson Tau test is a more flexible
approach compared to other methods of outlier analysis such as 2x standard deviation. In
the current studies, values that exceeded two-times standard deviation were automatically
excluded from all group analyses. Values flagged by the Modified Thompson Tau analysis
were further evaluated for the presence of false positive results. Any values that were
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deemed to have been marked from a false positive result were not excluded from group
analyses as these values were not considered to be true outliers.
There were three main types of statistical analyses conducted throughout these
studies: t-test, One-, and Two-Way ANOVAs. Standard t-tests were utilized for data sets
which directly compared behavioral or molecular responses in two specific groups.
Importantly, these analyses were only applied to data sets to determine if the mean
responses differed to a single variable (i.e. stress only or treatment only). In instances where
a single variable was compared across 3 groups, a One-Way ANOVA was utilized.
Determination of the effects of stress and treatment (2 variable analysis) prompted the use
of a standard Two-Way ANOVA. Similarly, analyses to determine the effects of stress,
treatment, and time as it pertained to cardiovascular measurements (3 variable; Chapter 5)
were subjected to a standard Three-Way ANOVA. Notably, these ANOVA results were
utilized to determine whether a particular variable produced statistically significant effects
(a=0.05) on the measured mean responses. To evaluate statistical significance between
specific groups (ex. drug defeat vs. vehicle defeat), post-hoc analyses were conducted.
Post-hocs for each study were selected based on sample sizes and group variances.
Specifically, post-hoc analyses in Chapters 3 and 5 were evaluated using the Fisher LSD
post hoc as these data sets had unequal variances, unequal sample sizes, and were largely
unpredictable. In contrast data collected in Chapter 4, were analyzed using the Holm-Sidak
post-hoc analysis to account for unequal sample variance. All t-tests, ANOVAs, and
subsequent post-hoc analyses were conducted using GraphPad Prism 6 software (La Jolla,
CA).
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Table 2.1 Summary table of tissue punch size, quantity, and volumes of beads and lysis
buffer for homogenization.
Brain Region
CeA
Hippocampus
LC
DR

Punch Size
(L x W x D mm)
1 x 1x 1
1x1x1
1x1x1
1x1x2

# of Tissue
Punches
2
4
2
1
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Bead
Volume (µL)
100
200
100
100

Lysis Buffer
Volume (µL)
200
400
200
200

Figure 2.1 Histological verification of punch placement at the level of the CeA (A),
hippocampus (B), and DR (C). The left most panel depicts the Paxinos and Watson Brain
atlas used as a reference point for punch acquisition. The center panel depicts the prepunch slice obtained immediately prior to punch acquisition. The right most panel depicts
the post punch slice obtained immediately after punch acquisition. Black circles serve as
reference points between each panel to depict ideal punch placement.
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Chapter 3
The “What”: Inflammation as a consequence of social defeat and its
implication in stress-induced depressive-like behaviors

3.1 Introduction
Findings in humans and animals have begun to implicate stress-induced
inflammation in the pathogenesis of depressive- and anxiety-like behavioral states. These
findings have suggested that exposure to stress results in a robust activation of the
inflammatory system. Moreover, several of these studies have detailed the protective
effects of cytokine inhibition in the emergence of behavioral dysfunction following stress
exposure. However, these studies also have major drawbacks. For example, the majority
of studies assessing inflammation as it relates to stress and the emergence of behavioral
dysfunction have focused their attention on one or two cytokines. Based on these narrow
assessments, it is still unclear how broad these stress-induced inflammatory effects are in
the periphery and the brain. Similarly, use of bone marrow transplants (Hodes et al., 2014),
genetic manipulation (Wohleb et al., 2014b), and direct drug infusion into the brain via
permanent intracerebroventricular cannulas (Wood et al., 2015) are invasive or unethical
for use in humans and therefore have low therapeutic translatability.
Several studies have attempted to circumvent these issues by using other injectable
compounds including resveratrol (RSV). RSV is a commercially available non-flavonoid
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polyphenol found in the skin of strongly pigmented fruits and vegetables including red
grapes and berries (Langcake and Pryce, 1976). Several studies in humans and rodents have
suggested that RSV may represent a useful adjuvant for the treatment of a number of
disorders due to its strong antioxidant (Xia et al., 2017) and anti-inflammatory properties
(Falchetti et al., 2001; Donnelly et al., 2004; Fordham et al., 2014). The anti-inflammatory
effects of RSV have been well explored. These studies have demonstrated that RSV
functions to inhibit the production of histamine, cytokines, proteases, and nuclear factorkappa B in several inflammatory cell types including mast cells, macrophages, neutrophils,
and microglia (de la Lastra and Villegas, 2005; Zhang et al., 2010). In addition to these
cellular effects, RSV has clearly been demonstrated to produce anxiolytic (Patki et al.,
2013) and anti-depressive effects (Xu et al., 2010; Ahmed et al., 2014; Hurley et al., 2014;
Solanki et al., 2015) in a number of animal models.
Based on the strong clinical and pre-clinical data implicating inflammation in the
emergence of anxiety- and depressive-like behaviors, it was hypothesized that the
demonstrated behavioral effects of RSV would be directly associated with its antiinflammatory activity in the periphery and the brain. With respect to our social defeat
model, it was therefore expected that RSV would demonstrate anti-depressive effect in rats
exhibiting a passive coping phenotype. Moreover, based on findings in humans that stress
produces a general enhancement of inflammation that is not specific to one cytokine or
cytokine family, it was further hypothesized that social defeat in rodents would produce
similar effects resulting in the enhancement of a number of different cytokines in the brain
and periphery. To test these specific hypotheses, a study was designed as outlined in Figure
3.1.
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3.2 Methods
The methods outlined below represent specific details relevant to this particular
study. Additional methods including the process of social defeat and control manipulation,
sucrose preference, and tissue collection and homogenization are detailed in Chapter 2.

3.2.1 Resveratrol Treatment
For the purpose of this study, trans-resveratrol (Cayman Chemical Company; Ann
Arbor MI) was dissolved to a final concentration of 0, 10, and 30 mg/kg in a solution
consisting of 10% ethanol (Ultra Pure; Darien, CT), 15% Cremophor (Fisher Scientific;
Waltham, MA), and 75% saline (Abbott Laboratories; Chicago, IL). The trans- variant was
chosen as this particular isomer has been shown to be more effective in producing
antiproliferative (Anisimova et al., 2011) and anti-inflammatory effects following
administration (Rius et al., 2010). In addition to enhanced efficacy, the trans- isomer is
chemically more stable (Trela and Waterhouse, 1996) and is naturally more abundant
(Gambini et al., 2015) than the cis- isoform. One major consideration with the use of this
compound is its relatively low bioavailability. Oral administration of either the cis- or
trans- isoforms are rapidly metabolized (Wenzel and Somoza, 2005) and therefore do not
reach the brain (Shu et al., 2015). To circumvent this issue, this study utilized daily
intraperitoneal (i.p) injections. This administration route is very similar to oral
administration as the substances are absorbed by mesenteric vessels which drain into the
portal veins and pass through the liver (Lukas et al., 1971). Importantly, i.p injections have
been shown to result in significant detection of RSV in the brain (Shu et al., 2015). Similar
to oral gavage, these injections in rodents require significantly more handling and

43

temporary restraint during the drug administration process. To ensure that these additional
mild stressors would not skew the results of the study, i.p. drug administration of 0, 10, or
30 mg/kg began a week prior to the onset of social defeat or control allowing all rats to
habituate to the handling and injection process.

3.2.2 Flow Cytometry
Flow cytometry was utilized in this study to determine the effects of RSV on
intracellular cytokine expression following social defeat. In general flow cytometry is a
biochemical method that allows for the sorting, detection, and measurement of physical
and chemical properties of cells. For the purposes of this study, flow cytometry was utilized
to determine the relative inflammatory reactivity in CD4+ splenocytes following
defeat/control and RSV treatment. To this end, spleens were collected on the day of
euthanasia, weighed, and primary splenic cells were prepared. These primary splenic cells
were treated with 2 µg/mL concancavalin-A (ConA; Sigma Aldrich; St. Luis, MO)
overnight at 37oC and 5% CO2 to stimulate immune cell proliferation. Four hours prior to
immunostaining, intracellular trafficking was stopped using Golgi Stop (BD Biosciences;
San Jose, CA) per manufacturer recommendation. All samples were aliquoted to allow for
immunostaining of four individual inflammatory cytokines. The rat FITC anti-CD4 cell
surface antibody or isotype control were added to label T-helper cells (Biolegend; San
Diego, CA). Cell fixation and permeabilization was completed per manufacturer
recommendations with BD cytofix/cytoperm (BD Biosciences; San Jose, CA). The primary
antibodies utilized to label inflammatory cytokines were PE-anti-rat TNF-a (Biolegend;
San Diego, CA), Biotin-anti-rat IL-1b (Abcam; Caimbridge, MA), mouse-anti-rat IL-6
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(Invitrogen; Camarillo, CA), and PE-anti-rat IL-10 (BD Bioscience; San Jose, CA) or
appropriate isotype controls. For antibodies lacking fluorescent labels (IL-1b and IL-6), an
appropriate fluoroconjugated secondary was used (PE-anti-Biotin and PE-anti-mouse;
Biolegend; San Diego, CA). After immunostaining, all samples were stored in BD
cytofix/cytoperm staining buffer and protected from light at 4oC. Analysis of these samples
occurred the following day using the FC 500 Flow cytometry instrument (Beckman
Coulter; Fort Collins, CO).

3.2.3 Bio-Plex
For the purpose of this study, a cytokine Bio-Plex (BioRad; Hercules, CA) was
conducted to determine the concentration of IL-1b, IL-2, IL-4, IL-6, IL-10, IL-13,
granulocyte-macrophage colony stimulating factor (GM-CSF), INF-g, TNF-a, and MCP1. Plasma samples collected at rest on the day of tissue collection were run at a 1:4 dilution
per manufacturer protocol. Based on findings in a preliminary pilot, it was determined that
a final protein concentration of 275 µg/mL or 35 µg of protein is ideal for the detection of
these cytokines in brain homogenates. Based on the large sample sizes, several Bio-Plex
assays needed to be conducted. During the process of obtaining these data, it became
readily apparent that these kits suffer from significant inter-kit variability as shown in Table
3.1. To compensate for this unforeseen effect, data collected from each Bio-Plex assay
were normalized to the vehicle control samples run on that specific plate and expressed as
a percent of vehicle control.
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3.2.4 Additional analysis of putative mechanisms underlying the effects of RSV
In addition to the well documented anti-inflammatory effects of RSV, this
compound has been shown to indirectly affect NE and 5-HT neurotransmitter systems. To
evaluate whether this represents an additional mechanism by which RSV exerts antidepressive-like effects in the context of social defeat, this study included analysis of SIRT1 in the LC and 5-HT content and IDO enzymatic activity in the DR.

SIRT-1. As described in the introduction of Chapter 1, SIRT-1 is an NAD-dependent
deacetylase which inhibits a number of transcription factors. Important for the current
study, SIRT-1 has demonstrated regulatory control over nuclear factor-kappa B (Borra et
al., 2005; Bagul et al., 2015), a factor known to regulate transcription of inflammatory
cytokines (Lawrence, 2009). Importantly, RSV has been shown to reduce SIRT-1 in
microglial cell cultures (Zhang et al., 2017). Based on these data and our previous findings
that social defeat enhances IL-1b in the LC while reducing IL-1b in the DR (Wood et al.,
2015), the current study assessed SIRT-1 protein concentrations in LC homogenates
following defeat and RSV treatment. This was accomplished using a commercially
available SIRT-1 ELISA kit (Abcam; Cambridge, MA) that was run according to
manufacturer protocol.

IDO enzymatic activity. Another major factor that is known to contribute to the onset of
depressive-like behaviors is a reduction in 5-HT. As discussed in Chapter 1, one major
mechanism linked to reduced 5-HT following stress is through enhancements of IDO. IDO
is the rate limiting enzyme responsible for catalyzing tryptophan (Trp), the 5-HT precursor,
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to kynurenine (KYN) (Lestage et al., 2002; Guillemin et al., 2003; Hochstrasser et al.,
2011). Importantly, RSV treatment has been shown to reduce IDO protein and IDOmediated effects (Lin et al., 2017). Based on these data and studies indicating that the raphe
nuclei are the major sites of 5-HT production in the brain, IDO activity was measured in
the DR of socially defeated rats receiving the various doses of RSV.
The assay used in this particular study is an adaptation from that described by Matin
et al. (Matin et al., 2006). The design of this particular assay quantifies IDO activity by
measuring the conversion of its substrate Trp into KYN. Therefore, greater IDO activity is
indicated by increased KYN synthesis. As this was the first time this assay had been used
with tissue homogenates, there were a number of factors that needed to be piloted. It was
first necessary to assess whether endogenous Trp in DR homogenates would result in KYN
synthesis. To this end several practice DR samples were homogenized per the protocol
listed in Chapter 2.7. For this particular pilot study, 100µg of DR homogentates were
diluted in assay buffer in the presence of absence of 200 µM Trp (Acros Organics, Morris,
NJ). The assay buffer consisted of 50 mM potassium phosphate (pH = 6.5; monobasic:
Acros Organics, Morris NJ; dibasic: MP Biomedicals, Solon, OH), 20 mM ascorbic acid
(pH = 7; BDH Lab Depot, Dawsonville, GA), 10 µM methylene blue (Fisher Scientific;
Waltham, MA), and 100 µg/mL catalase (Fisher Scientific, Waltham, MA). Standards were
prepared from 500 µM stock solutions of L-kynurenine (Fisher Scientific, Waltham, MA)
at a concentration of 0, 1, 5, 7.5, 10, 25, 50, 75, and 100 µM in assay buffer. Standards and
samples were incubated at 37oC for 1 hr. After this hour incubation, 80 µL of 1 M sodium
hydroxide was added to each sample and standard, vortexed, and incubated at 60oC for 15
minutes to halt IDO enzymatic activity. Samples were vortexed one final time and 240 µL
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of each sample and standard were added in duplicate to a black clear bottom 96 well assay
plate (Corning Incorporated; Corning, NY). The fluorescence of kynurenine was
determined using an excitation wavelength of 360 nm and emission wavelength of 460 nm
on a Synergy 2 Multi-Mode Plate Reader (Bio Tek; Winooski, VT). This initial pilot
demonstrated that samples stimulated with 200 µM Trp produced a 3.5 fold increase in the
amount of KYN in DR homogenates, a significant increase above unstimulated
homogenates (t(12)=6.3), p<0.0001; Figure 3.2A). Based on these data, it was determined
that endogenous Trp does not greatly contribute to KYN production during the assay and
requires stimulation with exogenous Trp.
With this initial pilot completed, a second pilot was conducted to determine the
ideal concentration of L-tryptophan to use in conjunction with these analyses. This
particular pilot was deemed necessary as the original protocol by Matin et al. was optimized
for cell culture and it was unclear whether those conditions would be ideal for brain
homogenates. In this particular pilot 20 µL of DR homogenate was added to assay buffer
containing 20, 200, 500, and 2000 µM Trp. This pilot was run as outlined above and
concentrations were normalized to BCA assay protein concentrations. The resulting doseresponse curve verified that IDO in the DR had a km of 408 µM Trp or Log km 2.611 (Figure
3.2B). In line with the initial publication (Takikawa et al., 2001), this value was utilized
for the completion of these studies.
The last and final pilot was conducted to determine the optimal volume of brain
homogenate to be used in this assay. For this particular pilot protein volumes of 10, 20, 50,
and 100 µL were utilized for the completion of this assay. Findings from this pilot
determined that IDO activity as a function of DR sample volume was largely logarithmic
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in nature (Figure 3.2C). Notably, variability between samples in this particular pilot
increased as a factor of sample volume: the lowest 10 µL volume was associated with the
lowest variability across 12 samples while the highest 100 µL volume was associated with
the largest variability. Based on these data, it was determined that a volume of 20 µL would
provide good detection with the ability to visualize relative increases and decreases in IDO
activity without resulting in aberrant increases in variability. Based on these crucial pilot
studies, DR homogenates in the current study were run at 20 µL in assay buffer containing
408 µM Trp.

5-HT High performance liquid chromatography (HPLC). HPLC is a widely used
biochemical technique to separate and quantify compounds within a mixture. This
particular technique utilizes high pressures in excess of 1000 pounds to force a mixture of
solvent and sample through a column (Pavia et al., 2007). The resin in the column allows
for particles to bind (Pavia et al., 2007). As the solvent continues to flow through the
column, particles of lower molecular weight and size are eluted off (Pavia et al., 2007).
Larger particles remain bound to the column for longer periods of time. Once these
particles are eluted from the column, they pass through a sample detector (Pavia et al.,
2007). This signal is then amplified and recorded by the computer. Generally the data
collected using this method results in the formation of a curve (Pavia et al., 2007). The
overall concentration of each particle can then be determined by quantifying the area under
the curve (Pavia et al., 2007).
For this particular study, HPLC was utilized to determine the concentration of 5HT in DR homogenates. DR homogenates were spiked with dihydroxybenzylamine to
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serve as an internal standard. These spiked samples were filtered using Amicon Ultra 0.5
mL Centrifugal filters with a molecular weight cut of 3 kDA (Millipore; Billerica, MA).
Filtrates were collected via centrifugation at 16,000 x g for 30 minutes and 4oC. The HPLC
mobile phase consisted of 90 mM sodium phosphate monobasic, 50 mM citric acid, 1.7
mM 1-octanesulfonic acid, 50 µM disodium ethylenediaminetetraacetic acid (EDTA), and
10% acetonitrile. Stock 5-HT (Sigma Aldrich; St. Luis, MO) was diluted with a lab made
antioxidant solution (350 µL perchloric acid, 200 µL EDTA, 1.3 g sodium bisulfate in 300
mLs deionized water) to a final concentration of 500, 200, 100, and 10 nM. All HPLC data
were normalized to BCA protein values.

3.2.5 Statistics
Statistical analysis was conducted as outlined in Chapter 2. However, in order to
determine individual differences in behavioral responses during defeat, a k-means cluster
analysis of defeat latency was utilized to statistically separate rats into passive and active
coping phenotypes using JMP (Version 10; SAS, Cary, NC) as previously reported (Wood
et al., 2015).

3.3 Results
3.3.1 The effect of RSV on social defeat behavior an anhedonia
Defeat latencies, or the amount of time required for the intruder to demonstrate
behavioral submission, were recorded on each day of defeat and averaged. This average
was utilized to statistically separate rats into passive and active coping phenotypes using a
k means cluster analysis (Table 3.2). Two-way ANOVA analysis of these data sets
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indicated an anticipated effect of coping phenotype such that rats classified as passive
coping exhibited lower defeat latencies compared to their active coping counterparts. In
addition to the effect of coping, this analysis revealed an overall effect of treatment (F(2,39)=
4.4, p<0.05) such that active coping rats treated with 30 mg/kg RSV exhibited overall
higher defeat latencies compared to active coping rats treated with 0 or 10 mg/kg RSV.
While RSV dose-dependently enhanced defeat latency of active coping rats, treatment did
not affect defeat latencies in passive coping rats. To further explore the effects of coping
and RSV on behaviors during defeat, upright defensive postures on day 1 and day 5 were
quantified. In line with our previous findings, upright postures during defeat differed
greatly between coping phenotypes. On both day 1 (F(1,26)=12.6, p<0.01) and day 5
(F(1,28)=12.3, p<0.01; Figure 3.3A) of defeat, rats exhibiting active coping behaviors
demonstrated greater upright postures compared to rats classified as passive coping. Unlike
defeat latency, various doses of RSV did not affect upright posture (F(2,28)=1.3, p=0.3;
Figure 3.3A).
After assessing behaviors during defeat, the emergence of depressive-like
anhedonic behaviors were determined by calculating sucrose preference four days after the
final social defeat exposure. As discussed in Chapter 2.4, sucrose preference is a nonstressful behavioral assay to determine depressive-like behaviors without resulting in
cytokine release (Llorens-Martin et al., 2016). Findings from the current study indicated
that there was a significant stress x treatment interaction (F(4,40)=2.8, p<0.05; Figure 3.3B).
In vehicle-treated animals, sucrose preference was selectively reduced in rats
demonstrating a passive coping phenotype. In line with our previous publication (Wood et
al., 2015), sucrose preference in rats demonstrating an active coping phenotype were
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unchanged from that of rats exposed to the control exposure. Interestingly, treatment with
RSV resulted in a dose dependent increase in sucrose preference in passive coping rats.
However, only the highest, 30 mg/kg, dose completely blocked the development of
depressive-like anhedonia. No significant differences were detected across doses for active
coping rats or rats with a history of control. Importantly, based on the sucrose preference
test conducted prior to the defeat/control exposure, there were no pre-existing differences
between coping (F(2,30)=1.8, p=0.2) or treatment (F(2,30)=1.2, p=0.32) groups nor were there
significant variations in the total volume consumed (stress x coping: F(2, 61)=0.67, p=0.51;
treatment: F(2,61)=1.8, p=0.2).

3.3.2 The effect of RSV on peripheral inflammation
To determine the effects of social defeat on plasma cytokine levels, trunk blood
collected at rest at the time of euthanasia was run on a 10-Plex as previously described.
Bio-Plex analysis of plasma obtained at this timepoint revealed that there were no
significant alterations in cytokine concentrations between stress and treatment groups
(Table 3.3). Although the resting cytokines in the plasma were unaltered, it remained
possible that the peripheral inflammatory system requires stimulation in order to visualize
stress-induced increases in circulating cytokines. Since the spleen is a major site of
initiation of the peripheral immune response, splenic cells were harvested and stimulated
with ConA. Subsequent analysis using flow cytometry confirmed that cytokine production
was indeed enhanced in stimulated splenic cells. Specifically, ConA stimulation resulted
in enhanced expression of TNF-a (Figure 3.4, p<0.0001) and IL-1b (Figure 3.5, p<0.0001)
selectively in vehicle-treated rats demonstrating a passive coping phenotype. Importantly,
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the effects of stress on TNF-a in passive coping rats was completely blocked by treatment
with 10 and 30 mg/kg RSV (Stress x Treatment interaction: F(4,49)=7.0, p=0.0001; Figure
3.4). Similar treatment effects were also evident for IL-1b (Stress x Treatment interaction:
F(4,50)=3.9, p=0.007; Figure 3.5). It is important to note that not all cytokines demonstrated
these trends. For example, splenic IL-6 was not enhanced in either coping group following
stimulation with ConA. However, 30 mg/kg RSV treatment repressed IL-6 in all rats
regardless of stress history (Effect of treatment (F(2,50)=31.8, p<0.0001; data not shown).
In contrast, IL-10 was unaffected by both stress and treatment, further highlighting the idea
that cytokine responses following stress exposure are highly cytokine specific.

3.3.3 The effect of RSV on inflammation in the LC
There was great interest to determine the effects of stress and RSV treatment on
inflammation in the LC at this extended time point, especially given findings in the
periphery. Consistent with previous findings (Wood et al., 2015), cytokine levels at rest 5
days following the final defeat exposure were elevated in the LC of passive coping rats
(Figure 3.6). Specifically, IL-1b (effect of stress group: F(2,58)=10.6, p<0.0001; Figure
3.6A), GM-CSF (effect of stress group: F(2,60)=8.2, p<0.001; Figure 3.6B), and TNF-a
(effect of stress group: F(2,55)=5.2, p<0.01; Figure 3.6C) exhibited stress-induced increases
that were directly dependent of coping style. The present study further determined that
RSV treatment prior to and during social stress exposure significantly blocked stressinduced increases cytokine concentrations within the LC. However, only the 30 mg/kg dose
resulted in complete inhibition of stress-induced inflammation in the LC (effect of
treatment IL-1b F(2,58)=11.0, p<0.0001; GM-CSF F(2,60)=12.0, p<0.0001; TNF-a
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F(2,55)=13.9, p<0001). Similar to findings in the periphery, stress and treatment-induced
cytokine profiles in the LC varied greatly between cytokines. For example, IL-2, IL-6, IL10, and MCP-1 were unaffected by stress (Table 3.4). However, these cytokines were
responsive to RSV treatment such that the 30 mg/kg dose resulted in significant reductions
in these cytokines (effect of treatment: IL-2 F(2,45)=11.3, p<0.001; IL-6 F(2,65)=5.0, p<0.05;
IL-10 F(2,41)=12.6, p<0.0001; MCP-1 F(2,53)=20.3; p<0.0001; Table 3.4). Notably, RSV did
not result in a reduction of all cytokines tested. Specifically, a significant stress x treatment
interaction was evident for IL-4 (F(4,58)=2.5, p<0.05; Figure 3.6D). Unlike all of the other
cytokines measured, IL-4 demonstrated a dose dependent increase in cytokine
concentration such that the 30 mg/kg dose of RSV enhanced IL-4 across all stress groups.
Interestingly, active coping rats were more sensitive to this RSV-induced increase in IL-4
demonstrating a significant enhancement at the 10 mg/kg dose.
In order to determine a putative mechanism by which stress and RSV may result in
these alterations, the concentration of SIRT-1 was assessed in the LC of all stress and
treatment groups. SIRT-1 seemed a likely suspect as it directly regulates nuclear factorkappa B. However, in the present study, there were no differences in SIRT-1 expression
within the LC between control (335.4 ± 12.3 pg/mL, n=5) and passive coping (311.6 ± 10.0
pg/mL, n=6) rats. Furthermore, prior treatment with 30 mg/kg RSV did not alter SIRT-1
expression (control: 302.5 ± 10.0, n=6; passive coping: 308.1 ± 11.1, n=5).

3.3.4 The effect of RSV on inflammation in the DR
Our group has previously reported that social stress results in down regulation of
IL-1b and MCP-1 in the DR (Wood et al., 2015). Consistent with this, in the present study,
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expression of select cytokines were decreased in the DR of socially defeat rats (Table 3.5).
Specifically, stress and RSV treatment produced a significant interaction resulting in
reduced IL-2 (F(4,38)=7.5, p<0.001) and IL-4 (F(4,44)=4.6, p<0.01) expression regardless
of coping style. There was also a general effect of treatment for the remaining 7 analytes
(Table 3.5; IL-1b F(2,42)=12.4, p<0.0001; IL-6 F(2,45)=17.7, p<0.0001; IL-10
F(2,40)=16.9, p<0.0001; IL-13 F(2,43)=13.0, p<0.0001; GM-CSF F(2,40)=4.5, p<0.05;
TNF-a F(2,43)=7.1, p<0.01; MCP-1 F(2,42)=8.3, p<0.001) such that RSV treatment
functioned to lower cytokine levels regardless of stress history. The only exception is IL6, which demonstrated a dose-dependent increase. Treatment effects for IL-6, TNF-a, and
MCP-1, although statistically significant, likely are not biologically relevant due to the
modest changes exhibited by these cytokines. Importantly, while no general effects of
stress were detected for IL-1b and IL-10, vehicle-treated passive coping rats did exhibit
significant reductions of these cytokines within the DR as compared to their control and
active coping counterparts (Table 3.5).
Stress and inflammation are well known to result in a shift in 5-HT metabolism
towards the production of KYN through increased IDO activity (Lestage et al., 2002;
Guillemin et al., 2003; Hochstrasser et al., 2011). Therefore, the present study conducted
an IDO enzymatic activity assay and measured 5-HT levels via HPLC within the same DR
samples that were used to quantify cytokine levels. Using the adapted IDO assay, it was
determined that there were no significant effects of treatment or stress history on IDO
activity levels (Table 3.6). Importantly no differences were determined between vehicletreated control, passive, and active coping groups (F(2,3)=0.3, p=0.8). Subsequent HPLC
analysis of 5-HT concentrations within DR homogenates further indicated that neither
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stress nor RSV treatment produced significant alterations in 5-HT levels at rest 5 days after
the completion of social defeat (Table 3.6).

3.4 Discussion
The findings in this particular study were the first to explore the effects of the
natural anti-inflammatory agent RSV on susceptibility to social stress-induced
inflammation and depressive-like behavior. Moreover, this study was one of the first to
broadly characterize inflammation in the periphery and the LC and DR. Findings from the
current study demonstrated that circulating cytokines were not elevated at rest 5 days after
the final social defeat episode. However, data from stimulated splenic CD4+ T-cells
revealed that socially defeated rats characterized as passive coping did exhibit sensitized
release of IL-1b and TNF-a. This sensitized splenic release was blocked by both doses of
RSV. Unlike findings in the periphery which required stimulation with ConA, long lasting
neuroinflammation was detected under resting conditions selectively in the LC of passive
coping rats. Only the highest dose of RSV inhibited the depressive-like anhedonia and
remarkably, this was also the only dose that completely inhibited LC neuroinflammation
in passive coping rats. These data suggest that LC neuroinflammation plays a key role in
the susceptibility to social stress-induced depressive-like responses. These data also
highlight the importance of differentiating between peripheral and central inflammation.
Furthermore, the contrast between enhanced proinflammatory cytokines in the LC and
suppression in the DR illustrates the brain region specificity of stress-induced changes in
inflammation and further underscores the concept that changes in the plasma may not
represent the state of inflammation in the brain.
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One key feature of the resident-intruder paradigm is that it can produce depressivelike behaviors in rodents (Wood et al., 2010; Gomez-Lazaro et al., 2011; Perez-Tejada et
al., 2013; Hammels et al., 2015; Wood et al., 2015). In the current study, resilient and
susceptible subpopulations were determined using behavioral responses during defeat. In
line with previous findings (Wood et al., 2010; Wood et al., 2015), rats demonstrating
enhanced upright defensive postures during defeat and longer defeat latencies later
exhibited resilience in the sucrose preference test. In contrast, rats demonstrating low
upright defensive postures and short defeat latencies later exhibited susceptibility in the
sucrose preference test. While RSV did not shift the behavioral responses during social
defeat, it was capable of producing a dose-dependent increases in sucrose preference.
These data outlining an anti-depressive potential of RSV has also been reported by several
other groups using pharmacological manipulation (Ahmed et al., 2014), single prolonged
stress (Solanki et al., 2015), genetic models of depressive-like behavior (Hurley et al.,
2014), and the forced swim test (Xu et al., 2010).
Much of what is known regarding the relationship between depression and
inflammation in humans has shown that specific subpopulations of depressed patients
present with enhanced IL-6, TNF-a, and C-reactive protein. Moreover, these protein
concentrations have been positively correlated with symptom severity (Maes et al., 1997;
Musselman et al., 2001; Miller et al., 2002; Alesci et al., 2005; Motivala et al., 2005). In a
previous publication, our group demonstrated that peripheral inflammation was enhanced
24 hours after the final social defeat exposure (Wood et al., 2015). The current study was
aimed at expanding these findings. However, Bio-Plex analysis revealed that circulating
cytokines at rest 5 days after the final social defeat were unchanged from that of controls.
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This is not particularly surprising as many cytokines including TNF-a, GM-CSF, and IL2 reach complete clearance between 25 and 58 hours (Gillies et al., 1993; Foxwell et al.,
1998).
Although resting cytokine levels were normalized 5 days following the final social
defeat episode, data collected from stimulated splenic cells at this same time point indicated
that social defeat did enhance peripheral inflammatory potential selectively in passive
coping rats. These data further suggest that a secondary stress or immune challenge prior
to euthanasia would likely have resulted in a robust stimulation and release of cytokines in
the periphery. This particular phenomenon is often referred to as inflammatory priming. In
general, inflammatory priming refers to the process by which inflammatory responses can
become sensitized resulting in a faster and more robust release of cytokines following a
secondary challenge. There is a vast body of literature demonstrating that inflammatory
priming can occur following stress exposure (Frank et al., 2011; Frank et al., 2012; Weber
et al., 2013; Wohleb et al., 2014a; Fonken et al., 2016). However, the mechanism by which
this occurs is yet unclear.
It has been suggested that one major player in the emergence of inflammatory
priming is the spleen. In normal healthy individuals the spleen functions to recycle old red
blood cells with assistance from the inflammatory cells that naturally reside within the
spleen (Bronte and Pittet, 2013). Additionally, under these conditions, the spleen does not
produce inflammatory cells (Bronte and Pittet, 2013). However, it has been demonstrated
that exposure to stress can shift the function of this particular organ and promote
extramedullary hematopoiesis (McKim et al., 2018). Extramedullary hematopoiesis refers
to the generation of inflammatory cell types that occurs outside of the medulla of the bone.
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In addition to the generation of new inflammatory cells, the CD4+ T-cells found within the
spleen are highly morphologically flexible and can rapidly secrete cytokines into the
circulation upon stimulation (DuPage and Bluestone, 2016). Although the current study
did not determine the relative number of splenic CD4+ T-cells across stress and treatment
groups, the findings regarding ConA-induced stimulation of IL-1b and TNF-a support the
idea that inflammatory cell priming has occurred. Moreover, RSV treatment at 10 and 30
mg/kg was capable of completely inhibiting the exaggerated release of these cytokines
following ConA stimulation, suggesting that this compound is protective against the
peripheral inflammatory effects induced by defeat. However, these data also suggest that
inflammation in the periphery does not directly drive depressive-like behaviors.
If depressive-like behaviors were directly dependent on peripheral inflammation or
peripheral inflammatory potential, rats treated with the 10 mg/kg dose of RSV that exhibit
normal peripheral inflammatory responsivity would also exhibit normal hedonic behaviors.
While this dose did produce a nominal increase in hedonic behavior during sucrose
preference, these values were well below that of control and active coping rats. Hedonic
behaviors following social defeat in passive coping rats only returned to normal control
levels following treatment with the 30 mg/kg dose of RSV. Notably, this dose of RSV was
also the only dose to result in complete inhibition of stress-induced inflammation in the
LC. These data suggest that inflammation in the LC directly mediates the emergence of
depressive-like behaviors. However, it should be noted that increased proinflammatory
cytokines are not necessarily selective for vulnerable phenotypes, but rather are dependent
upon the brain region. For example, De Miguel and colleagues identified greater IL-1b
expression within the hypothalamus of active coping rats (De Miguel et al., 2011).
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Limited information exists on inflammation in the brains of depressed patients.
However, cytokine expression has been found to be increased in the cerebrospinal fluid of
a subset of depressed patients compared with non-depressed controls (Sasayama et al.,
2013; Kern et al., 2014a; Devorak et al., 2015). A recent advance in this field revealed
greater microglial activation in the brains of depressed patients (Setiawan et al., 2015),
demonstrating a potential mechanism for this neuroinflammation. Many parallels have
been found between these studies in humans and neuroinflammatory changes that occur as
a consequence of social stress in rodents. For example, social defeat has been shown to
increase the number of immune competent cells in the brain (Audet et al., 2011; De Miguel
et al., 2011; Wohleb et al., 2012). Importantly, these effects are not isolated to microglia.
Several studies have shown that stress results in a breakdown of the blood brain barrier
(Menard et al., 2017) which allows for peripheral macrophages to penetrate into the brain
(Wohleb et al., 2012; Wohleb et al., 2013; Wohleb et al., 2014a). Although the current
study did not assess the composition of inflammatory types within the LC, the findings
from the current study do suggest that inflammatory potential in the LC is enhanced
following social defeat.
This and other studies have demonstrated the anti-depressant efficacy of RSV.
Findings from the current study and others suggest that a strong mechanism for these
effects are likely driven through its potent anti-inflammatory properties. It has been well
established that inflammation is capable of producing a wide range of effects on neuronal
function. For example, cytokines promote excitability of LC-NE neurons (Borsody and
Weiss, 2004). This effect is likely mediated by activation of the glutamatergic system
(Kamikawa et al., 1998). Notably, exaggerated activation of the LC-NE system is
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associated with the pathophysiology of depression (Wong et al., 2000). Therefore, RSV’s
potent inhibitory effects on neuroinflammation within the LC may inhibit exaggerated
activation of this depressogenic brain region. Alternatively, as identified in the brains of
RSV-treated rats in the present study, RSV has also been shown to increase the release of
the anti-inflammatory cytokine IL-4 in isolated peripheral mononuclear cells (Falchetti et
al., 2001). These data suggest that RSV may also function through the recruitment of
endogenous anti-inflammatory pathways.
In addition to RSV’s potent anti-inflammatory effects, it has also been suggested
to inhibit nuclear factor kappa B through histone deacetylation by SIRT-1 (Borra et al.,
2005; Bagul et al., 2015). In the present study there were no differences in SIRT-1 protein
concentrations between stress and treatment groups. However, it is possible that stress and
RSV treatment could have affected SIRT-1 activity rather than blatantly altering protein
levels. Currently, studies determining a mechanistic basis by which RSV may effect SIRT1 are limited to cell culture (Borra et al., 2005), round worms, and fruit flies (Wood et al.,
2004). These studies have demonstrated that RSV binds to SIRT-1 resulting in a
conformational shift that alters SIRT-1 binding affinity (Borra et al., 2005). Taken together
with the anti-inflammatory effects, it is likely that there are a number of different
intersecting mechanisms underlying the efficacy of RSV in producing anti-depressive
effects.
Distinct from stress effects on neuroinflammation in the LC, it has previously been
reported that social defeat results in downregulation of IL-1b and MCP-1 protein in the DR
24 hours after stress exposure (Wood et al., 2015). Findings from this previous study
demonstrated that these inhibitory effects were more robust in active coping rats compared
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to those demonstrating passive coping phenotypes (Wood et al., 2015). The current study
expanded on these findings showing that these effects are not restricted to these two
particular cytokines. Furthermore, RSV functioned to reduce cytokine expression even
further in this brain region regardless of stress history. These opposing adaptations in
neuroinflammation within the LC and DR indicate the intricate nature of stress-induced
neuroinflammation and highlight the region specificity and temporal regulation of stressinduced neuroinflammatory phenotypes.
Although neuroinflammation in the DR was suppressed following social defeat, it
is known that the DR is also sensitive to proinflammatory cytokines. Stress and cytokines
have both been shown to shift catabolism of 5-HT to KYN through increasing the activity
of IDO (Lestage et al., 2002; Guillemin et al., 2003; Hochstrasser et al., 2011). In the
current study it was hypothesized that stress-induced reductions of cytokines and further
reductions produced by RSV treatment may serve as a protective mechanism to maintain
or increase 5-HT levels in the face of stress. However, in the present study resting levels
of IDO enzymatic activity and 5-HT concentrations within the DR were unchanged. There
are a number of potential reasons for these effects. It is probable that use of Trp
concentrations at the km concentration induced significant variability and could have
masked some of the stress and treatment effects. Therefore, future studies should be
designed to use the vmax, which is estimated to be approximately 800 µM. It is also probable
that while elevated levels of proinflammatory cytokines such as TNF-a and INF-g increase
IDO enzymatic activity (Robinson et al., 2005), reductions in proinflammatory cytokines
below non-stressed/resting levels may not necessarily exhibit regulatory control over IDO
activity. It is also plausible that effects in IDO may occur in close temporal proximity to
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social defeat rather than resulting in long lasting shifts in reactivity. In support of this,
studies evaluating the IDO-KYN pathway at 24 hours after the final social defeat exposure
have successfully indicated that social stress-induced increases in KYN production in the
DR (Fuertig et al., 2016).
From the study described in this chapter, it is clear that RSV may have significant
therapeutic potential based on its broad anti-inflammatory effects in the periphery and the
brain. Moreover, it has been clearly demonstrated that RSV is well tolerated by patients,
even at high doses (la Porte et al., 2010). While there is a lot of preclinical data to support
the use of RSV as an anti-depressive therapeutic, there are several issues that will need to
be addressed before this compound will be seriously considered for the treatment of
depression in humans. The primary issue with this treatment is the lack of mechanistic data.
By all accounts RSV is considered to be a “dirty” drug, affecting multiple systems without
a succinct mechanism of action. In addition to the noted effects on inflammation, oxidation,
SIRT-1, and IDO, RSV has also been shown to inhibit 5-HT and NE (NE) uptake (Yanez
et al., 2006), and inhibit monoamine oxidase activity (Yanez et al., 2006; Xu et al., 2010).
Therefore, understanding how RSV intervenes in stress-induced adaptations within the
brain will be critical in furthering our understanding of RSV’s therapeutic potential.
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Table 3.1 Comparison of average concentrations of cytokines detected over multiple Bio-Plex plates of
vehicle-treated control rats. Significant inter-kit variability was detected ranging from 14-75%CV in the brain
and 47-140%CV in the plasma across cytokines. Therefore, vehicle-treated control rats were run on each plate
and data included in the manuscript data was normalized to percent of vehicle-treated controls run on each
respective plate. Data in the table below are represented as the average absolute concentration in pg/mL ± SEM
for all vehicle-treated rats across multiple plates (2-3 as indicated below).
Plasma: samples run over 2 kits with the same vehicle controls on each.

Control

IL-1b

IL-2

IL-4

IL-6

IL-10

IL-13

GM-CSF

TNF-a

MCP-1

547.4

289.2

104.1

526.8

349.1

117.0

159.4

63.7

893.4

±193.5

±102.3

±36.8

±186.2

±123.4

±41.4

±56.4

±24.1

±515.8

Locus coeruleus: samples run over 3 kits with the same vehicle controls on each.
64
Control

IL-1b

IL-2

IL-4

IL-6

IL-10

IL-13

GM-CSF

TNF-a

MCP-1

11.8

40.5

3.2

14.0

36.7

2.4

24.6

9.4

20.8

±2.2

±5.7

±0.6

±2.8

±7.8

±0.6

±4.3

±1.1

±6.6

Dorsal raphe: samples run over 2 kits with the same standards and vehicle control on each.

Control

IL-1b

IL-2

IL-4

IL-6

IL-10

IL-13

GM-CSF

TNF-a

MCP-1

24.1

64.6

2.3

22.3

95.9

7.3

4.2

9.8

9.8

±0.4

±3.76

±0.02

±0.1

±0.5

±0.2

±0.1

±0.1

±0.2

Table 3.2 Quantification of passive and active coping
phenotypes. K-means cluster designations of defeat latency are
reported as average (s) ± SEM. Post-hoc analysis indicated 30
mg/kg treated active coping rats had significantly higher defeat
latencies compared to 0 and 10 mg/kg treated active coping rats
(* p<0.05).
Dose of RSV

Cluster 1 (Passive)

Cluster 2 (Active)

0

208.7 ± 47.3

651.3 ± 50.4

10

230.3 ± 21.8

702.1 ± 27.2

30

279.9 ± 8.4

853.9 ± 46.2 *
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Table 3.3 Resveratrol and stress do not affect resting plasma cytokine levels. Data expressed as
percent of vehicle (0 mg/kg) control, average ± SEM for control (con), passive coping (PC), and
active coping (AC) groups.
Cytokine
Analyte
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0 mg/kg RSV
Con
PC
AC

10 mg/kg RSV
Con
PC
AC

30 mg/kg RSV
Con
PC
AC

IL-1β

100.0
± 7.6

88.9
± 11.5

86.7
± 1.9

92.7
± 14.8

95.2
± 6.4

74.2
± 5.9

99.7
± 14.8

77.0
± 4.6

84.6
± 8.3

IL-2

100.0 ±
7.2

92.8
± 6.9

99.3
± 4.5

98.0
± 7.1

96.7
± 4.8

84.2
± 7.9

101.6
±5.0

87.7
± 6.5

96.3
± 11.1

IL-4

100.0
± 7.6

96.1
± 4.9

107.4
± 4.1

114.2
± 7.3

97.4
± 1.3

95.0
± 19.5

99.5
± 6.1

77.5
± 4.5

95.7
± 12.0

IL-6

100.0
± 6.5

93.8
± 4.5

103.3
± 4.9

111.9
± 4.5

92.1
± 4.8

84.3
± 14.5

104.7
± 4.9

96.2
± 6.7

104.1
± 7.6

IL-10

100.0
± 6.4

95.9
± 2.2

98.4
± 3.0

105.1
± 5.5

95.2
± 2.9

86.9
± 13.9

100.8
± 5.9

87.2
± 3.6

90.3
± 10.0

IL-13

100.0
± 5.3

94.3
± 7.5

98.7
± 3.6

97.2
± 9.7

98.6
± 4.0

80.0
± 7.6

104.9
± 3.1

90.6
± 4.0

94.8
± 7.2

GM-CSF

100.0
± 9.8

90.2
± 8.3

92.3
± 1.4

90.6
± 6.6

86.4
± 7.3

73.3
± 14.4

103.8
± 4.7

82.3
± 3.0

80.7
± 10.9

TNF-α

96.7
± 6.0

102.0
± 6.8

100.6
± 5.6

108.8
± 8.6

97.5
± 3.2

83.0
± 7.3

97.6
± 5.3

84.7
± 8.5

80.9
± 6.5

Table 3.4 Resveratrol dose dependently decreases neuroinflammation in the LC. Social
stress exposure did not alter the expression of IL-2 (3A) or IL-6 (3B) but did alter cytokine
release of IL-10 (3C) and MCP-1 (3D) within the LC. Treatment with 30 mg/kg RSV reduced
all cytokine concentrations within the LC. Data expressed as percent of vehicle (0 mg/kg)
control, average ± SEM for control (con), passive coping (PC), and active coping (AC)
groups. ƒp<0.05 vs. passive and active; αp<0.05 vs. control and passive; σp<0.05 vs. control
and active
Cytokine
Analyte
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IL-2
IL-6
IL-10
MCP-1

0 mg/kg RSV
Con
PC
AC

10 mg/kg RSV
Con
PC
AC

30 mg/kg RSV
Con
PC
AC

93.9
± 11.1
98.3
± 3.6
99.8

90.1
± 6.8
102.3
± 10.7
115.2
± 14.4

61.5
± 7.2
88.5
± 7.3
103.6
± 4.8

66.2
± 1.0
88.9
± 8.5
96.6
± 7.2

± 14.8α

95.1
± 9.7

66.7
± 13.0

58.1
± 9.4

56.1
± 32.1

± 4.2ƒ

76.4
± 12.1
96.6
± 5.5
127.7
± 1.2

85.1
± 7.7
94.1
± 2.1
123.8
± 3.6

90.2
± 6.3
98.1
± 4.6
97.4
± 4.5

108.2
± 8.4

110.0
± 7.3

102.5
± 6.2

95.2
± 3.5

105.3
± 2.9
99.5
± 3.9
110.5
± 3.1
120.4
± 2.5σ

54.8
± 1.8
69.9
± 6.2
67.6

Table 3.5 Stress and resveratrol reduce cytokine expression in the DR. RSV treatment reduced cytokine
expression in a dose dependent manner. Furthermore, a history of social defeat stress reduced cytokine
expression of IL-1β, IL-2, IL-4, and IL-10. Data are expressed as percent of vehicle (0 mg/kg) control
(average ± SEM) for control (Con), passive coping (PC), and active coping (AC) groups. ƒp<0.05 vs. 0 mg/kg
Con + AC; #p<0.01, * p<0.0001 vs 0 mg/kg Con
Cytokine
Analyte

0 mg/kg RSV
Con
PC
AC
100.0
87.6
96.1
±1.7
±2.5ƒ
±3.3

10 mg/kg RSV
Con
PC
AC
91.8
95.6
101.1
±4.1
±1.3
±5.0

30 mg/kg RSV
Con
PC
AC
86.4
83.6
81.6
±4.4
±2.4
±1.1

IL-2

96.3
±4.8

70.4
±2.7*

74.8
±3.7*

77.0
±4.1

81.9
±0.9

87.7
±2.3

66.8
±4.6

64.9
±1.3

62.0
±2.1

p<
0.0001

IL-4

100.0
±1.0

88.6
±2.1#

90.7
±2.3#

90.8
±1.5

95.4
±2.3

95.5
±2.1

81.5
±1.7

83.2
±1.4

80.0
±1.6

p<
0.0001

IL-6

100.0
±0.4

102.3
±0.6

102.0
±0.7

101.8
±0.7

101.0
±0.5

100.9
±0.8

104.0
±0.5

103.8
±0.4

104.4
±0.5

p<
0.0001

IL-10

100.0
±0.6

91.0
±1.2#

94.6
±2.6

95.8
±1.6

96.6
±1.5

95.7
±2.4

86.3
±1.2

88.2
±1.0

88.1
±2.0

p<
0.0001

IL-13

100.0
±2.7

97.4
±1.2

101.6
±2.0

98.7
±2.2

102.4
±2.2

105.3
±2.1

94.5
±2.8

94.4
±1.2

91.3
±1.1

p<
0.0001

GM-CSF

100.0
±1.6

82.7
±6.4

96.6
±5.8

104.2
±10.3

93.7
±5.9

114.5
±17.3

85.3
±5.2

83.1
±7.1

83.7
±4.1

p < 0.05

TNF-α

100.0
±0.9

98.6
±0.4

98.3
±1.2

98.6
±0.5

98.7
±1.1

99.9
±1.4

95.9
±0.3

96.4
±0.8

96.7
±0.5

p < 0.01

MCP-1

100.0
±0.9

98.7
±0.9

98.3
±1.2

98.6
±0.5

98.7
±1.1

99.9
±1.4

94.9
±1.0

96.4
±0.8

96.7
±0.5

p < 0.001

IL-1β

Tx Effect
p<
0.0001
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Table 3.6 Resting IDO and 5-HT concentrations in the DR. Data are expressed as average ± SEM of
control (Con), passive coping (PC), and active coping (AC) groups.
0 mg/kg RSV

10 mg/kg RSV

30 mg/kg RSV
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Con

PC

AC

Con

PC

AC

Con

PC

AC

IDO Activity

0.137

0.127

0.307

0.138

0.185

0.165

0.264

0.331

0.249

(µM Kyn)

±0.026

±0.006

±0.066

±0.035

±0.043

±0.045

±0.124

±0.051

±0.056

pmol/mg

3745 ±

3096 ±

3344 ±

4171 ±

2931 ±

4669 ±

3223 ±

3283 ±

4097 ±

5HT

930

253

471

1031

66

1397

1220

247

1002

RSV/Vehicle Treatment

Tissue Collection

Daily Social Defeat/Control
-7

-2

1
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Pre-stress Sucrose Preference

5

9

10

Post-stress Sucrose Preference

Figure 3.1 RSV study design and timeline. Rats were treated with 0 (Vehicle), 10, or 30 mg/kg RSV for 7 days
prior to the start of social stress and throughout the social stress period (D -7 - D5). Two days prior to the onset of
social defeat or control exposure (D-2) rats were exposed to a sucrose preference test. Sucrose preference was
conducted 4 days after social defeat or control (D9, 7-8pm) and approximately 14 (±2) hours later (D10), all rats
were euthanized.

C.
0.6
0.5
0.4
0.3
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Figure 3.2 IDO assay pilot data. (A) Stimulation of dorsal raphe brain homogenates with 200 µM L-Tryptophan (Trp)
produces a 3.5-fold increase in Kynurenine (KYN) detection over that of 0 μM. (B) Tryptophan dose dependently increased
KYN and demonstrated an km of 408 µM (2.611, dotted line). (C) 20 µL of DR homogenate produced higher IDO activity as
measured by greater KYN production. ****p<0.0001

Figure 3.3 Effects of stress and RSV treatment on behavior. (A)
Active and passive coping rats exhibited distinctly different time
spent in upright posture regardless of treatment (* p<0.05 vs.
within treatment active coping group). (B) Decreased sucrose
preference in passive coping rats was dose dependently blocked
by RSV treatment (** p<0.01 vs. 0 mg/kg control and active
coping, α p<0.001 vs. 30 mg/kg passive coping; β p<0.01 vs. 30
mg/kg passive coping.
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Figure 3.4 RSV decreased expression of the pro-inflammatory cytokine TNFα
following Con-A stimulation in splenic cells of passive coping rats. Data are
expressed as the percentage of total CD4+ cells expressing TNFα. (A, B, C) Data
shown are flow cytometry dot plots from one representative animal in each group
shown. (D) Graph of combined data from all experiments. ƒp<0.0001 vs. control +
vehicle; *p<0.0001 vs. active + vehicle; **p<0.0001 vs. passive + vehicle.
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Figure 3.5 RSV decreased Con-A stimulated splenic IL-1β expression in passive
coping rats. Data are expressed as the percentage of total CD4+ cells expressing IL1β. (A, B, C) Data shown are flow cytometry dot plots from one representative animal.
(D) Graph of combined data from all experiments. ƒp<0.0001 vs. control + vehicle;
*p<0.01 vs. active + vehicle; ** p<0.05 vs. passive + vehicle; *** p<0.01 vs. passive
+ vehicle.
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Figure 3.6 RSV dose dependently reduces neuroinflammation in the LC. Social defeat
resulted in elevated levels of inflammatory cytokines in vehicle and 10 mg/kg RSV
treated passive coping rats as evidenced by increased (A)IL-1β, (B)GM-CSF, and (C)
TNF-α in LC homogenates. Importantly, only treatment with 30 mg/kg RSV
completely blocked social stress induced inflammation in passive coping rats.
Surprisingly, 30 mg/kg RSV also resulted in increased concentrations of antiinflammatory IL-4 (D). Active coping rats were more sensitive to this effect as they
exhibited a significant increase from controls and passive coping rats when treated
with 10 mg/kg RSV. Within treatment comparisons: α p<0.05 passive vs. control and
active; β p<0.05 passive vs. control; γ p<0.05 passive vs. active; ƒ p<0.05 active vs.
control and passive.
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Chapter 4
The “Why”: Determining which immediate stress-induced mechanism
is capable of promoting inflammation

4.1 Introduction
One particularly notable effect discussed in the final paragraphs of Chapter 3 are
the effects of RSV on NE. Depression has long been associated with complex dysregulation
of the NE system (Klimek et al., 1997; Ressler and Nemeroff, 2000; Moret and Briley,
2011; Serafini, 2012). This long history has resulted in the creation of a number of
therapeutics and has resulted in the generation of the monoamine hypothesis of mood
disorders. However, anti-depressive therapeutics that target the NE system take several
weeks of continuous use in order to produce behavioral effects. This has led to the
suggestion that NE may not be the primary mechanism that is involved in the emergence
of depressive-like behaviors. It has been suggested that inflammation may be a more viable
target for the treatment of depression. These suggestions stem from a variety of studies
indicating the therapeutic efficacy of anti-inflammatory agents in producing antidepressive effects. One such study indicated that infusion of infliximab was not only
capable of producing nearly immediate and sustained suppression of inflammation but also
improved depressive-like behavioral symptoms following the second acute injection of this
compound (Raison et al., 2013). Notably, these effects were strongest in patients exhibiting
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treatment resistance and enhanced inflammation at the beginning of the study (Raison et
al., 2013).
While it seems that long term dysregulation of the NE system may be a secondary
effect, it is important to note that NE is well known to regulate the inflammatory system.
In the periphery, NE has been well documented to act on a and b adrenergic receptors on
the cell surface of macrophages and neutrophils to stimulate cytokine release (Flierl et al.,
2009; Li et al., 2015). Moreover, NE signaling through these receptors in the periphery are
capable of augmenting the peripheral immune response to a subsequent immune challenge
(Spengler et al., 1990; Kavelaars et al., 1997; Grisanti et al., 2010). Although less is
understood regarding the inflammatory effects of NE in the brain, it has been reported that
NE does play a distinct role in neuroinflammation (Johnson et al., 2005; Jardanhazi-Kurutz
et al., 2011; Gyoneva and Traynelis, 2013; Bharani et al., 2017) by acting on b adrenergic
receptors on the cell surface of microglia (Johnson et al., 2005).
Notably, separate lines of evidence have demonstrated that stress-induced NE and
inflammatory responses do demonstrate temporal overlap. Studies in humans have
indicated that, in general, NE peaks approximately 20 minutes after the initiation of stress
and remains elevated above that of non-stressed controls for up to 40 minutes (Kuebler et
al., 2013). While this timepoint does not line up with inflammatory responses following an
initial stress exposure which peak at 8-12 hours following stress, this time point does line
up with inflammatory responses following repeated stress (peak concentrations at
approximately 30 min to 1 hour after stress) (Cheng et al., 2015). Taken together these data
suggest that NE and inflammation may represent intersecting mechanisms that may lead to
the emergence of behavioral dysfunction following stress exposure.
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As discussed in Chapter 1, the LC serves as the major source of NE to the brain and
is poised to contribute to peripheral NE through descending projections to sympathetic
spinal nerves (Samuels and Szabadi, 2008; Bruinstroop et al., 2012). Importantly,
inflammation in the LC is known to result in increased activity of the LC (Kurosawa et al.,
2016) presumably resulting in enhanced NE release to LC targets including the periphery,
dorsal raphe (DR) and central amygdala (CeA). These data further suggest that stressinduced NE and inflammation may exist in a positive feedback loop by which activation
of one system potentiates the activation of another which ultimately results in dysregulation
of both systems. Since direct studies assessing the involvement of the NE system in stressinduced inflammation have not been completed, the current study utilized N-(2chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4), a noradrenergic neurotoxin, to
selectively lesion LC NE neurons. Based on the data discussed above, it was hypothesized
that this lesion would prevent social defeat induced inflammation in the periphery as well
as LC projection regions such as the DR and CeA. Moreover, since social defeat is known
to result in inflammatory priming, it was hypothesized that DSP-4 treatment may also
inhibit defeat-induced inflammatory priming in these regions.

4.2 Methods
Similar to Chapter 3, the methods outlined below represent specific details relevant
to this particular study. Additional methods including the process of social defeat and
control manipulation, behavioral quantification, tissue collection, and homogenization are
detailed in Chapter 2. In order to guide discussion of the data and allow for ease of
understanding, a detailed study timeline is presented in Figure 4.1.
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4.2.1 Surgery
For the purpose of this particular study, permanent guide cannulas (22 gauge;
Plastics One; Roanoke, VA) were implanted into the right lateral ventricle. Bregma, or the
intersection between the coronal and sagittal suture of the skull, served as the reference
point for cannula implantation. All cannulas were implanted -0.8 mm caudal and -1.5 mm
lateral from Bregma at a depth of -4.2 mm from the surface of the skull as described in a
previous publication (Wood et al., 2015). All rats received post-surgical analgesia
(Flunixin, 2.5 mg/kg; Henry Schein; Melville, NY) and supportive therapy of Bacon
Softies (Bio-Serv; Flemington, NJ) daily for 48 hours. Importantly, surgical implantation
occurred 10 days prior to the first social defeat exposure. This recovery time was
deliberately chosen as surgical procedures significantly activate the inflammatory system
(Arias et al., 2009). This is to be expected as many of these cytokines provide beneficial
effects at the site of surgery to promote wound healing (Szpaderska and DiPietro, 2005).
Rodents typically reach full recovery between 5-7 days following surgery, during which
time they are closely monitored (Pritchett-Corning et al., 2011). Despite reaching “full”
surgical recovery at 7 days, it has been demonstrated that inflammation following surgery
can last beyond this time. Specifically, a study in Sprague Dawley rats indicated that
cytokines remained elevated for up to 8 days following surgery (Loram et al., 2007).
Therefore, the 10-day recovery period was selected to ensure that latent post-surgical
inflammation did not confound the results of the current study.
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4.2.2

Drug preparation and injection
Seven days prior to the start of social defeat or control manipulation, all

experimental rats (male Sprague Dawley) were randomly assigned into DSP-4 or vehicle
treatment groups. 8 µL, the equivalent of 400 µg, of DSP-4 or vehicle (1% ascorbic acid
in phosphobuffered saline) was infused via the implanted cannula over a period of 3
minutes. This particular dose of DSP-4 was selected as it has been well documented to
reduce NE in LC projection regions by 70% (Sziray et al., 2010). Importantly, DSP-4 does
not destroy LC neurons. Instead, this particular drug specifically functions to deplete NE
by increasing NE release (Bortel, 2014), enhancing NE turnover (Bortel, 2014), and
downregulating tyrosine hydroxylase (Hormigo et al., 2012), dopamine b-hydroxylase
(Wang et al., 2014), and the NE transporter (Wang et al., 2014). In this way DSP-4
functionally reduces NE by depleting NE stores and inhibiting NE synthesis and re-uptake
into the neuron. These cumulative effects of DSP-4 are evident as early as 6 hours after the
injection (Grzanna et al., 1989) and are known to last for up to 40 days (Villani et al., 1996).
Based on the extended duration of DSP-4 efficacy and the 21-day study design, only a
single dose of DSP-4 needed to be administered.
It is important to note that while DSP-4 demonstrates exquisite selectivity of LCNE neurons (Fritschy and Grzanna, 1991), it has been suggested that DSP-4 may also
produce minor depleting effects on serotonin (5-HT) neurons (Jonsson et al., 1981).
Therefore, to protect against these potentially confounding effects, the selective 5-HT
reuptake inhibitor Citalopram was administered at a dose of 10 mg/kg via an intraperitoneal
(i.p.) injection 30 minutes prior to DSP-4 or vehicle infusion. Citalopram was specifically
chosen for this study as it not only demonstrates high selectivity for 5-HT transporters
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(Hiemke and Hartter, 2000) but also has been shown to protect 5-HT terminals when
combined with DSP-4 (Howard et al., 2008). Moreover, the low dose (10 mg/kg) of
Citalopram was selected as this particular dose is known to effectively protect against 5HT depletion without producing potentially confounding behavioral effects (Crowley et
al., 2005; Howard et al., 2008; Tonissaar et al., 2008).

4.2.3 Tissue collection conditions
Validation of study design. In order to visualize whether a history of social defeat stress
(with or without the LC lesion) was capable of producing inflammatory priming, all rats,
regardless of prior stress history were exposed to social defeat immediately prior to tissue
collection. However, it was first necessary to verify that this particular design would allow
for the detection of stress-induced cytokines rather than simply reflecting an increase in
resting inflammation. Therefore, a separate cohort of animals were generated. All animals
in this separate cohort followed the same surgical, treatment, and 5-day social defeat or
control design as outlined in Figure 4.1. Importantly, this particular cohort was euthanized
under resting non-stress levels on day 11. Inflammatory data collected from these rats serve
as a measure to identify the effect of stress and treatment on resting cytokine levels.
Moreover, comparison of these resting levels with that of social defeat-induced levels on
day 11 serve as validation for the overall study design. Euthanasia and tissue collection
were followed as outlined in Chapter 2.

Social defeat-induced inflammatory sensitization. As mentioned in section above, one
of the major aims of the current study was to determine whether a history of social defeat
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produced inflammatory priming. To this end, all rats regardless of previous stress history
were exposed to social defeat on day 11, 6 days after the 5th stress or control exposure. Rats
were euthanized immediately after this 30-minute stress exposure as outlined in Chapter 2.

4.2.4 HPLC
Similar to the design described in Chapter 3, the current study utilized HPLC in
order to determine the relative concentration of NE in the plasma and hippocampal, CeA,
and DR homogenates. All samples were spiked with 10nM dihydroxybenzylamine
(Thermo Scientific; Waltham, MA) to serve as an internal standard. Samples were then
filtered using centrifugation with Amicon Ultra 0.5 mL Ultracel spin filters (Millipore;
Billerica, MA). Plasma samples were filtered using Amicon spin filters with a 50 kDA
molecular weight cut off while all brain homogenates were filtered using spin filters with
a 3 kDA molecular weight cut off. Regardless of the specific filter used, all filtrates were
collected following a 30-minute centrifugation at 16,000 x g and 4oC. These filtrates were
then run on the HPLC. All data were normalized to the dihydroxybenzylamine internal
standard. Results from brain homogenates were further normalized to protein
concentration.

4.2.5 Bio-Plex analysis
Defeat-induced circulating (plasma) and brain region specific inflammatory effects
were determined using Bio-Plex analysis (Bio-Rad; Hercules, CA). Homogenized CeA and
DR tissues were loaded onto the plate at a concentration of 275 µg/mL. Plasma samples
were diluted 1:4 per manufacturer recommendation. All samples and standards were run in
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duplicate according to manufacturer protocol. Plates were read using the same Luminex
Bio-Rad Bio-Plex system described in Chapter 2. Based on the large sample size, it was
necessary to run several assays in order to collect these data. In order to control for interkit variability, vehicle control rats were run on each plate. All collected Bio-Plex data were
subsequently normalized to percent of vehicle. Replicate Bio-Plex values resulting from
repeated sampling of vehicle controls were averaged following percent control calculations
conducted across each plate. For certain cytokines this resulted in a vehicle control group
average that was not equal to 100%.

4.2.6 Plasma Cort measurements
In addition to HPLC and Bio-Plex analysis, plasma samples were also probed for
the concentration of Cort following the social defeat exposure on the day of euthanasia. To
this end, collected plasma samples were run on a Cort ELISA (Enzo Life Sciences;
Farmingdale, NY). Plasma samples were diluted 1:40 and run according to manufacturer
protocol. Plates were read using a Synergy 2 Multi-Mode plate reader (Bio Tek; Winooski,
VT) and quantified using the corresponding Gen5 software (Bio Tek; Winooski, VT).

4.3 Results
4.3.1 Verification of LC-NE lesion with DSP-4
Prior to running the study, it was imperative to determine whether the dose of DSP4 administered produced significant reductions of NE in LC projection regions. The
hippocampus was ideal for this purpose as the LC is the exclusive source of NE to this
region (Loy et al., 1980). HPLC analysis of hippocampal homogenates verified that the

83

400 µg dose of DSP-4 reduced NE by approximately 85% (Average Hippocampal NE
pmol/µg protein ± SEM; Vehicle: 34.5 ± 6.4; DSP-4: 4.9 ± 1.5; t(11) = 4.2, p<0.01). These
data are comparable to studies using the standard 50 mg/kg intraperitoneal dose (Harro et
al., 1995; Cheetham et al., 1996; Harro et al., 1999; Kask et al., 2000) and direct ICV
injection of 400 µg of DSP-4 (Sziray et al., 2010) in which hippocampal NE was depleted
by approximately 70 - 100%. These data verify that the drug treatment and administration
route are effective in lesioning LC-NE projections.

4.3.2 Behavior during defeat
To determine the effects of DSP-4 on intruder behavior during the 5 consecutive
days of social defeat exposure, upright defensive postures were quantified from video
recordings obtained on days 1 and 5 of defeat. Comparison of upright posture on days 1
and 5 indicated that both DSP-4 and vehicle-treated rats exhibited greater durations of
upright posture on the 5th exposure (Effect of day: F(1,16) = 6.0, p<0.05; Average ± SEM
(s); Vehicle: 199.2 ± 53.3; DSP-4 120.4 ± 38.9) compared to the 1st exposure (Average
time in upright postures ± SEM (s); Vehicle: 94.2 ± 28.9; DSP-4: 26.6 ± 16.8). These
effects were independent of treatment designation (Effect of treatment: F(1,16) = 1.9, p=0.2)
for both day 1 (p=0.08) and day 5 (p=0.5). In addition to quantifying upright posture, the
amount of time required to induce behavioral submission (i.e. defeat latency) was also
quantified across the 5-day social defeat exposure. Similar to findings in upright posture,
DSP-4 and vehicle-treated rats demonstrated nearly identical defeat latencies across the 5day social defeat period (Average ± SEM; Vehicle: 215.8 ± 66.3; DSP-4: 270.7 ± 55.4),
suggesting that DSP-4 does not alter the submissive behavior of intruder rats to the
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aggressive resident. It is important to note that these effects were not as a result of the
relative intensity of the defeat experienced by vehicle and DSP4-treated rats. As analysis
of resident attacks during each defeat episode indicated that both DSP-4 and vehicle-treated
rats encountered a similar number of attacks (t(11) = 0.4).

4.3.3 Validation of Study design
It has been well established that the time course of stress- or endotoxin-induced
release of cytokines can vary depending on the rats stress history and the cytokine being
measured (Johnson et al., 2002; Cheng et al., 2015). Cytokine levels in response to an initial
acute stress exposure or immune challenge can require up to 4 hours to peak. However,
subsequent stress or immune challenges promote sensitized cytokine responses in the
plasma and brain. This sensitization has been shown to be associated with a reduced time
course of cytokine induction with peak responses occurring as early as 1 hour (Johnson et
al., 2002; Cheng et al., 2015). Based on these findings, it was crucial to verify that plasma
and brain samples collected immediately after the acute social defeat challenge on day 11
(30 minutes after the start of defeat) were reflective of a time point at which stress-induced
elevations in cytokines were evident. To this end, two distinct preliminary studies were
conducted in which plasma and brain tissue were collected under resting non-stress
conditions from a subset of vehicle and DSP4-treated rats with a history of control or
defeat.
Determination of resting-inflammatory tone in the CeA and DR following social
defeat and DSP-4 treatment. In Chapter 3 it was demonstrated that social defeat-induced
plasma cytokine levels did not differ between rats with a history of control or defeat 5 days
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after the final social defeat exposure. However, neuroinflammation at this same timepoint
was significantly enhanced in the LC. Based on these previous findings, it was pertinent to
determine if a history of social defeat or DSP-4 treatment produced long-lasting increases
in resting neuroinflammatory tone within the CeA. Additionally, findings from Chapter 3
support stress-induced inhibition of cytokines in the DR. However, it was unclear what
effects DSP-4 treatment may have on cytokine expression in this region. Therefore, DR
neuroinflammatory responses were also assessed. To this end, a subset of DSP-4 and
vehicle-treated rats were euthanized at rest 6 days after the 5th social defeat or control
exposure. Subsequent Bio-Plex analysis of the CeA indicated that neither a history of social
defeat nor DSP-4 treatment significantly altered resting cytokine concentrations in the CeA
(Table 4.1). In contrast, analysis of the DR indicated that DSP-4 treatment did result in an
overall enhancement of resting neuroinflammatory tone. Specifically, IL-1b was
significantly enhanced in all DSP4-treated rats regardless of stress history (Table 4.2).
Similar effects were also evident for IL2, IL-4, and TNF-a (Table 4.2). Although resting
inflammatory tone was enhanced in DSP4-treated rats at rest within the DR, subsequent
post-hoc analysis did not identify significant differences between specific stress and
treatment groups.

Verification of acute defeat-induced cytokine concentrations. Following determination
of the effects of stress and DSP-4 treatment on resting inflammatory tone in the CeA and
DR, a second validation study was conducted to confirm that stress-induced cytokine
release could be detected at the chosen 30-minute post-stress time point. Cytokine levels
from the plasma, CeA, and DR were compared between vehicle control rats euthanized
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under resting conditions and those that were subject to the acute social defeat challenge on
day 11. Bio-Plex analyses of plasma indicated that this 30-minute stress exposure did result
in an overall enhancement of inflammation compared to resting non-stress levels.
However, the magnitude of these stress-induced alterations were largely cytokine specific.
For example, plasma IL-1b, IL-4, and IL-13 demonstrated robust increases following the
acute defeat challenge, while IL-6 remained unchanged from vehicle-treated rats
euthanized under resting non-stress conditions (Table 4.3). Similar cytokine dependent
enhancement following the acute defeat challenge was also evident for the CeA (Table
4.3). In contrast, the acute defeat challenge resulted in an overall reduction in cytokines in
the DR (Table 4.3), which nicely recapitulate findings discussed in Chapter 3.
Taken together, these data suggest that cytokine measurements collected 30
minutes after the acute social defeat challenge are reflective of stress-induced levels.
However, it is important to note that these levels do not represent peak cytokine
concentrations. Additionally, it is highly unlikely that these cytokine concentrations are
reflective of increases in protein expression especially in vehicle-treated rats with a
previous history of control. Instead, these data likely represent the release of cytokine
containing vesicles from inflammatory cell types including macrophages (Arango Duque
and Descoteaux, 2014) and microglia (Bianco et al., 2005).

4.3.4 Effects of DSP-4 on release of social defeat-induced circulating cytokines in rats
with a history of control or stress
After verifying the study design, Bio-plex analyses were conducted on plasma
collected from DSP-4 and vehicle-treated rats exposed to the acute defeat challenge. In
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vehicle-treated rats, a history of social defeat resulted in the facilitation of 3 out of 10
circulating stress-induced cytokines. Specifically, IL-6 (Effect of Stress History: F(1,18) =
5.1, p<0.05; Figure 4.2A), INF-g (Effect of Stress History: F(1,18) = 7.3, p<0.05; Figure
4.2B), and TNF-a (Effect of Stress History: F(1,18) = 6.3, p<0.05; Figure 4.2C) were
significantly enhanced in vehicle-treated rats with a history of social defeat compared to
vehicle-treated rats with a history of control. Consisted with NE’s known facilitative effects
on immune regulation, rats receiving the noradrenergic neurotoxin DSP-4 exhibited robust
inhibition of stress-induced release of all 10 cytokines measured (Figure 4.2 and Table 4.4)
including IL-1b (Effect of Treatment: F(1,18) = 28.3, p<0.0001; Figure 4.2D), IL-4 (Effect
of Treatment: F(1,18) = 28.5, p<0.0001; Figure 4.2E), and IL-13 (Effect of Treatment:
F(1,17) = 20.1, p<0.001; Figure 4.2F). In addition to resulting in a general inhibition of
acute defeat-induced inflammation, DSP-4 also inhibited inflammatory priming of IL-6
(Effect of Treatment: F(1,18) = 28.3, p<0.0001; Figure 4.2A), INF-g (Effect of Treatment:
F(1,18) = 26.9, p<0.0001; Figure 4.2B), and TNF-a (Effect of Treatment: F(1,17) = 23.3,
p<0.001; Figure 4.2C) evidenced in vehicle-treated rats with a history of social defeat.
These data suggest that the LC-NE system does play an intricate role in the emergence of
stress-induced inflammation in the periphery. Moreover, the findings regarding selective
facilitation of IL-6, INF-g, and TNF-a suggest that social defeat does not result in a general
priming of the inflammatory system but rather produces cytokine-specific sensitization.

4.3.5 DSP-4 treatment affects peripheral NE and Cort
In order to verify that the LC-NE system did indeed contribute to these effects,
HPLC was conducted in the same plasma samples used for Bio-Plex analysis. These data
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confirmed that DSP-4 did in fact reduce the peripheral NE response to social defeat (Effect
of Treatment: F(1,20) = 8.9, p<0.01; Figure 4.3). Notably, plasma NE following the acute
social defeat challenge were positively correlated to with the expression of several plasma
cytokines including IL-6 (r = 0.44, p<0.05) and INF-g (r = 0.43, p<0.05). These data
support previous reports that describe the proinflammatory potential of circulating NE
(Spengler et al., 1990; Kavelaars et al., 1997; Johnson et al., 2005; Grisanti et al., 2010)
and further suggest for the first time that the LC may be a significant source of social stressinduced NE in the periphery.
It is also recognized that NE can regulate a number of peripheral effectors including
Cort. Therefore, these studies also quantified plasma Cort following the acute defeat
exposure in vehicle and DSP4-treated rats. Interestingly, plasma Cort following the acute
defeat challenge were directly opposing to effects in plasma NE and inflammation.
Specifically, Cort concentrations were selectively blunted in vehicle-treated rats with a
history of defeat (Effect of Stress History: F(1,15) = 14.4, p<0.01; Figure 4.4). Treatment
with DSP-4 blocked defeat-induced decreases in Cort in rats with a history of defeat (Effect
of Treatment: F(1,14) = 12.3, p<0.01). To evaluate whether Cort responses in the plasma
following the acute social defeat challenge were related to plasma inflammation,
correlational analyses were conducted. These subsequent analyses demonstrated that Cort
responses were negatively correlated with 9 of the 10 measured cytokines including IL-1b
(r = -0.58, p<0.05), IL-6 (r = -0.60, p<0.05), and TNF-a (r = -0.59, p<0.05). It has been
suggested that Cort can exert anti-inflammatory effects (Coutinho and Chapman, 2011).
Although the current study did not directly assess the putative anti-inflammatory potential
of Cort, these data do suggest that Cort may indeed be related to peripheral inflammation.
89

Moreover, these data suggest that in addition to regulating peripheral inflammation through
the enhancement of circulating NE, the LC-NE system may further impact peripheral
inflammation by indirectly modifying secondary systems that exhibit anti-inflammatory
potential.

4.3.6 Stress-induced neuroinflammation is enhanced in the CeA of DSP4-treated rats
with a history of social defeat
In order to determine the putative role of the LC derived NE on stress-induced
inflammation in the brain, Bio-Plex analyses were conducted in several LC projection
regions including the CeA. The Bio-Plex data from this region indicated that social defeatinduced inflammatory priming was also evident in the CeA following the acute defeat
challenge. Similar to findings in the plasma, vehicle-treated rats with a history of social
defeat exhibited modest yet consistent increases in CeA cytokines including IL-1b (Stress
History x Treatment Interaction: F(1,16) = 5.5, p<0.05; Figure 4.5A), IL-6 (Stress History x
Treatment Interaction: F(1,16) = 6.0, p<0.05; Figure 4.5B), INF-g (Stress History x
Treatment Interaction: F(1,17) = 8.1, p<0.05; Figure 4.5C), and TNF-a (Effect of Stress
History: F(1,17) = 11.9, p<0.01; Figure 4.5D) compared to vehicle-treated rats with a history
of control. Importantly, this stress-induced neuroinflammatory priming was not just
evident for pro-inflammatory cytokines, as many of the anti-inflammatory cytokines
analyzed such as IL-1 receptor antagonist (IL-1RA; Effect of Stress History: F(1,17) = 9.8,
p<0.01; Effect of Treatment: F(1,17) = 10.9, p<0.01; Figure 4.5E) and IL-4 (Stress History
x Treatment Interaction: F(1,16) = 6.0, p<0.05; Figure 4.5F) were also elevated in vehicletreated rats with a history of defeat compared to vehicle-treated rats with a history of
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control. Strikingly, treatment with DSP-4 sensitized neuroinflammatory responses to acute
social defeat, but only in rats with a previous history of social defeat. Specifically, of the
22 measured cytokines (Figure 4.5; Table 4.5), 21 cytokines were significantly enhanced
in DSP4-treated rats with a history of social defeat which greatly exceeded that of vehicletreated rats with a history of defeat. Together these data suggest that the LC-NE system
may serve to inhibit or regulate neuroinflammation within the CeA. Moreover, social
defeat-induced sensitization in vehicle-treated rats with a history of social defeat suggests
that a history of defeat may result in concomitant dysregulation of the LC-NE and
neuroinflammatory systems.

4.3.7 Acute defeat-induced neuroinflammation in the CeA is associated with loss of
NE
HPLC analysis of CeA tissue homogenates was performed to verify the suspected
effects of LC-NE on regulation of stress-induced neuroinflammation. Comparison of
vehicle-treated rats indicated that a history of social defeat exposure resulted in significant
reductions of NE in the CeA (Effect of Stress History: F(1,16) = 4.8, p<0.05; < 0.05; Figure
4.6A). Notably, the reductions of CeA NE in vehicle-treated rats with a history of social
defeat were strikingly similar to the NE content detected in rats treated with DSP-4. To
more clearly establish a relationship between CeA NE and inflammation, subsequent
correlational analyses were conducted. These data suggested that NE was negatively
associated with several cytokines. These associations were evident for both
proinflammatory cytokines including TNF-a (r = -0.53, p<0.05; Figure 4.6B) and INF-g (r
= -0.48, p<0.05; Figure 4.6C) and anti-inflammatory cytokines such as IL-4 (r = -0.51,
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p<0.05; Figure 4.6D). Taken together these data support the suggestion that NE in the CeA
likely exerts anti-inflammatory effects and that loss of NE through a history of social defeat
or DSP-4 disinhibits inflammation in this region.

4.3.8 A history of social defeat has opposing effects on acute defeat-induced
neuroinflammation within the DR of vehicle and DSP4-treated rats
As discussed in Chapter 3, social defeat is known to produce region specific
alterations in cytokine expression. Based on the previously described reduction of cytokine
concentration in the DR, there was great interest to determine whether the LC-NE system
contributed to these effects. Consistent with the findings described in Chapter 3, a history
of social defeat exposure resulted in suppression of cytokines within the DR. For example,
the concentration of IL-1b (Effect of Stress History: F(1,17) = 5.3, p<0.05; Figure 4.7A) was
markedly reduced in the DR of vehicle-treated rats with a history of social defeat following
the acute social defeat challenge compared to vehicle-treated rats with a history of control.
Interestingly, this stress-induced reduction in cytokines was not evident for other
proinflammatory cytokines. For example, the concentrations of TNF-a did not differ
between vehicle-treated rats with a history of social defeat and vehicle-treated rats with a
history of control (Effect of Stress History: F(1,17) = 0.2, p=0.7; Figure 4.7B). While the
majority of pro-inflammatory cytokines did not differ between vehicle-treated rats, several
anti-inflammatory cytokines exhibited expected social defeat-induced reductions in the
DR. For example, IL-2 (Stress History x Treatment Interaction: F(1,17) = 13.1, p<0.01;
Figure 4.7C) and IL-4 (Stress History x Treatment Interaction: F(1,17) = 6.0, p<0.05; Figure
4.7D) were both reduced in vehicle-treated rats with a history of defeat.
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Unlike findings in the plasma and CeA, the effects of DSP-4 in the DR were largely
cytokine specific. For example, DR concentrations of IL-1b in DSP4-treated rats were
unchanged from that of vehicle-treated controls (Figure 4.7A). In contrast, TNF-a was
enhanced in all DSP4-treated rats regardless of stress history (Effect of Treatment: F(1,17)
= 9.1, p<0.01; Figure 4.7B). Notably, IL-2 (Figure 4.7C) and IL-4 (Figure 4.7D) patterns
differed as well with DSP-4 producing selective enhancement of these cytokines in the DR
of rats with a history of social defeat. Based on the seemingly sporadic nature of these
cytokine patterns following social defeat, it is likely that social defeat-induced cytokine
responses within this brain region are largely independent from NE content within the DR.

4.3.9 Acute defeat-induced cytokine concentrations are largely independent from NE
content within the DR
Based on the intriguing findings regarding cytokine expression in the DR, HPLC
analysis was conducted using the same tissue samples utilized for Bio-Plex analysis.
Notably, NE content within the DR was unaffected by stress (Effect of Stress History: F(1,
16)

= 0.2, p=0.7) and DSP-4 treatment (Effect of Treatment: F(1,16) = 0.02, p=0.9; data not

shown). Similarly, neither stress nor DSP-4 treatment altered 5-HT content in the DR
(Effect of Stress: F(1,

16)=2.6,

p=0.1; Effect of Treatment: F(1,

16)=1.7;

p=0.2; data not

shown).

4.4 Discussion
Dysregulation of the noradrenergic system has been clearly associated with the
pathogenesis of stress-related disorders. While therapeutics targeting the NE system are
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effective in alleviating the behavioral symptomatology in certain patient populations, these
kinds of traditional anti-depressive therapies require weeks of continuous use and only
produce remission in approximately 28% of people (Fava, 2000; Trivedi et al., 2006).
Moreover, NE depletion studies are largely ineffective in inducing or worsening symptoms
of major depression (Miller et al., 1996b; Miller et al., 1996a; Delgado, 2000), suggesting
that rather than a direct effect of NE, antidepressant therapies targeting this system may
rely on changes within a secondary system that is modulated by NE. Stress-induced
inflammation represents one such secondary system. This suggestion comes from several
studies that directly implicate inflammation in the emergence of depressive-like behaviors
and findings from other groups showing that NE can regulate inflammatory responses in
the periphery and the brain. However, up until this point no studies had been designed to
directly assess the involvement of NE in stress-induced inflammatory responses.
Therefore, the current study was unique as it demonstrated for the first time that the LCNE system is a significant source of plasma NE in response to social defeat stress and
supports the notion that the LC noradrenergic system facilitates inflammatory priming in
the periphery. Moreover, this study was further extended to identify the novel findings that
a history of repeated exposure to social defeat produced brain region specific alterations in
cytokine expression that are distinctly regulated by NE.
It has long been recognized that the peripheral sympathetic nervous system is
capable of regulating immunity by activating adrenergic receptors on the cell surface of
macrophages. These effects of NE are known to result in the release of cytokines (Flierl et
al., 2009; Li et al., 2015) and can further augment inflammatory responses to an immune
challenge (Spengler et al., 1990; Kavelaars et al., 1997; Grisanti et al., 2010). Until
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recently, the contribution of central noradrenergic systems to these responses remained
relatively unknown. Engler et al. provided the first report of LC-NE involvement in
peripheral inflammatory responses. This particular study demonstrated that DSP-4
treatment and the resulting loss of LC-NE inhibited lipopolysaccharide-induced cytokine
release from splenocytes (Engler et al., 2010). Moreover, DSP-4 treatment functioned to
reduce the percentage of natural killer cells within the spleen (Engler et al., 2010). Taken
together these findings suggest that there are likely multiple overlapping mechanisms by
which the LC-NE system can promote peripheral inflammation. In line with these findings,
the particular study outlined in this Chapter determined that peripheral cytokine responses
to social defeat were regulated by LC-NE projections as DSP-4 lesion effectively blunted
plasma NE and inhibited acute defeat-induced release of plasma cytokines. Beyond the
acute effects of stress on cytokine release, a history of stress exposure has been shown to
promote the priming of peripheral inflammatory responses such that a subsequent stress or
immune challenge promotes a larger and faster inflammatory response. Mechanistically,
this inflammatory priming has been tied to enhanced secretion of cytokines from
inflammatory cells that exhibit greater migratory and inflammatory capacity (Bierhaus et
al., 2003; Nance and Sanders, 2007; Grisanti et al., 2010; Wohleb et al., 2014a). The
sympathetic nervous system is suggested to be critical in the production of these effects as
it innervates a number of lymphoid tissues (Felten et al., 1985; Wohleb et al., 2014a). While
the study described in this Chapter did not directly assess the number and reactivity of
inflammatory cell types, inflammatory priming was evident based on findings that stressinduced cytokine release was augmented in rats with a history of stress compared with rats
with a history of control. Moreover, findings that DSP-4 inhibits this stress-induced
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priming in the plasma provides direct support for the involvement of the LC-NE system in
this process.
Most of the data outlining the role of NE on inflammation has been determined by
assessing peripheral responses. However, a few studies using cell culture have begun to
elucidate the role of NE in central inflammatory responses. These studies have suggested
that NE can produce inhibitory as well as facilitatory effects on inflammation depending
on the cellular environment. Under normal resting conditions, NE is known to activate b2adrenergic receptors on the cell surface of microglia (Mori et al., 2002). Activation of these
receptors in turn enhances cyclic adenosine monophosphate (cAMP) and ultimately results
in the inhibition of pro-inflammatory cytokine release (Mori et al., 2002). However, in a
pro-inflammatory environment, as is seen after stress or an immune challenge, microglia
are capable of shifting the expression of cell surface receptors from a predominantly b2 to
a predominantly a2-adrenergic receptor composition (Gyoneva and Traynelis, 2013). In
contrast to the b2 receptors, activation of the a2 receptors on microglia fail to inhibit proinflammatory cytokine release (Mori et al., 2002). Instead these receptors promote the
expression of cathechol-O-methyl transferase (COMT) and B-cell lymphoma-extra large
(Bcl-xl) (Mori et al., 2002). These particular findings suggest that microglia found in proinflammatory environments are capable of recruiting pathways that protect against
apoptotic events, such as the generation of free radicals, and facilitates the degradation of
extracellular NE. In this way microglia become more resilient and are poised to maintain a
proinflammatory environment.
The study described in this chapter did not assess whether social defeat or DSP-4
promoted a shift from b2 to a2 adrenergic receptors on microglia. However, findings from
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the CeA support the putative anti-inflammatory role of NE. Whether it was a history of
social defeat or DSP-4 treatment, reductions in NE were clearly associated with increases
in inflammatory responses within the CeA following the acute social defeat challenge.
Importantly, these findings also support a role for NE withdrawal in neuroinflammatory
priming or sensitization. In contrast, inflammatory responses in the DR were much less
predictable. In general, exposure to social defeat resulted in modest inhibition of DR
cytokines. Subsequent HPLC data further indicated that these effects appeared to be
independent of NE. However, the lack of effects in NE could have resulted from a
compensatory upregulation from other NE containing brain regions. While the LC is the
major source of NE to the brain, it is not the sole source. There are a number of other NE
containing nuclei which project to the CeA and DR including the ventromedial medulla
(Zardetto-Smith and Gray, 1995) and lateral habenula (Aghajanian and Wang, 1977; Kalen
et al., 1989). These NE inputs seem to differentially contribute to the NE content in these
brain regions following stress and DSP-4 exposure. Specifically, the exhibited loss of NE
in the CeA following both stress and DSP-4 treatment suggest that the ventral medulla
which innervates this region did not come on-line to compensate for this loss. In contrast,
normalized levels of NE in the DR suggest that the lateral habenula likely compensated for
the stress and DSP-4 induced loss of NE.
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Table 4.1 A history of social defeat and DSP-4 do not alter resting CeA cytokine
concentration. Data presented as average percent of vehicle control ± SEM.
Analyte

Vehicle

DSP-4

Main Effect of Treatment
(Tx)/Stress

Control

Defeat

Control

Defeat

IL-1β

100.0±
10.8

98.1±
3.8

108.5±
14.2

105.6±
8.7

Stress: F(1,20)=0.04, p=0.83
Tx: F(1,20)=0.51, p=0.48

IL-2

100.0±
14.0

100.5±
7.4

117.6±
13.0

114.9±
9.8

Stress: F(1,20)=0.01, p=0.93
Tx: F(1,20)=1.70, p=0.21

IL-4

100.0±
8.9

98.6±
2.4

103.9±
10.0

106.3±
7.3

Stress: F(1,20)=0.002,
p=0.96
Tx: F(1,20)=0.45, p=0.51

IL-6

100.0±
4.5

101.6±
2.6

99.1±
7.4

102.5±
4.7

Stress: F(1,20)=0.20, p=0.66
Tx: F(1,20)=0.0001, p=0.996

IL-10

100.0±
4.2

103.8±
1.6

106.1±
4.6

105.3±
4.0

Stress: F(1,20)=0.12, p=0.73
Tx: F(1,20)=0.76, p=0.39

IL-13

100.0±
11.4

112.9±
4.9

108.7±
13.1

118.7±
9.7

Stress: F(1,20)=1.01, p=0.33
Tx: F(1,20)=0.41, p=0.53

GM-CSF

100.0±
12.6

108.0±
11.2

111.7±
11.9

97.1±
6.7

Stress: F(1,20)=0.10, p=0.76
Tx: F(1,20)=0.001, p=0.97

INF-g

100.0±
11.3

106.9±
7.0

102.9±
18.1

108.6±
13.8

Stress: F(1,19)=0.17, p=0.68
Tx: F(1,19)=0.02, p=0.88

TNF-a

100.0±
4.1

93.4±
3.9

96.3±
4.6

91.6±
1.9

Stress: F(1,20)=2.37, p=0.14
Tx: F(1,20)=0.56, p=0.46
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Table 4.2 DSP-4 and a history of social defeat differentially regulate resting cytokine
concentrations in the DR. Data presented as average percent of vehicle control ± SEM.
Vehicle
Control
Defeat

DSP-4
Control
Defeat

IL-1β

100.0±
22.6

97.7±
16.9

151.5±
7.6

137.5±
9.6

Main Effect of Treatment
(Tx)/Stress
Stress: F(1,17)=0.36, p=0.55
Tx: F(1,17)=11.56, p<0.01

IL-2

100.0±
23.9

110.1±
11.9

152.8±
14.3

135.9±
16.4

Stress: F(1,17)=0.04, p=0.85
Tx: F(1,17)=4.99, p<0.05

IL-4

100.0±
9.8

109.3±
15.7

138.7±
7.0

126.9±
7.9

Stress: F(1,17)=0.02, p=0.90
Tx: F(1,17)=8.16, p<0.05

TNF-a

100.0±
9.0

97.5±
10.9

116.5±
4.2

115.8±
9.9

Stress: F(1,17)=0.03, p=0.87
Tx: F(1,17)=3.25, p=0.09

Analyte
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Table 4.3 Comparison of plasma, CeA, and DR in resting non-stress controls (NSC) and
rats exposed to a single social defeat (SDC). Data presented as the mean pg/mL cytokine
concentration ± SEM. ND is used in instances where cytokine values fell below the limit
of detection. *p<0.05; **p<0.01, ****p<0.0001.
Plasma
NSC
SDC
t-test
results

IL-1b
48.4±4.8
178.7±47.3*

IL-4
20.2±2.4
1072.0±288.0*

IL-6
232.8±24.7
208.1±66.1

IL-10
172.2±15.9
353.1±93.0*

TNF-a
37.0±3.5
616.4±252.2*

t(5)=2.7

t(5)=3.7

t(6)=0.7

t(5)=1.9

t(5)=2.27

CeA
NSC
SDC
t-test
results

IL-1b
5.6±1.0
11.7±2.4
t(4)=2.3

IL-4

IL-6

IL-10

0.4±0.1
1.7±0.3*
t(4)=4.3

13.8±1.8
17.5±1.0
t(4)=1.8

3.8±0.7
13.2±2.5*
t(4)=3.6

TNF-a
0.4±0.03
32.4±6.9*
t(5)=4.6

DR
NSC
SDC
t-test
results

IL-1b
18.6±0.7
3.1±0.3****
t(4)=20.1

IL-2
31.8±2.6
11.15±0.5**
t(4)=7.8

IL-10
66.2±2.2
46.3±3.4**
t(5)=4.9

100

MCP-1
36.1±1.2
22.0±0.8****
t(5)=9.7

Table 4.4 DSP-4 inhibits acute defeat-induced plasma cytokine release. Data presented as average
percent of vehicle control ± SEM. #p=0.06, *p<0.05, **p<0.01 vs. vehicle control; αp<0.01,
β
p<0.001, γp<0.001 vs. vehicle defeat.
Vehicle

DSP-4

Main Effect of

Analyte
Control

Defeat

Control

Defeat

99.8±

137.1±

66.9±

54.5±

11.1

8.2

19.2

7.6β

100.2±

114.9±

58.4±

50.6±

10.1

9.3

12.8*

7.4 β

96.5±

110.8±

58.7±

49.5±

9.4

3.1

3.9**

6.1γ

105.4±

135.1±

45.5±

54.7±

12.8

8.7

8.8**

11.4γ

IL-2
101
IL-10

GM-CSF

MCP-1

Treatment
F(1,17)=17.3, p<0.001

F(1,18)=24.0, p<0.001

F(1,16)=53.5, p<0.0001

F(1,18)=42.7, p<0.0001

Table 4.5 DSP-4 and a history of social defeat enhance cytokine concentration in the CeA after an acute defeat
challenge. Data presented as average percent of vehicle control ± SEM. αp<0.05, βp<0.001, γp<0.001 vs. vehicle-treated
rats with a history of defeat; *p<0.05, **p<0.01, ***p<0.01 vs. DSP4-treated rats with a history of control.
Analyte

Vehicle Control Vehicle Defeat DSP-4 Control

DSP-4 Defeat

Main Effect of

701.6 ± 65.0γ**

Stress x Tx: F(1,16)=6.0, p<0.05
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IL-2

100.0 ± 11.8

193.9 ± 32.8

262.8 ± 84.7

IL-5

100.0 ± 44.5

432.5 ± 223.9

658.3 ± 307.3 2346.9 ± 417.5β**

IL-7

100.0 ± 33.7

762.0 ± 348.8

639.3 ± 265.5

2077.0 ± 183.0α*

Stress: F(1,17)=13.2, p<0.01; Tx: F(1,17)=10.3, p<0.01

IL-10

100.0 ± 18.7

197.0 ± 36.4

175.2 ± 33.6

299.3 ± 34.0

Stress: F(1,17)=9.7, p<0.01; Tx: F(1,17)=6.3, p<0.05

IL-12 (p70)

100.0 ± 16.3

479.1 ± 236.2

601.3 ± 271.4 2140.6 ± 229.4β**

IL-13

100.0 ± 15.2

286.9 ± 104.4

220.4 ± 70.8

543.6 ± 138.6

Stress x Tx: F(1,16)=5.1, p<0.05

IL-18

100.0 ± 2.6

114.9 ± 7.5

123.7 ± 12.2

172.5 ± 9.0β*

Stress: F(1,16)=9.2, p<0.01; Tx: F(1,16)=15.0, p<0.01

EPO

100.0 ± 12.0

164.1 ± 24.4

152.0 ± 22.9

222.6 ± 22.1

Stress: F(1,17)=8.0, p<0.05; Tx: F(1,17)=5.4, p<0.05

GRO-KC

100.0 ± 14.6

198.6 ± 63.3

230.8 ± 71.4

658.3 ± 90.8β**

Stress x Tx: F(1,16)=5.2, p<0.05

GM-CSF

100.0 ± 26.2

437.9 ± 237.6

560.4 ± 249.0 1973.8 ± 204.3β**

M-CSF

100.0 ± 17.2

180.2 ± 37.9

182.0 ± 43.3

MIP-1a

100.0 ± 30.6

731.1 ± 403.2 1090.7 ± 501.3 3958.0 ± 481.5β**

Stress x Tx: F(1,16)=5.7, p<0.05

RANTES

100.0 ± 18.2

400.0 ± 183.9

472.5 ± 190.3 1595.2 ± 141.8β**

Stress x Tx: F(1,16)=5.3, p<0.05

VEGF

100.0 ± 27.2

429.2 ± 166.7

307.0 ± 121.6 1078.1 ± 157.7α**

Stress: F(1,17)=14.3, p<0.01; Tx: F(1,17)=8.7, p<0.01

462.3 ± 59.3β**

Stress x Tx: F(1,15)=5.3, p<0.05

Stress x Tx: F(1,16)=5.3, p<0.05

Stress x Tx: F(1,16)=5.2, p<0.05
Stress x Tx: F(1,16)=5.0, p<0.05

Figure 4.1 DSP-4 study design and timeline for animals with a history of social defeat (A)
or control (B). 10 days prior to the onset of stress all rats were implanted with
intracerebroventricular (ICV) cannulas. Seven days prior to stress, DSP-4 or vehicle were
administered. DSP-4 and vehicle-treated rats were subjected to either 5 daily exposures to
social defeat or control. Six days after the final social defeat/control exposure, all rats,
regardless of stress history, were exposed to an acute social defeat challenge immediately
prior to euthanasia and tissue collection. A separate subset of rats was exposed to 5 daily
control sessions and euthanized 6 days later under resting, non-stress conditions (subset
not represented in figure).
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Figure 4.2 DSP-4 suppresses acute defeat-induced plasma cytokine release. Following the acute social
defeat challenge, vehicle-treated animals with a history of social defeat exhibited enhanced (A) IL-6, (B)
INF-γ, and (C) TNF-α, compared with vehicle-treated controls consistent with stress-induced
inflammatory priming. Strikingly, treatment with DSP-4 (panels A-F) suppressed stress-induced
facilitation of IL-6, TNF-α, and INF-γ, as well as increases in (D) IL-1β, (E) IL-4 and (F) IL-13,
regardless of stress history. *p<0.05 vs. vehicle control; βp<0.001 vs. vehicle defeat.
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Figure 4.3 DSP-4 treatment inhibits acute defeat-induced plasma NE induced by a history of social defeat. (A) Following
the acute social defeat challenge, vehicle-treated rats with a history of social defeat exhibit a sensitized peripheral NE
response. In contrast, acute defeat-induced plasma NE is blunted in rats treated with DSP-4. These acute defeat-induced
plasma NE responses were positively correlated with a number of cytokines including (B) IL-6 and (C) INF-γ. αp<0.05 vs.
vehicle-treated rats with a history of defeat.

Figure 4.4 DSP-4 inhibits stress-induced habituation of Cort responses. (A) Vehicletreated rats with a history of social defeat selectively exhibit a habituated Cort response
following the acute defeat challenge. In contrast, treatment with DSP-4 inhibited Cort
habituation in rats with a history of defeat. Acute defeat-induced Cort concentrations were
negatively correlated with a number of acute defeat-induced cytokines including (B) IL1β, (C) IL-6, and (D) TNF-α. *p<0.05 vs. vehicle-treated rats with a history of control;
αp<0.05 vs. vehicle-treated rats with a history of defeat.
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Figure 4.5 DSP-4 exacerbates acute defeat-induced neuroinflammatory priming in the CeA. Following the
acute social defeat challenge, vehicle-treated rats with a history of social defeat exhibited moderate but
consistent increases in pro-inflammatory cytokines (A) IL-1β, (B) IL-6, (C) INF-γ, (D) TNF-α and antiinflammatory (E) IL-1RA and (F) IL-4 compared with vehicle-treated rats with a history of control.
Treatment with DSP-4 produced modest increases in stress-induced cytokines in rats with a history of
control, while the LC-NE lesion robustly exacerbated the neuroinflammatory priming evident in rats with a
history of social defeat exposure for all cytokines except TNF-α. *p<0.05 vs. vehicle-treated rats with a
history of control; ƒp=0.07, βp<0.001 vs. vehicle-treated rats with a history of defeat; γp=0.07 #p<0.05,
##p<0.01 vs. DSP4-treated rats with a history of control. Dotted horizontal line indicates 100% of vehicle
control.

Figure 4.6 DSP-4 and a history of social defeat reduce NE content within the CeA (A)
which is negatively correlated with TNF-a (B), INF-g (C), and IL-4 (D). ƒp=0.07, #p=0.06
vs. vehicle-treated rats with a history of control.
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Figure 4.7 A history of stress and DSP-4 treatment produce cytokine specific effects in the
DR following acute defeat challenge. Following the acute defeat challenge, vehicle treated
rats generally exhibited a reduction of (A) IL-1β, (B) TNF-α, (C) IL-2, and (D) IL-4.
However, the magnitude of these reductions were largely cytokine dependent. While
treatment with DSP-4 modestly enhanced IL-1β independent of stress history, TNF-α, IL2, and IL-4 were selectively enhanced in DSP-4 treated rats with a history of social defeat.
#
p<0.05 vs. DSP-4 treated rats with a history of control; βp<0.05 vs. vehicle treated rats
with a history of defeat.
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Chapter 5
The “How”: Discrete inflammatory sensitive mechanisms that may
underlie behavioral and physiological deficits following stress

5.1 Introduction
Thus far, Chapters 3 and 4 have focused on the “what” and “why” underlying stressinduced inflammation. Specifically, these previous chapters have described the breadth of
stress-induced cytokine release in the periphery and the brain, implicated these
inflammatory responses in the emergence of depressive-like behaviors, and further
suggested that NE derived from the LC may be directly involved in these processes.
However, the looming question remains, how does stress-induced inflammation promote
the emergence of behavioral dysfunction? What specific receptor systems are impacted?
And importantly, if these receptor systems can be blocked, does this ameliorate the
behavioral effects of stress exposure?
Several studies have begun to assess the specific neural effects of inflammation.
These studies have largely reported that inflammation results in enhanced neural activation
as evidenced by increased c-fos and miniature excitatory post synaptic potentials (Ming et
al., 2013; Prager et al., 2013; Kurosawa et al., 2016). This cytokine-induced activation has
been noted in a number of brain regions including the central amygdala (CeA) (Ming et
al., 2013; Prager et al., 2013). As described in Chapter 1, the CeA has been extensively
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studied over the past 6 decades. The vast literature generated over this time has
demonstrated that the CeA plays an intricate role in regulating the behavioral and
autonomic responses to fear (Fadok et al., 2018). In addition to executing unconditioned
behavioral responses to fear, the CeA is also critical in fear learning (Ciocchi et al., 2010;
Li et al., 2013a; Fadok et al., 2017) and is involved in the detection and evaluation of
potentially aversive stimuli or situations (Ozawa et al., 2017). Stress is a robust activator
of the CeA. In both humans and animals stress is well documented to promote
hyperactivation of the CeA (Roozendaal et al., 1997; Bryant et al., 2008; Roozendaal et al.,
2009; Pitman et al., 2012) and a subsequent loss of inhibitory control (Zhang et al., 2018)
which has been directly correlated with measures of anxiety (Swartz et al., 2014) and
depression (Yang et al., 2010). Electrophysiological studies in slice preparations have
indicated that amygdalar hyperactivation results from a depolarization in the resting
membrane potential which effectively reduces the threshold for the generation of action
potentials (Neugebauer et al., 2003). In addition to lowering the threshold for the
generation of action potentials, it has been suggested that stress also enhances the
sensitivity of the amygdala to the excitatory neurotransmitter glutamate likely due to
increased expression of glutamatergic receptors (Mozhui et al., 2010).
There are several different neuronal mechanisms by which this could occur.
However, converging data in the hippocampus (Desai et al., 1999; Peters et al., 2010) and
basolateral amygdala (Sharp, 2017) suggest that signaling through tyrosine receptor kinase
(Trk)B may be directly responsible for these exhibited shifts in neuronal excitability. TrkB,
also known as tropomyosin receptor kinase B, is the high affinity receptor for BDNF.
Unbound TrkB exists as a silent monomer in the plasma membrane. However, upon
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binding of BDNF or its low affinity ligand neurotrophin-3 (NT-3), TrkB homodimerizes
resulting in the activation of the intracellular tyrosine kinase domain. This activation
promotes the autophosphorylation of a number of tyrosine residues on the intracellular
domain of this receptor which allows for the subsequent phosphorylation and activation of
3 distinct signaling cascades: mitogen-activated protein kinase (MAPK)/extracellular
signal-regulated kinase (ERK), calmodulin-dependent kinase II (CaMKII), and protein
kinase B (Akt) (Figure 5.1) (Kandel et al., 2000a). In general, BDNF and subsequent
activation of the TrkB receptor have long been implicated in the modification of synaptic
pathways by altering pre- and post-synaptic terminals to enhance the overall sensitivity of
neurons to excitatory amino acid neurotransmitter glutamate (Martin and Finsterwald,
2011). It is through these actions that BDNF is suggested to contribute to LTP (Martin and
Finsterwald, 2011) and enhancing electrical excitability (Li et al., 1998).
However, detailed signaling studies have indicated that these particular cellular
signaling effects are directly dependent on specific TrkB signaling cascades. For example,
TrkB signaling through MAPK and ERK has been shown to promote neuronal activation
as evidenced by the induction of cfos (Kidambi et al., 2010; Shan et al., 2015). Moreover,
activation of ERK has been directly implicated in producing depolarization of resting
membrane potentials (Stamboulian et al., 2010). Similar effects on neuronal activation and
enhanced excitability have also been reported to occur following the activation of CaMKII
(Wang et al., 2003b; Lee et al., 2009; Lucchesi et al., 2011; Klug et al., 2012). Although
MAPK and CaMKII are distinct branches and are dependent upon the activation of
different phosphate residues on the TrkB receptor, these two pathways converge onto the
cAMP response element binding protein (CREB). This convergence likely explains the
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strikingly similar molecular effects elicited by these two pathways. Unlike MAPK and
CaMKII, Akt, the third and final branch of the TrkB signaling cascade, functions to inhibit
c-fos activation (Yokoyama et al., 2013) by facilitating the trafficking of inhibitory gaminobutyric acid (GABA) receptors to the plasma membrane (Wang et al., 2003a).
Notably, Akt is in direct opposition to MAPK as the upstream adaptor proteins responsible
for the activation of both of these pathways compete for binding at the tyrosine residue 515
on the TrkB receptor (Gervais et al., 2006; Yokoyama et al., 2013).
In addition to producing opposing cellular signaling effects, MAPK/ERK, CaMKII,
and Akt also produce opposing behavioral effects. Specifically, MAPK/ERK and CaMKII
have been implicated in the emergence of anxiety- (Maldonado et al., 2014; Tran and
Keele, 2016) and depressive-like behaviors (Di Benedetto et al., 2013; Li et al., 2013b).
Furthermore, activation of these two specific branches of the TrkB signaling cascade in the
amygdala directly underlie the acquisition and expression of fear related behavioral
responses (Rodrigues et al., 2004; Di Benedetto et al., 2009; Maldonado et al., 2014). In
contrast activation of the Akt signaling cascade has been implicated in anti-depressant (Shi
et al., 2012; Leibrock et al., 2013) and anxiolytic effects (Leibrock et al., 2013). Based on
these vastly different molecular and behavioral effects, it is probable that stress-induced
activation of these particular branches of the TrkB signaling cascade may directly underlie
stress resiliency and susceptibility such that preferential signaling through MAPK/ERK
and CaMKII may promote stress susceptibility while preferential signaling through Akt
may confer resilience.
Another important regulator of stress susceptibility and resiliency is autonomic
balance. In healthy individuals the autonomic nervous system, which is comprised of

113

sympathetic and parasympathetic branches, is well balanced. The sympathetic branch of
the autonomic nervous system is best known for its implication in producing the “fight or
flight” response. The “fight or flight” response is a general term describing a variety of
physiological effects that occur following the subjective perception of threat, fear, or stress.
In general, this response is meant to ready an organism to either confront the threat or
retreat. To this end the sympathetic nervous system enhances blood pressure and heart rate,
results in dilation of the pupils, and temporarily shuts down digestive function. In contrast,
the parasympathetic nervous system is best known for its involvement in processes falling
under the colloquial terms “rest and digest”. This is a very simplistic view of the autonomic
nervous system and suggests that these systems function exclusively and independently
from one another. However, under normal healthy resting conditions, the sympathetic and
parasympathetic nervous systems act in concert to maintain a number of physiological
processes including micturition, peristalsis, pupillary responses, and maintenance of blood
pressure and heart rate (Kandel et al., 2000b).
Stress is well documented to produce long lasting disruptions of the autonomic
nervous system resulting in an imbalance between sympathetic and parasympathetic
control. Direct measures of sympathetic and parasympathetic tone are nearly impossible to
obtain. However, studies in humans and animals have determined that measurement of
heart rate variability (HRV) can be utilized to indirectly determine sympathetic and
parasympathetic control of the heart. In general, HRV can best be conceptualized as the
fluctuation of time between heart beats. In the normal healthy heart, HRV is chaotic
(Goldberger, 1991) due to the intricate and dynamic interplay between sympathetic and
parasympathetic input to the heart. It is thought that this “chaos” is integral in the ability
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for the cardiovascular system to rapidly adapt (Beckers et al., 2006). However, in response
to stress, HRV can become drastically reduced as the intervals between heart beats become
monotonous and uncharacteristically regular (Kim et al., 2018). Stress-induced reductions
in HRV have been shown to occur either as a result of parasympathetic withdrawal,
enhanced sympathetic outflow, or a combination of the two (Gorman and Sloan, 2000).
Importantly, reductions of HRV have been directly associated with behavioral states such
as aggression, anxiety, and depression and is suggested to be accompanied by higher
mortality rates due to cardiovascular complications such as the emergence of coronary
heart disease and arrhythmias (Gorman and Sloan, 2000).
Several studies have begun to further assess the involvement of HRV in stress
responsivity and more importantly stress susceptibility and resiliency. An important
advancement in this particular field of research was published in 2015 by Minassian et al.
(Minassian et al., 2015). In what is known as the Marine Resilience Study, Minassian et al
demonstrated that individuals exhibiting reduced HRV prior to deployment were more
likely to meet PTSD diagnostic criteria upon their return (Minassian et al., 2015). These
findings were later expounded upon in a follow up study named Warriors Achieving
Resilience. Findings from this particular study confirmed those reported by Minassian et
al (Pyne et al., 2016). However, this particular study indicated that the basal reductions in
HRV prior to deployment were directly associated with lower resting vagal tone (Pyne et
al., 2016). Taken together, these data suggest that individual differences in HRV may not
only underlie the development of stress-induced pathology but may also serve as a
preliminary screen to determine stress susceptibility and resiliency. Notably, studies
assessing emotional processing and HRV have indicated that individuals that exhibit lower
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HRV also exhibit impaired neuronal regulation of the amygdala (Sakaki et al., 2016).
While it is unclear if the amygdala is directly involved in reduced HRV and vagal
withdrawal, it has been demonstrated that electrical stimulation of the CeA results in an
increase in blood pressure and heart rate (Iwata et al., 1987).
Based on the strong link between the CeA and behavior as well as HRV, it was
hypothesized that the CeA may be a crucial hub that integrates and controls a variety of
physiological and neuronal responses that ultimately predict and underlie stress
susceptibility and resiliency. Therefore, identification of specific signaling pathways that
are disrupted in the CeA of stress susceptible individuals is critical to further elucidate the
neuronal mechanisms underlying the emergence of anxiety- and depressive-like behavioral
states. As outlined earlier in this chapter, TrkB is an ideal target to begin this investigation
due to the inherent opposition that exists between the MAPK/ERK and Akt signaling
cascades. In order to address these distinct hypotheses, two studies were designed as
illustrated in Figure 5.2.

5.2 Methods
The sections contained below describe detailed methods involved in the completion
of these studies. Detailed methods for social defeat, sucrose preference, and tissue
collection are not discussed to limit repetitive discussion. However, these sections are
discussed in detail in Chapter 2.
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5.2.1 Ferret Odor
Unpublished data from our group has suggested that behavioral and Cort responses
to ferret odor can effectively predict subsequent susceptibility and resiliency to social
defeat. This particular behavioral assay involves placing a rat into a large Plexiglas
cylinder. The cylinder itself has a diameter of approximately 7.75 inches and is 16 inches
in height. These dimensions provide the rat enough space to freely turn around and ensures
that the rat cannot escape. A small metal clip fastened to a rubber coated wire is attached
to the side of the cylinder and freely dangles in close proximity to the rat. After the rat is
placed into this tank, a 1x1 inch ferret scented towel is inserted into the clip. Video
recordings of this exposure are captured for subsequent analyses of freezing behavior. 30
minutes after the initiation of this exposure, a small amount of blood (approximately 100
µL) is obtained via tail bleed using small volume EDTA lined tubes. Plasma is then
collected via centrifugation at 3200 rpm and 4oC for 15 minutes. The resulting plasma is
subsequently stored at -80oC until Cort analyses are conducted using a standard Cort
ELISA (Enzo Life Sciences; Farmingdale, NY). It is important to note that this 30-minute
time point for Cort analysis does not reflect peak Cort measures. Peak Cort responses have
been consistently reported to occur approximately 1 hour after the initiation of stress
(Dorey et al., 2012; Gong et al., 2015). Therefore, these Cort measures do not assess
differences in maximal release but rather serve as an assessment of general physiological
reactivity.
Data collected by previous members of the Wood lab determined that analysis of
freezing behavior across the first 5 minutes of the ferret odor exposure and plasma Cort
were the most reliable predictors of subsequent susceptible and resilient subpopulations.
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Specifically, it was determined that rats demonstrating low freezing and low Cort responses
during the exposure to ferret odor also demonstrated active coping resilient phenotypes
during social defeat. Conversely, rats demonstrating high freezing and high Cort responses
went on to exhibit passive coping susceptible phenotypes during social defeat. The
interaction between ferret odor responses and social defeat behavior for these unpublished
data were determined post hoc and were not utilized as a predictive measure as this
particular study was meant to evaluate the potential for ferret odor to be used as a
prescreening method. However, these post hoc evaluations did indicate that this
prescreening method was approximately 95% accurate in determining a rats natural
tendency towards stress susceptibility or resiliency.
Based on the suggested utility of this paradigm, the studies described in this chapter
were the first to utilize this method to predict behavioral responses to social defeat. For
both of the studies outlined in Figure 5.2, ferret odor was conducted prior to any other
surgical or behavioral manipulation. Rats in both studies were exposed to the ferret scented
towel for a total of 10 minutes. In accordance with the methods for the unpublished results,
behavioral responses during this 10-minute period were video recorded for subsequent
analysis. After the 10-minute exposure, rats were returned to their home cage and allowed
to rest until blood collection at 30 minutes. Plasma was collected and later analyzed for
Cort using the same Cort ELISA (ENZO Life Science; Farmingdale, NY) as the
unpublished data. For the purposes of these studies, freezing behaviors were analyzed with
the use of ANY-maze (Stoelting Co.; Wood Dale, IL). ANY-maze is a program which
analyzes a myriad of behavioral responses based on parameters set by the experimenter.
For the purposes of ferret odor, a protocol was created with freezing thresholds of 40 (on)
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and 60 (off) with a minimum freezing duration of 1 ms. To ensure that these settings would
provide accurate data, this particular protocol was utilized to analyze previously hand
scored videos. The average difference in freezing responses between these two methods
were 5.8 ± 0.4 s (average ± SEM). Notably, this difference was determined by comparing
freezing behaviors across the 1st 5 minutes of exposure for a total of 33 animals, suggesting
that the ANY-maze protocol does accurately detect freezing behaviors.
In order to separate animals into susceptible and resilient subgroups, cumulative
freezing responses during the 1st 3, 4, and 5 minutes and obtained plasma Cort
concentrations (ng/mL) were analyzed using the statistical software jmp (SAS Institute;
Cary, NC). A distribution analysis was conducted for each of these factors. Any data points
flagged as outliers (values exceeding twice the standard deviation) were excluded from the
analysis and the distribution was recalculated. Rats demonstrating freezing and Cort
responses in the bottom 50th percentile were classified as low responders. Conversely, rats
demonstrating freezing and Cort responses in the top 50th percentile were classified as high
responders. Importantly, these classifications were later verified using behavioral
responses during defeat. Moreover, this post hoc verification method was further used to
classify rats that were originally deemed outliers or those with freezing and Cort responses
that fell exactly on the 50% cut off.

5.2.2 Surgery
Rats receiving surgery were transported from the animal colony to our designated
surgical suite and allowed to habituate from transport for a minimum of 30 minutes.
Aseptic techniques were strictly enforced to minimize possible infection. To this end, all
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surgical tools, gauze, blue absorbent pads, and cotton swabs were autoclaved prior to
surgery. Additional materials required for surgery including syringes, scalpels, needles,
drapes, silk suture, polyglycolic acid sutures, and gloves, were purchased from the supplier
to be individually wrapped and sterile. A certified and calibrated vaporizer was utilized to
deliver anesthesia (Isothesia Isoflurane; Henry Schein; Melville, NY). Rats were placed
into a knockdown chamber which was subsequently filled with 5% isoflurane for 2
minutes. After this initial knock down period, rats were removed from the chamber,
weighed, and placed either into a nose cone (transmitter surgery) or fastened into the
stereotaxic device (cannula surgery). Isoflurane was then reduced to 2.5% for the duration
of the surgery. Breathing was closely monitored for anesthesia-induced respiratory
depression. In the event that an animals breathing began to slow substantially, the
percentage of isoflurane was dropped no lower than 1.5% until breathing had normalized.
Body temperature was constantly monitored via rectal thermometer and regulated with a
digital heating pad. Approximately 5 minutes prior to the completion of surgery, Flunixin
(2.5 mg/kg; Henry Schein; Melville, NY), a nonsteroidal anti-inflammatory and analgesic,
was injected subcutaneously. Following surgery, all rats were placed into a clean cage with
nesting material and given dietary support of Bacon Softies (Bio-Serv; Flemington, NJ)
and Diet Gel (Clear H2O; Portland, ME). Pain medication and dietary support were
administered on the day of and 24 hours following surgery to minimize discomfort from
surgical procedures.

Cannula Surgery. All rats for the molecular and behavioral studies were bilaterally
implanted with stainless steel guide cannulas directed toward the CeA. For this particular
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surgery, each rat was secured into the stereotax such that head movement to the right and
left was limited. Once the animal was securely in place, hair on the scalp was removed and
the area was cleaned three times with alternating applications of betadine and alcohol. At
this point, a small incision was made at the top of the scalp exposing the skull. Excess
tissue was removed with the scalpel and any bleeding as a result of tissue removal was
absorbed with sterile cotton swabs. Sterile stainless-steel guide cannulas (26 gage, 8 mm
below pedestal; PlasticsOne; Roanoke, VA) were fastened into the cannula arm attached
to the stereotax. Prior to drilling holes for the cannula, head placement was verified by
measuring Bregma and pseudo-Lambda. In the event that the Medial/Lateral measurement
between these two landmarks differed by more than 0.3mm, the rats head was adjusted and
measurements were reacquired. Coordinates for the bilateral CeA cannula placement were
calculated relative to Bregma as -2.3 Anterior/Posterior, ± 4.1 Medial/Lateral, and were
implanted at a depth of 6.2 mm relative to the surface of the brain. In addition to the
cannulas, two small support screws were fastened into the skull. Cannulas were semipermanently adhered to the skull using dental cement (Lang Dental; Wheeling, IL).

Transmitter Surgery. Rats in the behavioral and cardiovascular study were also implanted
with HDS-11 telemetry devices (Data Sciences International; St. Paul, MN). Transmitter
surgeries occurred immediately prior to cannula implantation. After the initial knockdown
and weighing, animals were placed onto a sterile pad on the surgical table. The nose was
gently inserted into the nose cone and the abdomen was exposed. Hair from the abdomen
and a small portion of hair from the right pectoral area was removed. Both areas were
thoroughly cleaned using three alternating applications of betadine and alcohol. An
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incision was made into the skin of the abdomen exposing the abdominal muscle.
Connective fascia was gently separated from the skin and the abdominal muscle
surrounding the incision to enhance ease for opening the abdominal cavity and facilitate
abdominal wound healing (Franz et al., 2001).
The abdominal cavity was slowly opened using small scissors. Organs were gently
moved to the right and the left to expose the descending vena cava and abdominal aorta. A
4 x 4 inch pad of sterile gauze was tightly rolled and inserted into the abdominal cavity to
keep the organs out of the way. After insertion, the roll of sterile gauze was soaked in sterile
0.9% injectable saline. Connective tissue was gently separated away from the surface of
the vena cava and the abdominal aorta using dry sterile cotton swabs. A portion of the aorta
immediately below the renal bifurcation was gently separated from the vena cava using
forceps. A piece of sterile suture was then threaded underneath using catheter forceps. This
process was repeated just above the iliac bifurcation. A small amount of injectable saline
was applied to the exposed aorta to rehydrate the vessel. During this time, the sterile
transmitters, the catheter inducer, and vet bond were prepared. After this preparation and
removal of all unnecessary surgical tools, the vessel was occluded using the two strands of
suture threaded underneath the abdominal aorta. The inducer was quickly inserted into the
vessel and the catheter was gently inserted and glued into place. The entire process of
occlusion, insertion, gluing, and de-occlusion occurs over a period of 45 seconds. To ensure
the catheter remains anchored to the abdominal aorta, a small cellulose patch is glued over
the top of the insertion site. The rolled gauze is then removed from the abdominal cavity
and the main body of the transmitter is inserted. The two ECG leads that are attached to
the transmitter are then exposed through the abdominal muscle. The muscle is then sutured
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closed with silk suture. During this process the transmitter is attached to the abdominal
muscle as the suture is guided through a number of rubber channels on the surface of the
device. This ensures that the transmitter remains in place and reduces strain on the catheter.
The exposed ECG leads are subsequently sutured in two distinct locations. The first
is sutured to the muscle just below and to the left of the xiphoid process, the cartilaginous
section at the lower portion of the sternum. The other lead is sutured to the pectoral muscle
just below the clavicle. This particular lead placement is known as the Modified Lead II
configuration (Berry, 2012). Although single ECG leads can provide useful data regarding
cardiac rhythm and heart rate, accurate visualization of the different components of the
ECG wave requires the presence of at least two ECG leads (Berry, 2012). Adherence of
the negative lead to the pectoral muscle and the positive lead on the lower left portion of
the rib cage has been demonstrated to provide the most clear temporal resolution of
individual ECG waves (Berry, 2012). Once the ECG leads are fastened into place with silk
suture, the skin is sutured closed using the absorbable polyglycolic acid sutures.

5.2.3 Drug Preparation
Several studies have begun to show the utility of N-[2-[[(Hexahydro-2-oxo-1Hazepin-3-yl)amino]-carbonyl]phenyl]benzo[b]thiophene-2-carboxamide

(ANA-12)

in

ameliorating anxiety- (Greenberg et al., 2013; Azogu and Plamondon, 2017a, b) and
depressive-like behaviors (Shirayama et al., 2015; Zhang et al., 2015b; Zhang et al., 2015a;
Zhang et al., 2016). Previously available Trk antagonists function to inhibit Trk
phosphorylation by directly competing with BDNF for the receptor binding pocket. Since
the binding pocket of TrkA, B, and C are highly conserved, these competitive antagonists
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display low selectivity for specific Trk receptor subtypes (De Smet et al., 2014). Therefore,
ANA-12 is a great advance as it selectively binds to the allosteric sites of the TrkB receptor
(Cazorla et al., 2011). The initial characterization of this compound indicated that ANA12 binds to both TrkB allosteric sites with a Kd of 10 nM for the high affinity site and 12
µM for the low affinity site (Cazorla et al., 2011). While several studies have directly
injected ANA-12 into discrete brain regions, the concentrations utilized vary between
studies and dose responses have not been openly published. Based on these limitations, a
pilot study was conducted to determine the dose of ANA-12 that produced maximal
inhibition of social defeat-induced TrkB phosphorylation. Rats in this study were exposed
to 5 days of social defeat. 500 nL of ANA-12 at a dose of 0, 0.25, 1, 2.5, and 10 µg (40%
dimethyl sulfoxide in 0.9% saline) were infused 30 minutes prior to social defeat on days
1, 3, and 5. Analysis of phosphorylated and total TrkB 4 hours after the final infusion (3.5
hours after the final defeat) on day 5 indicated that ANA-12 produced a dose dependent
reduction of ANA-12 (Figure 5.3A). Notably, the 2.5 µg dose produced maximal inhibition
of defeat-induced phosphorylation (Figure 5.3A). Subsequent non-linear analysis further
identified that ANA-12 in CeA homogenates has an IC50 of approximately 0.6 µg (Figure
5.3B). Importantly, these effects in phosphorylated TrkB did not result from differences in
total TrkB (Effect of dose: F(4, 18)=0.09, p=0.99; Figure 5.3C) or due to differences in the
housekeeping protein b-actin (Average b-actin signal ± SEM; 0 µg dose 397.6 ± 143.6;
0.25 µg dose 249.0 ± 50.22; 1 µg dose 342.5 ±126.8; 2.5 µg dose 324.2 ± 114.6; 10 µg
dose 355.1 ± 202.2; Effect of Dose F(4, 18)=0.2, p=0.96).
Based on the pilot study discussed above, 500 nL containing 2.5 µg of (ANA-12)
or vehicle (40% dimethylsulfoxide in 0.9% saline) were bilaterally infused into the CeA in
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order to assess whether CeA TrkB signaling contributes to the development of stressinduced behavioral dysfunctions and disruptions in cardiovascular regulation. Drug and
vehicle infusion were conducted using a micropump that was set to deliver the 500 nL
across a period of 1 minute. The effectiveness of ANA-12 to inhibit defeat-induced
phosphorylation of TrkB was verified using western blot analyses in tissues collected 4
hours after the final social defeat challenge. This particular time point was chosen as the
initial characterization of ANA-12 indicated that this drug produces maximal effects 4
hours after infusion (Cazorla et al., 2011). Details regarding the western blot analyses are
presented in section 5.2.7 of this chapter.
In addition to verifying the effectiveness of ANA-12 on TrkB phosphorylation, a
subset of animals were studied to determine drug spread. ANA-12 is still a relatively new
compound having first been described in 2011. As such biotinylated and fluorescently
tagged ANA-12 has not become commercially available. In order to estimate drug spread,
500 nL of a 1% solution of Chicago sky blue in vehicle (40% DMSO in 0.9% saline) was
bilaterally infused into the CeA at a rate of 0.5µL per minute immediately prior to
euthanasia. Brains were collected, blocked into anterior and posterior sections, and flash
frozen in ice cold 2-Methylbutane. Collected anterior brains were subsequently sliced on a
cryostat to the most rostral level of the CeA at which time 30 µm slices were collected and
mounted onto Superfrost Plus Microscope Slides (Fisher Scientific; Waltham, MA). Slides
were stained with a Neutral Red solution, dehydrated, fixed in Histo-Clear (National
Diagnostics; Atlanta, GA), and coverslipped. After allowing the slides to dry for 24 hours,
slices were imaged using a Zeiss axioscope 20 microscope with brightfield/darfield
capabilities and camera attachment. The resulting photos were then analyzed for drug
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spread using ImageJ (NIH Research Services Branch; Bethesda, MD). Each image was
carefully photographed to capture the rhinal fissure and the descending limb of the corpus
collosum. The distance between these two structures remains relatively constant
throughout the development of the CeA at approximately 1.75 mm (Paxinos and Watson,
2007). Therefore, these structures were used as the set point for size in ImageJ. To better
visualize the area of drug spread, each image was first converted to black and white and
the threshold was adjusted to 194 and 250. These adjustments in color were consistently
applied to each image to ensure accurate comparability. The area of drug spread, indicated
by the darkest area in the photo was then outlined and calculated by ImageJ (Figure 5.4).
Based on this method, it was determined that the drug encompassed an area of
approximately 0.57 ± 0.08 mm2 (average ± SEM). Since the area of the CeA is
approximately 1 mm2 at its largest and most developed point, these data suggest that the
drug did not spread to neighboring structures and was well maintained in the CeA.

5.2.3 Cardiovascular Measurements
This section gives specific details on the acquisition and calculation of
cardiovascular data obtained from rats with implanted HDS-11FO transmitters. All
cardiovascular data were generated using Ponemah version 6.3 acquisition and analysis
software (Data Sciences International, St. Paul, MN).

Determination of HRV. In order to determine long term shifts in HRV, cardiovascular
data were obtained for the first 5 minutes of every hour. This persistent monitoring began
at the start of the light cycle (7 am) 48 hours prior to the first social defeat or control
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exposure. This 48-hour period was used to determine the baseline resting blood pressure
and HR during both the dark and the light cycle for each individual rat. These hourly
cardiovascular recordings were continued throughout the 5-day social defeat or control
exposure period and ended on day 8 of the study (3 days after the final social defeat or
control exposure, see Figure 5.2). Ponemah is designed to conduct frequency analysis of
HRV. Frequency analysis has long been used as a tool to measure HRV as this particular
method of calculation provides a more precise assessment of autonomic function (Ori et
al., 1992). There are three major components to frequency analysis of HRV: high frequency
(HF) domain, low frequency (LF) domain, and the LF:HF ratio. In general it is thought that
the HF is indicative of vagal parasympathetic activity while the LF domain is a nonspecific
index of sympathetic activity (Ori et al., 1992). Therefore, the LF:HF ratio is an estimate
of sympatho-vagal balance (Ori et al., 1992). In order to conduct these analyses, all
acquired ECG data were separated into 1 minute and 40 second bins. Fast Fourier
transformation of these segments was conducted within the Ponemah program and spectral
power was quantified with frequency bands of 0.04 to 1.0 Hz corresponding to the LF
domain while bands of 1.00 to 3.00 Hz corresponded to the HF domain in accordance with
previously published work (Kuwahara et al., 1994; Wood et al., 2012; Carnevali et al.,
2013; Finnell et al., 2018).

During Defeat. The major benefit of using the HDS-11F0 transmitters is that it allows for
the collection of blood pressure and HR in awake freely moving animals. The only
requirement is that the animals are on the corresponding receiver. Therefore, it is possible
to detect cardiovascular measures during a variety of behavioral assays and challenges
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including social defeat. Our group has previously shown that stress-induced cardiovascular
responses differ greatly between behaviorally susceptible and resilient rats (Wood et al.,
2012; Finnell et al., 2018). To determine the effects of stress and drug treatment on blood
pressure and heart rate, cardiovascular recordings were obtained on day 1 and day 5 of
social defeat or control exposure. These recordings were obtained in 1-minute segments
for 1 hour prior to any drug or stress manipulation (baseline), 30 minutes post drug or
vehicle infusion, and during the 30-minute social defeat or control period. Mean arterial
pressure (MAP) and HR for each rat were subsequently calculated as a change from
baseline.

Arrhythmia Analyses. In addition to providing accurate blood pressure and HR
measurements, the HDS-11F0 transmitters generate blood pressure and ECG traces. These
two waveforms can be viewed simultaneously providing a beat by beat record of
cardiovascular events. One important aspect of these ECG and blood pressure traces is that
it allows for the identification and verification of arrhythmic events. Notably, previous
work from our group has shown that stress produces differential effects on arrhythmic
events in susceptible and resilient rats during the stress challenge (Finnell et al., 2018).
Based on the suggestion that the CeA may promote a number of cardiovascular
abnormalities including the generation of arrhythmias (Markgraf and Kapp, 1988;
Markgraf and Kapp, 1991), the current study utilized the ECG and blood pressure traces
obtained during days 1 and 5 to analyze the emergence of arrhythmias using he Lambeth
Convention (Walker et al., 1988; Curtis et al., 2013). Based on these well established and
widely used methods, continuous cardiovascular traces during baseline, post-injection, and
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defeat for day 1 and day 5 were visually examined for disturbances in blood pressure. When
a disturbance was identified, the ECG trace was evaluated to determine whether the
identified blood pressure disturbance corresponded to a true arrhythmic event.
During the analysis, several different types of arrhythmias were noted. Premature
ventricular contractions (PVCs) were by far the most common type of arrhythmic event.
PVCs occur as a result of a spontaneous contraction of the ventricles which is evidenced
by the presence of a sporadic QRS wave following a normal sinus beat in the ECG trace.
Although these arrhythmias are generally benign, individuals with high PVC burden are at
a greater risk for developing cardiomyopathy (Cantillon, 2013). Another class of
ventricular arrhythmia commonly detected in the cardiovascular traces obtained in this
study were bigeminies. Bigeminal arrhythmias can occur due to sporadic ventricular
contractions or result from failures in impulse generation or conduction (Wing and Phibbs,
1977). In general, bigeminal rhythms look like repeating heart beats with one long and one
short beat occurring in close temporal proximity. Unlike PVCs, bigeminal rhythms are
more likely to result in cardiac mortality including the emergence of sudden cardiac arrest
(Lerma and Glass, 2016).
In addition to quantifying the number of each arrhythmia that occurred during
baseline, post-injections, and during defeat/control exposure on day 1 and 5, arrhythmic
burden was calculated. Arrhythmic burden can most easily be conceptualized as a
nonspecific index of arrhythmic risk. Using the conventions described by Khoo et al. (Khoo
et al., 2006), arrhythmias were assigned point values as outlined in Table 5.1. These point
values are indicative of the overall risk of developing subsequent cardiovascular
disfunction and mortality. Therefore, the total arrhythmic burden represents the sum of
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weighted PVCs and bigeminial occurrences during each phase of exposure on day 1 and
day 5.

5.2.4 Elevated Plus Maze (EPM)
The EPM is a widely used behavioral assay for anxiety-like responses. Since the
first description of this model in 1984 by Handley et al (Handley and Mithani, 1984), over
7000 publications have utilized this method for the determination of anxiety-like responses
in rodents. Unlike other behavioral assays for anxiety-like responses that require exposure
to a noxious stimuli, the EPM capitalizes on a rodents natural tendency to prefer dark
enclosed spaces and avoidance of exposed open spaces (Barnett, 2017). Notably, this
particular behavioral method has been shown to have high face, construct, and predictive
validity which explains the widespread use of this model (Walf and Frye, 2007). For the
purpose of this study, rats were exposed to the EPM for a total of 5 minutes. Rats were
placed into the center of the plus shaped maze facing an open arm. Behavioral responses
during this 5-minute exposure were video recorded for later analysis. The plus maze was
cleaned between animals using 5% ammonium hydroxide solution to remove any latent
odors from the previous animal.
Behavioral analysis was conducted with the use of ANY-maze (Stoelting Co.;
Wood Dale, IL). A new protocol was created to quantify entries into the open and closed
arms. Instead of using the center point of the animal to designate entries or exits, the
detection settings were modified to quantify the entire animal. An entry was scored when
60% of the animal was present within a specific zone (open arm N, open arm S, closed arm
E, closed arm W, center). This particular measure was chosen as rats in the current study

130

would often stretch across a number of zones to investigate an open arm. By using the
whole animal and setting the threshold to 60%, these inspections were not included as arm
entries. All EPM data were analyzed using the same protocol to ensure cohesiveness
between animal sets. In order to assess anxiety-like states, the ratio of open to closed arm
time was calculated in accordance with other published work (Handley and Mithani, 1984;
Walf and Frye, 2007).

5.2.5 Tissue Homogenization
CeA punches collected in the molecular study were homogenized according to the
protocol outlined in Chapter 2 with one exception. In order to measure TrkB, homogenates
needed to be separated into membrane and cytosolic fractions. In order to accomplish this,
lysates were transferred to a clean fresh tube immediately following physical disruption
with the bullet blender. Bead free samples were then centrifuged at 14000 rcf and 4oC for
15 minutes. The resulting supernatant (cytosolic fraction) was transferred to a clean labeled
tube and stored at -80oC for future analysis. The pelleted membrane fraction was
resuspended using cold phosphobuffered saline and stored at -80oC. Additional
information regarding lysis buffer preparation can be found in Chapter 2.

5.2.6 Bio-Plex
Chapters 3 and 4 clearly showed the utility of Bio-Plex analyses to simultaneously
detect and quantify data for a number of cytokines from a single sample. This particular
study was not aimed at detecting cytokines. However, based on the popularity of this
method Bio-Rad has expanded upon this technique and now has kits available to study a
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number of cellular signaling targets. The current study utilized this method to quantify
phosphorylated and total Akt, CREB, ERK 1/2, and MAPK in CeA samples obtained in
the molecular study (4 hours after the final social defeat or control exposure). All data
reported in this chapter were ultimately calculated as the ratio of phosphorylated to total
protein for each target.
Detection of phosphorylated TrkB signaling effectors. Similar to the initial cytokine
Bio-Plex, this study was the first to utilize this particular method to quantify
phosphorylated TrkB signaling effectors in brain homogenates. Therefore, a pilot study
was run to determine the amount of protein that needed to be loaded onto the plate. Pilot
tissue collected at the same 4-hour time point following social defeat were loaded onto the
Bio-Plex plate at with a final concentration of 20, 50, 100, 200, 275, 500, 750, 1000, 1250,
and 1500 µg/mL. In general, the protocol for the molecular Bio-Plex was extremely similar
to that of the cytokine Bio-Plex with the exception that the protocol spans over two days.
Day 1 consisted of bead, sample, and control preparation. The samples were then allowed
to incubate at room temperature overnight on a plate shaker set to 400 rpm. Antibodies and
the fluorescent tag were then added during day 2 of the assay in an identical manner to that
of the cytokine Bio-Plex (Chapter 2). The plate was read using the same Bio-Rad Luminex
system to determine the fluorescence associated with each bead. The resulting data were
graphed against the log transform of the protein concentration loaded and the resulting
curves were analyzed for the EC50. The EC50 represents the concentration of a drug or a
compound that produces half of the maximal response. Based on these analyses the EC50
values varied between targets (Figure 5.5 A-C). Based on these curves it was decided that
a protein concentration of 700 µg/mL, equivalent to 35µg of protein, would be used on the
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Phospho-Plex kits as this allowed for the visualization of relative increases and decreases
for each target.

Detection of total TrkB signaling effectors. Similar to the Phospho-Plex, a pilot study
was conducted to determine the ideal amount of protein to be utilized for the detection of
total Akt, CREB, ERK 1/2, and MAPK. The pilot study was run nearly identically to that
described in the Phospho-Plex section with exception that protein concentration ranged
from 20, 50, 100, 200, 275, to 500 µg/mL. As with the Phospho-Plex, EC50 values varied
between targets (Figure 5.5 D-F). Ultimately it was decided that 200 µg/mL, equivalent to
10 µg of protein, would be ideal to visualize relative increases and decreases of each target.

5.2.7 Western Blot Analysis
Western blot analyses were conducted in this study to determine the concentration
of BDNF, phosphorylated, and total TrkB in CeA homogenates collected 4 hours after the
final social defeat or control exposure. Western blot is a widely utilized method for
detecting and visualizing specific proteins of interest. Briefly, samples containing 1x bmercaptoethanol with a loading buffer are heated to 75oC for 5 minutes. This results in a
denaturization or linearization of the protein within the sample and also induces a negative
charge on the protein. The samples are then carefully loaded onto a polyacrylamide gel
containing sodium dodecyl sulfate. An electrical current is then passed through the gel.
This electrical current interacts with the negatively charged protein and induces protein
migration down the gel. Smaller proteins tend to move faster as they can more easily pass
through the pores of the gel. As a result, proteins with larger molecular weights will remain
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closer to the top, while smaller proteins will be closer to the bottom of the gel. Once the
proteins have been separated by size, they are subsequently transferred to a membrane. The
current study utilized a polyvinylidene difluoride (PVDF) membrane. Similar to the gels,
these membranes contain pores. In order to open the pores of the membrane it is first soaked
in methanol. The gel and membrane are then placed into a transfer cassette. Similar to the
separation of the proteins within the sample, an electrical current is sent through the
cassette. In this case the negative current propels the negatively charged protein to move
forward into the membrane. Once the protein has transferred, the membrane can then be
probed with a number of antibodies to determine the presence and relative concentration
of specific protein targets.
As stated earlier, the current study utilized this method to determine the presence
and relative concentration of BDNF, phosphorylated, and total TrkB. In order to achieve
this, individual western blots were conducted. For the detection of BDNF, 20 µg of CeA
cytosolic fractions were loaded onto the gel. After transfer, membranes were incubated
overnight at 4oC with primary antibodies consisting of rabbit anti-BDNF (1:1000; EMD
Millipore; Burlington, MA) and mouse anti-GAPDH (1:1000; Abcam; Cambridge, UK).
The following morning, the primary antibodies were removed and the membranes were
thoroughly washed. Fluorescent secondary antibodies were then applied to the membrane
(goat anti-rabbit 680, goat anti-mouse, 800; Li-Cor Biosciences, Lincoln, NE) at a
concentration of 1:15000 and allowed to incubate at room temperature for 1 hour. The
secondary antibody was then removed, the membranes were washed a final time, and then
immediately imaged using a Li-Cor Odyssey Imaging system. Detection of phosphorylated
and total TrkB was nearly identical. For these analyses 20 µg of collected CeA membrane
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fractions were utilized. pTrkB was detected using rabbit anti-pTrkB (1:500; Abcam,
Cambridge, UK) and mouse b-arrestin (1:5000; Fisher Scientific; Waltham, MA). Total
TrkB was detected using rabbit anti-TrkB (1:1000; Abcam; Cambridge, UK) and mouse
b-arrestin (1:5000; Fisher Scientific; Waltham, MA).

5.3 Results
5.3.1 Behavioral and cort responses during ferret odor accurately predict coping
responses during defeat
Exposure to ferret odor activates stress sensitive brain regions such as the CeA
(Butler et al., 2011). Recent data from our lab suggests that the behavioral and
cardiovascular responses to ferret odor can be predictive of subsequent susceptibility or
resiliency to social defeat stress (unpublished data). Specifically, these data suggest that
high freezing and cort plasma levels in response to ferret odor are associated with the
passive coping susceptible phenotype exhibited during social defeat. In contrast, low
freezing and low cort were associated with the active coping resilient phenotype. Based on
these unpublished findings this study utilized a ferret odor test to predict behavioral
responses to social defeat, resulting in an even distribution of passive and active coping
rats in each defeat-treatment group. In line with our previous findings, rats were separated
into “low” and “high” responders using freezing behaviors across the 1st 5 minutes and
plasma cort concentrations collected 30 minutes after exposure. As expected plasma cort
concentrations between these two groups were significantly different (t(46)=4.1, p<0.001)
with high responders exhibiting approximately twice the amount of cort compared to low
responders (Figure 5.6A). Comparisons of cumulative freezing behaviors across the 1st 5
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minutes did indicate an effect of time (F(4, 245)=16.6, p<0.0002; Figure 5.6B). While an
effect of grouping did not reach statistical significance (F(1,245)=2.2, p = 0.1; Figure 5.6B),
the graph clearly shows that freezing behaviors in high and low responder rats begin to
diverge starting at the 3rd minute of exposure. These data agree with our previous findings
that also determined that individual differences in freezing behaviors could first be
visualized at this particular time point. It is important to note that the selected 30-minute
time point for cort analysis does not reflect peak cort concentrations (Dorey et al., 2012;
Gong et al., 2015). Therefore, these data do not assess differences in maximal release but
rather serve as an assessment of general physiological reactivity.
The accuracy of high and low responder classifications using ferret odor was
confirmed by evaluating the behavioral responses during social defeat. Average defeat
latencies for each rat were calculated across the 5-day social defeat period. Rats classified
as low responders during ferret odor demonstrated longer defeat latencies compared with
rats designated as high responders (average defeat latency ± SEM (s); low responder: 338.6
± 48.4; high responder: 170.0 ± 28.4; t(8)=2.8, p<0.05). According to our previously
published work (Wood et al., 2013; Wood et al., 2015; Finnell et al., 2017b), these defeat
latencies in low and high responders are indicative of active and passive coping
phenotypes, respectively. Based upon this behavioral verification, low and high responder
groups for the remainder of the publication are classified as active and passive coping.

5.3.2 Stress-induced alterations of TrkB signaling
Prior to starting the extensive cardiovascular and behavioral study it was critical to
verify (1) that social defeat enhanced the phosphorylation of TrkB and its downstream
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signaling effectors and (2) that ANA-12 inhibited these effects. Analysis of phosphorylated
TrkB indicated a significant stress by treatment interaction (F(2, 19)=4.5, p<0.05; Figure
5.7A, B). Strikingly, exposure to social defeat in vehicle-treated passive coping rats
resulted in a nearly 3-fold increase in phosphorylated TrkB within the CeA compared with
vehicle-treated control and active coping rats (Figure 5.7A). As expected, treatment with
ANA-12 inhibited this defeat-induced enhancement of TrkB phosphorylation in passive
coping rats (Figure 5.7A). Importantly, these effects were not due to differences in total
TrkB protein levels (Effect of Stress: F(2, 15)=0.5, p=0.6; Effect of Treatment: F(1, 15)=0.2;
p=0.7; Table 5.2). These notable effects in phosphorylated TrkB functioned to verify the
effectiveness of social defeat in the activation of this particular receptor and confirmed that
ANA-12 infusion could inhibit these processes. However, it remained unclear which
signaling cascades were coupled with this defeat-induced phosphorylation.
In order to address this question, signaling Bio-Plex kits were utilized to probe for
both phosphorylated and total Akt, CREB, ERK 1/2, and MAPK. Interestingly, TrkB
signaling effectors were differentially affected by coping during defeat and treatment.
Surprisingly, repeated ANA-12 treatment selectively and robustly increased the ratio of
phosphorylated to total Akt in non-stress controls (Stress x Treatment Interaction: F(2,
24)=5.0,

p<0.05; Figure 5.7B), while there was no effect of social defeat. Repeated stress

exposure in vehicle-treated rats did, on the other hand, result in an enhancement in
phosphorylated MAPK (Effect of Stress: F(2, 25)=4.1, p<0.05; Figure 5.7C) and ERK1/2
(Effect of Stress: F(2,

27)=3.7,

p<0.05; Figure 5.7D). Notably, these effects were most

pronounced in passive coping rats predicted to display susceptibility to the behavioral and
physiological effects of stress. Although statistical analysis was unable to identify an
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overall effect of ANA-12 treatment, there were no statistical differences in phosphorylated
MAPK and ERK1/2 between ANA-12 treated groups (p³0.09). Similarly, statistical
analysis was unable to identify treatment (F(1, 27)=0.9, p=0.3) or stress effects (F(2, 27)=2.1,
p=0.1) in phosphorylated CREB at this timepoint (data not shown) However, these data
largely mirror findings in phosphorylated MAPK and ERK1/2 with passive coping vehicletreated rats displaying trends towards greater ratios of phosphorylated versus total CREB.
Notably, these effects were not associated with differences in BDNF at this specific time
point (Effect of Stress: F(2, 22)=0.1, p=0.9; Effect of Treatment: F(1, 22)=0.3, p=0.6; Table
5.2). Taken together, these data suggest that coping during social defeat is associated with
differences in CeA TrkB signaling. Moreover, based on the extended timepoint at which
these data were collected (4 hours after the final infusion), these findings further suggest
that CeA TrkB signaling in passive coping rats is likely dysregulated. Based on the reported
contribution of CeA TrkB signaling through MAPK/ERK in the emergence of depressiveand anxiety-like phenotypes, it is plausible that this signaling cascade may underlie
susceptibility to the behavioral and physiological consequences of stress in passive coping
rats. This question was directly probed in the subsequent sections that outline findings from
the behavior and cardio study (Figure 5.2).

5.3.4 CeA TrkB signaling is critical for the emergence of active coping phenotypes
during defeat
To further characterize the effects of CeA TrkB signaling on social defeat behavior,
average defeat latencies and upright postures during defeat were quantified for rats in the
behavioral and cardiovascular study. These rats were grouped into passive and active
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coping prior to social defeat exposure based on their responsiveness during ferret odor as
described. As expected, vehicle-treated rats that were predicted to exhibit active coping
behaviors demonstrated significantly greater defeat latencies compared with vehicletreated rats predicted to be passive coping (Treatment x Group Interaction: F(2, 24)=7.4,
p<0.05; Figure 5.8A). Surprisingly, treatment with ANA-12 significantly reduced defeat
latencies in rats predicted to exhibit active coping (Figure 5.8A). These data suggest that
inhibition of CeA TrkB signaling promotes submissive behaviors in rats otherwise
predicted to be resilient. Similar effects were also demonstrated with regard to defensive
upright postures.
Analysis of upright posture on day 1, another behavior exhibited by the active
coping phenotype (Wood et al., 2010), indicated a significant interaction between coping
groups and treatment (Treatment x Coping interaction: F(1,

14)=6.3,

p<0.05) such that

vehicle-treated active coping rats exhibited a greater amount of time in upright postures
compared with vehicle-treated passive coping rats and ANA-12 treated rats of both
groupings (Figure 5.8B). Upright posture on day 5 of social defeat demonstrated similar
trends with vehicle-treated active coping rats exhibiting the greatest duration of upright
posture during defeat compared with vehicle-treated passive coping rats (Effect of Group:
F(1, 12)=5.1, p<0.05; Figure 5.8C). Similar trends were evident on day 5 in ANA-12 treated
rats. However, these effects did not reach statistical significance (Effect of Treatment: F(1,
12)=0.3, p<0.06; Figure 5.8C). Similar to defeat latency, upright postures on day 1 and 5
in vehicle-treated active and passive coping rats are in line with our previous publications
(Wood et al., 2013; Wood et al., 2015; Finnell et al., 2017b) further verifying the
effectiveness of ferret odor exposure as a method for prescreening coping responses during
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defeat. Importantly, findings in ANA-12 treated rats indicate that CeA TrkB signaling
seems to be crucial in the expression of active coping behaviors as these rats exhibited
enhanced submissive behaviors and reduced defensive postures.

5.3.5 Coping and ANA-12 differentially affect stress evoked blood pressure and HR
Day 1 (acute response to novel social stress). After baseline resting cardiovascular data
was collected, cardiovascular responses during day 1 began with the determination of postinjection MAP and HR across all stress and treatment groups. Notably, there were no
differences in MAP (Effect of stress: F(2, 30)=0.02, p=1.0; Effect of Treatment: F(1, 30)=0.33,
p=0.6) or HR (Effect of stress: F(2, 31)=0.6, p = 0.6; Effect of Treatment: F(1, 31)=0.1, p=0.8)
between stress and treatment groups during the 30 minute post-infusion period (Table 5.3).
Notably, there were significant effects of coping and treatment on MAP and HR during the
first social defeat or control exposure (Figure 5.9). Specifically, vehicle-treated active
coping rats exhibited significantly enhanced stress evoked MAP above that of controls and
passive coping rats (Effect of Stress: F(2, 496)=70.1, p<0.0001; Figure 5.9A). Interestingly,
treatment with ANA-12 produced differential effects on MAP depending on stress and
coping condition. In controls, ANA-12 did not alter MAP (Effect of Treatment: F(1, 354)=0.4,
p=0.5; Figure 5.9B) and only modestly reduced defeat-induced MAP in active coping rats
(Effect of Treatment: F(1,

287)=1.9,

p=0.2; Figure 5.9C). In striking contrast, ANA-12

treatment in passive coping rats robustly enhanced defeat-induced pressor responses during
the social defeat exposure on day 1 (Effect of Treatment: F(1, 255)=40.3, p<0.0001; Figure
5.9D). The initial social defeat exposure also produced significant enhancement in HR in
both vehicle-treated active and passive coping rats above that of controls (Effect of Stress:
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F(2, 430)=57.6, p<0.0001; Figure 5.9E). ANA-12 also produced robust, yet distinct effects
on heart rate. Specifically, tachycardic responses were largely blunted in controls (Effect
of Treatment: F(1, 375)=4.0, p<0.05; Figure 5.9F) and active coping rats (Effect of Treatment;
F(1, 256)=78.9, p<0.0001; Figure 5.9G) treated with ANA-12. Notably, defeat-induced HR
on day 1 was unaffected by ANA-12 treatment in passive coping rats (Effect of Treatment:
F(1,

202)=1.9,

p=0.2; Figure 5.9H). These data not only highlight differences in

cardiovascular reactivity of passive and active coping rats to the pressor and tachycardic
responses to defeat, but for the first time suggest that CeA TrkB signaling may be
intricately involved in these responses.

Day 5 (acute response to repeated social defeat stress). First, it was established that
MAP did not differ between stress (Effect of Stress: F(2, 31)=1.8, p=0.2) and treatment
(Effect of Treatment: F(1,31)=0.7; p=0.4) during the 30-minute post-infusion period (Table
5.3). However, there was a significant stress by treatment interaction (F(2,31)=3.9, p<0.05)
in tachycardic responses to the infusion such that ANA-12 treated passive and active
coping rats demonstrated greater HR during the 30-minute post-infusion period compared
to vehicle-treated passive and ANA-12 treated control rats (Table 5.3).
The hemodynamic response to stress, on the other hand, was maintained similar to
day 1 upon the 5th exposure to social defeat as indicated by the robust pressor response to
social stress in both passive and active coping groups treated with vehicle (Figure 5.10A).
Notably, these pressor responses in vehicle-treated passive coping rats exhibited enhanced
sensitivity to the pressor-inducing effects of social defeat during the 5th exposure. In
contrast, ANA-12 treatment did not alter MAP in non-stress control (Effect of Treatment:
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F(1,

350)=0.04;

p=0.9; Figure 5.10B) and active coping rats (Effect of Treatment: F(1,

299)=0.7, p=0.4; Figure 5.10C) while moderately enhancing MAP upon the start of stress
in passive coping rats (Effect of Treatment: F(1, 222)=5.5, p<0.05; Figure 5.10D).
Notably, tachycardic responses to social defeat followed similar trends. In vehicletreated rats, social defeat enhanced HR to a comparable extent in passive and active coping
rats (Effect of Stress: F(2, 468)=53.0, p<0.0001; Figure 5.10E). ANA-12 treatment in nonstress controls functioned to reduce HR (Effect of Treatment: F(1, 359)=22.3, p<0.0001;
Figure 5.10F). In contrast, ANA-12 treatment in active (Effect of Treatment: F(1, 251)=15.8,
p<0.0001; Figure 5.10G) and passive coping rats (Effect of Treatment: F(1,

224)=46.3,

p<0.0001; Figure 5.10H) functioned to enhance tachycardic responses. These HR data
suggest that repeated inhibition of CeA TrkB signaling via ANA-12 may enhance
cardiovascular reactivity to stress exposure. However, findings in MAP suggest that these
effects are isolated to HR and may be associated with differential activation of CeA
microcircuits in active and passive coping rats.

5.3.6 ANA-12 treatment completely inhibits social defeat-induced arrhythmias
Based on the intriguing effects of ANA-12 treatment and social defeat on MAP and
HR, it was hypothesized that ANA-12 may also impact the emergence of social defeat
evoked arrhythmias. Blood pressure and ECG waveforms during the baseline, postinjection, and defeat periods of each day were evaluated for the presence of PVCs and
Bigeminal beats. Example wave forms of normal sinus rhythms, PVCs, and bigeminal
beats are provided in Figure 5.11A-C. Interestingly, arrhythmic burden during defeat on
day 1 was significantly enhanced by social defeat exposure (F(2,17)=3.9, p<0.05; Figure
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5.11D). Post-hoc analyses indicated that these effects were strongest in vehicle-treated
active coping rats. Notably, these effects were largely driven by the emergence of PVCs
(Figure 5.11E) as there were virtually no bigeminal beats detected during defeat on day 1
(Effect of Stress: F(2,19)=1.1, p=0.4; Figure 5.11F). However, effects in stress-induced
PVCs were not strong enough to reach statistical significance (Effect of Stress: F(2,19)=2.3,
p=0.1). Arrhythmias on day 1 were largely unaffected by ANA-12 treatment (Arrhythmic
burden Effect of Treatment: F(1,17)=0.0006; p=1.0; PVCs Effect of Treatment: F(1,16)=0.1,
p=0.7; Bigeminal beats Effect of Treatment: F(1,19)=0.3, p=0.6).
While arrhythmic effects during day 1 were relatively nominal, arrhythmic events
during the 5th social defeat exposure were significantly more robust. Analysis of arrhythmic
burden revealed a striking stress by treatment interaction (F(2,16)=5.2, p<0.05) such that
social defeat in vehicle-treated passive coping rats exhibited significantly greater
arrhythmic burden during defeat on day 5 compared with all other stress and treatment
groups (Figure 5.11G). This enhancement of arrhythmic burden in vehicle-treated rats was
associated with an increase in PVCs (Effect of Stress: F(2,15)=3.4, p=0.06; Figure 5.11H)
and bigeminal beats (Effect of Stress: F(2,

17)=5.7,

p<0.05; Figure 5.11I). In line with

arrhythmic burden, these effects were strongest in vehicle-treated passive coping rats
indicating greater cardiovascular reactivity to social defeat. Notably, inhibition of CeA
TrkB signaling with ANA-12 completely inhibited these effects in both active and passive
coping rats (PVCs Effect of Treatment: F(1,15)=8.6, p<0.05; Bigeminal beats Effect of
Treatment: F(1,17)=6.8, p<0.05). Importantly, arrhythmic burden during baseline and postinjection did not differ between stress or treatment groups on either day 1 (Baseline Effect
of Stress: F(2, 20)=1.0, p=0.3; Baseline Effect of Treatment: F(1, 20)=0.8, p=0.4; Post-injection
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Effect of Stress: F(2, 19)=0.1, p=0.7; Post-injection Effect of Treatment: F(1, 19)=0.4, p=0.5;
data not shown) or day 5 (Baseline Effect of Stress: F(2, 29)=0.3, p=0.5; Baseline Effect of
Treatment: F(1,

29)=0.0,

p=0.8; Post-injection Effect of Stress: F(2,

19)=0.3,

p=0.6; Post-

injection Effect of Treatment: F(1, 19)=0.9, p=0.3; data not shown). Taken together, these
data suggest that repeated exposure to social defeat results in an overall enhancement of
arrhythmic events that are directly associated with the coping behaviors adopted during
stress. Findings that arrhythmic events at baseline and post-injection do not differ between
groups, suggests that these effects are explicitly driven by social defeat exposure and do
not result from baseline increases in arrhythmic events. Moreover, these arrhythmogenic
effects of social defeat were completely blocked by ANA-12 treatment suggesting that CeA
TrkB signaling is integral to these effects.

5.3.7 Quantification and evaluation of depressive- and anxiety-like behaviors
In order to evaluate depressive- and anxiety-like behaviors, the current study
employed the use of a sucrose preference test and EPM. Findings from these assays
suggested that stress and ANA-12 treatment differentially contribute to the development
of depressive- and anxiety-like behaviors following the cessation of social defeat.
Specifically, inhibition of CeA TrkB signaling via ANA-12 inhibited the emergence of a
depressive-like phenotype in active and passive coping rats (Effect of Treatment: F(1,
35)=11.1, p<0.01; Figure 5.12A). These depressive-like effects were strongest in the 1

st

hour

of sucrose preference. Although, these effects dissipated by the 3rd hour, data collected at
this time did suggest that there was still a trend for treatment (Effect of Treatment: F(1,
35)=3.4,

p=0.07) with passive coping rats exhibiting an overall reduction in sucrose
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consumption (average percent sucrose consumed ± SEM; vehicle control 92 ± 1.9; vehicle
active coping 92.2 ± 1.8; vehicle passive coping 85.8 ± 5.0). Importantly, these effects did
not result from differences in the total volume consumed (Effect of Stress: F(2, 49)=0.7,
p=0.5; Effect of Treatment: F(1, 49)=0.9; data not shown).
The current study evaluated open and closed arm time (raw and the ratio) as well
as the percentage of open arm entries in order to determine the emergence of anxiety-like
behaviors. Analysis of open arm time confirmed that exposure to stress produced anxietylike behavioral phenotypes (Effect of Stress: F(2, 32)=3.6, p<0.05; Figure 5.12B). Although
variable, these data suggest that anxiety-like behaviors following social defat are enhanced
in passive coping rats. Treatment with ANA-12 did not protect against the development of
anxiety-like behaviors (Effect of Treatment: F(1,

32)=0.9,

p=0.3). Interestingly, data

evaluating the percentage of open arm entries suggested that ANA-12 may have increased
the anxiety-like behavioral effects of social defeat (Effect of Treatment: F(1,

30)

= 3.9,

p=0.06; Figure 5.12C). In contrast to these two measures, there were no differences in the
duration spent in the closed arm of the EPM (Effect of Stress: F(2, 33)=1.3, p=0.3; Effect of
Treatment: F(1,33)=0.7; Figure 5.12D). Instead, there was a significant stress by treatment
interaction for time spent in the center of the maze (F(2,31)=3.8, p<0.05). Although it is
currently unclear what these data mean in the scope of anxiety-like behaviors, passive
coping vehicle-treated rats spent greater durations in the center of the maze compared with
all other stress and treatment groups (Average time in center ± SEM (s); vehicle control
19.5 ± 4.0; vehicle active coping 21.0 ± 4.0; vehicle passive coping 30.5 ± 8.5; ANA-12
control 28.5 ± 3.4; ANA-12 active coping 19.9 ± 7.9; ANA-12 passive coping 9.5 ± 2.3).
Importantly, there were no differences in distance traveled between stress (F(2, 34)=2.9,
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p=0.1) and treatment groups (F(1, 34)=0.03; p=0.9; data not shown), suggesting that these
effects are not due to reduced locomotor activity.

5.3.8 12-hour dark cycle HRV
To evaluate if social defeat and ANA-12 produced overall disruptions in
cardiovascular health, resting dark cycle blood pressure, HR, and HRV were measured
throughout the 5-day social defeat period and for 3 days after the final social defeat
exposure. HRV in terms of LF, HF, and LF/HF ratio across the 8 days of social defeat did
not differ greatly between stress and treatment groups (Table 5.4).

5.4 Discussion
The CeA has been extensively studied over the past 6 decades. The comprehensive
literature generated over this prolonged period of time has suggested that the CeA functions
as an integrative hub to coordinate a number of behavioral and physiological responses
during stress and fear (Ressler, 2010). These effects are attributed to CeA neuromodulation
of a number of brain regions including the periaqueductal gray (Rizvi et al., 1991), dorsal
motor nucleus of the vagus (Gray and Magnuson, 1987), hypothalamus (Cassell et al.,
1986; Gray et al., 1989; Callahan et al., 2013), locus coeruleus (McCall et al., 2015),
nucleus tractus solitarius (Saha, 2005), and rostral ventrolateral medulla (Saha, 2005).
Although CeA neurons are primarily inhibitory GABAergic, several studies have
determined that a significant population CeA projection neurons also express corticotropinreleasing factor (CRF) and enkephalin (Cassell et al., 1986; Gray and Magnuson, 1992).
Mounting evidence has suggested that stress indiscriminately enhances the activation of
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CeA neuronal populations (Takahashi et al., 2011; Fang et al., 2018) likely resulting in a
concomitant release of GABA, CRF, and enkephalin. In this way the CeA can
simultaneously facilitate and impede neuronal activation in specific projection regions
resulting in the induction of complex behaviors and physiological responses. Although the
current studies did not differentiate between neuronal cell types, findings reported in this
manuscript indicate that CeA TrkB signaling may be critical in this process. Administration
of ANA-12 and effective inhibition of TrkB phosphorylation and signaling directly
inhibited the emergence of upright defensive postures, enhanced submissive tendencies
during defeat, and protected against the emergence of depressive-like behavior while
anxiety-like behaviors were largely unaffected. Similar to the broad behavioral effects,
ANA-12 treatment functioned to enhance defeat-induced blood pressure and HR while
simultaneously inhibiting defeat-induced arrhythmias. Importantly, data obtained in the
current studies suggest that individual differences in stress coping and susceptibility may
be directly related to differences in stress-induced CeA microcircuitry.
Several studies have begun to assess whether active/passive phenotypes are indeed
associated with differences in the activation of CeA microcircuits. For example, a study by
Reyes et al in 2015 demonstrated that passive coping during social defeat was directly
associated with enhanced activation of CeA CRF afferents and LC neurons. In contrast,
rats demonstrating active coping phenotypes did not exhibit this maintained activation
(Reyes et al., 2015). Similar effects have also been reported with regard to the
periaqueductal gray (Keay and Bandler, 2001), a brain region involved in behavioral
freezing responses (Watson et al., 2016). Although the contribution of the CeA in these
responses remains unclear, it has been documented that the medial and lateral divisions of
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the CeA distinctly project to this region (Li and Sheets, 2018). Notably, the medial and
lateral subdivisions of the CeA are the primary sites of CRF containing cells (Cassell et al.,
1986) which have specifically been implicated in discriminative fear responses (Sanford et
al., 2017) and directly mediate the adoption of defensive active coping behaviors (Fadok
et al., 2017). Although findings from the current study cannot definitively implicate CeA
TrkB signaling on CRF projecting neurons, the inhibition of active coping defensive
behaviors induced by ANA-12 treatment does suggest that these neuronal populations were
likely affected and are intricately involved in the behavioral responses to social defeat.
In addition to mediating the behavioral response to stress and fear, the CeA is well
known to contribute to stress or fear-induced cardiovascular activation via connectivity
with the nucleus tractus solitarius and rostral ventrolateral medulla (Saha, 2005). In
general, stimulation studies have determined that CeA activation differentially regulates
these brain regions resulting in the inhibition of the nucleus tractus solitarius while
promoting the activation of the rostral ventrolateral medulla (Saha, 2005). By blocking
bottom-up peripheral parasympathetic feedback and enhancing peripheral sympathetic
outflow, the combined effects on these two brain areas results in an increase in blood
pressure and heart rate. While findings from the current study support the involvement of
these particular circuits in the pressor and tachycardic responses to social defeat on day 1
and day 5, CeA TrkB signaling in these responses seems to be isolated to passive coping
rats and further suggests differential activation of CeA microcircuits.
In contrast, stress-induced CeA TrkB signaling was intricately involved in the
arrhythmogenic effects of social defeat. The current study indicated that social defeat
directly increases in the frequency of PVCs and bigeminal rhythms. These effects are likely
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driven by CeA connectivity with the dorsal motor nucleus of the vagus. Serving as the
major source of parasympathetic outflow to the periphery, the dorsal motor nucleus of the
vagus exhibits control over a vast number of physiological systems and processes including
ventricular excitability (Machhada et al., 2015). In general, it has been demonstrated that
vagal withdrawal shortens ventricular refractive periods and lowers the threshold for the
generation of ventricular beats (Machhada et al., 2015). Stress and CRF are both capable
of inducing vagal withdrawal (Wood and Woods, 2007) allowing for the possibility that
CeA CRF fibers may directly contribute to these effects. Notably, findings from the current
study support a role for the CeA TrkB signaling in defeat-induced arrhythmic events as
ANA-12 infusion directly into the CeA 30 minutes prior to the social defeat challenge
completely blocked defeat-induced PVCs and bigeminal events.
Based on the strong effects noted during defeat, it was predicted that ANA-12
treatment would protect against the emergence of depressive- and anxiety-like responses.
Surprisingly, analysis of behavior following social defeat indicated that ANA-12 was
largely ineffective in blocking the emergence of an anxiety-like behavioral phenotype.
Numerous studies have suggested that the CeA is intricately involved in the emergence of
anxiety-like behaviors (Swartz et al., 2014; Gilpin et al., 2015; Babaev et al., 2018).
Anxiety is often thought of as a heightened state of vigilance with a consistent feeling of
apprehension. However, anxiety can also be thought of as a state of sustained fear.
Sustained fear describes behavioral and emotional states that are associated with the
anticipation of an unpredictable or potential threat. In contrast, phasic fear describes
emotional and behavioral states that are directed at a specific threat. Studies in humans and
rodents have suggested that these two processes involve distinct yet interrelated neural
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circuits. Specifically, it has been shown that phasic fear is directly driven by the amygdala
while sustained fear is driven by the bed nucleus of the stria terminalis (BNST) (Davis et
al., 2010; Münsterkötter et al., 2015). Although the study in humans was not able to
implicate specific divisions of the amygdala in these responses (Münsterkötter et al., 2015),
rodent studies have established that phasic fear is directly associated with activation of the
CeA (Davis et al., 2010). This differentiation between evoked fear and anxiety-like
behavioral responses and the distinct involvement of the CeA and BNST in these effects
has been well supported in the literature (Gafford and Ressler, 2015). Based on these data
and suggestions it would be interesting to expand upon these findings to determine if
repeated social defeat exposure and ANA-12 would affect the expression of phasic fear at
this extended time point.
The molecular data collected in the current study suggest that stress exposure may
have resulted in persistent alterations of CeA neuronal function. This assumption is
supported by analysis of CeA homogenates collected 4 hours after the final drug infusion.
At this particular time point, rats with a history of social defeat demonstrated significant
enhancements in phosphorylated TrkB, MAPK, and ERK 1/2. Unexpectedly, ANA-12
treated controls that demonstrated only modest increases in phosphorylated TrkB exhibited
significant increases in phosphorylated Akt. As discussed in the introduction, MAPK/ERK
and Akt are competing signaling pathways (Gervais et al., 2006; Yokoyama et al., 2013)
that produce vastly different molecular and behavioral effects. Notably, these stress and
treatment effects were not associated with differences in BDNF at this particular time point.
It is entirely plausible that a history of social defeat may have altered BDNF release into
the CeA and that the chosen time point is simply not ideal to visualize these differences.
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However, studies assessing the effects of BDNF in the CeA are equivocal and are highly
dependent upon the methods utilized (Pandey et al., 2006; Taylor et al., 2011). However,
the sustained phosphorylated TrkB, MAPK, and ERK at this extended time point do
suggest that social defeat may have altered intracellular mechanisms responsible for
regulating TrkB signaling. Protein tyrosine phosphatases (PTPs) a large family of protein
phosphatases that function to dephosphorylate and thus inhibit TrkB signaling (Sapieha et
al., 2005; Gatto et al., 2013). This particular protein family is widely expressed throughout
the brain (Lorenzetto et al., 2014) and demonstrates sensitivity to stress (Yang et al., 2012;
Dabrowska et al., 2013). Notably, stress-induced reductions of PTPs are functionally
associated with enhanced glutamate sensitivity (Dabrowska et al., 2013) and extended
durations of ERK1/2 activation (Yang et al., 2012). In addition to the documented effect
of stress, inflammation has also been shown to inhibit PTPs (Grinnell et al., 2012; Seo et
al., 2013; Duan et al., 2014). Several of our previous studies have demonstrated that social
defeat in males and witness stress in females is associated with a significant enhancement
of neuroinflammation within the CeA (Finnell et al., 2018; Finnell et al., 2019). Notably,
these inflammatory profiles were associated with the emergence of cardiovascular
dysfunction, anxiety- and depressive-like behaviors (Finnell et al., 2018). Based on the
strong relationship between inflammation and stress-induced behavioral dysfunction, it
would be intriguing to develop a study to further characterize the relationship between
inflammation, PTPs, and TrkB signaling.
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Table 5.1 Arrhythmic burden scoring guide. This table consists of
the points assigned to each arrhythmia for the calculation of
arrhythmic burden.
Points Assigned

Arrhythmic Beat

0

Normal Sinsus/Absence of Arrhythmias

1

Isolated PVC

2

2 or 3 consecutive PVCs (Salvo)

3

Bigeminal or Trigeminal Rhythms

4

Asystole
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Table 5.2 Summary of additional western blot analyses for total TrkB and BDNF and
comparison of housekeeping proteins used for normalization. Data expressed as an average
± SEM.
Primary Targets (normalized signal to appropriate housekeeping proteins)
Vehicle

ANA-12

Statistical

Target
Control

Active

Passive

Control

Active

Passive

Total

60.4 ±

139.7 ±

109.0 ±

115.1 ±

73.4 ±

110.7 ±

TrkB

6.8

79.4

39.2

33.1

30.1

54.4

37.5 ±

51.0 ±

49.6 ±

53.9 ±

47.4 ±

46.7 ±

Analysis
N.S. Stress
(p=0.2), Tx

BDNF

(p=0.2)
N.S. Stress
(p=0.9), Tx

5.2

4.3

5.9

13.1

1.9

6.4

(p=0.6)

Housekeeping proteins (raw fluorescence)

b-actin

551.0 ±

425.8 ±

449.3 ±

346.4 ±

244.8 ±

(p=0.4), Tx
198.9

9392.0
GAPDH

214.6 ±

N.S. Stress

± 935.8

59.0

145.5

163.0

157.7

8562.5

7502.0

7998.0

±

±

±

1764.4

1282.7

1051.5

8500.0
± 430.7

46.9

(p=0.7)
N.S. Stress

7780.0
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± 929.5

(p=0.95), Tx
(p=0.3)

Table 5.3 MAP and HR during the post-infusion period on day 1 and day 5. Data expressed
as the average change from baseline ± SEM in mmHg or beats per minute. *p<0.05 vs
vehicle passive and ANA-12 control.
Day 1
Statistical
Vehicle

ANA-12

Analysis

10.9 ±

9.9 ±

11.2 ±

11.6 ±

12.9 ±

10.8 ±

2.5

2.1

1.6

2.4

1.3

1.4

MAP

N.S. Stress
(p=1.0), Tx

74.6 ±

65.1 ±

73.5 ±

56.0 ±

61.3 ±

84.1 ±

HR

(p=0.6)
N.S. Stress
(p=0.6), Tx

14.7

16.8

18.1

12.3

8.9

6.8

(p=0.7)

Day 5
11.5 ±

11.9 ±

11.7 ±

10.1 ±

11.5 ±

18.1 ±

MAP

N.S. Stress
(p=0.2), Tx

1.2

1.6

2.1

2.5

2.4

3.6

59.2 ±

70.9 ±

67.4 ±

45.5 ±

76.0 ±

105.1 ±

HR

(p=0.4)
Stress x Tx:
F(2,31)=3.9,

9.1

8.3

8.9

8.6
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7.8

8.6*

p<0.05

Table 5.4 Social defeat and ANA-12 treatment do not change resting HRV. Data presented
as the average percent of baseline ± SEM.
Day 1

Vehicle

ANA-12

Control

Defeat

Control

Defeat

LF

105.4 ± 9.9

99.2 ± 4.5

104.1 ± 6.8

87.9 ± 5.0

HF

134.7 ± 20.1

111.4 ± 16.1

118.3 ± 19.4

96.0 ± 19.9

LF:HF

88.4 ± 6.0

98.4 ± 3.7

106.2 ± 4.7

112.1 ± 7.3

LF

93.8 ± 4.5

103.0 ± 6.0

79.8 ± 6.0

90.0 ± 4.4

HF

107.6 ± 14.3

114.5 ± 17.1

83.3 ± 15.6

80.6 ± 10.3

LF:HF

108.1 ± 2.6

106.1 ± 5.3

110.9 ± 11.6

110.3 ± 10.8

LF

95.6 ± 4.9

103.0 ± 5.9

104.3 ± 4.7

99.2 ± 3.6

HF

105.9 ± 15.0

117.5 ± 15.6

109.0 ± 19.8

87.0 ± 5.8

LF:HF

97.9 ± 5.0

106.1 ± 5.3

110.9 ± 11.6

110.3 ± 10.8

LF

99.7 ± 9.1

106.4 ± 6.1

105.1 ± 5.2

95.1 ± 4.2

HF

112.5 ± 16.9

105.4 ± 19.1

134.0 ± 36.1

99.2 ± 8.3

LF:HF

94.0 ± 7.9

110.2 ± 11.1

98.1 ± 19.9

106.9 ± 7.3

Day 3

Day 5

Day 8
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Figure 5.1 Schematic of TrkB signaling cascade. Following BDNF
binding and TrkB homodimerization and autophosphorylation, three
distinct signaling cascades are initiated. Notably, MAPK/ERK and
Akt compete for the same phosphate residue (515) on the receptor.
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Figure 5.2. Study design, timeline, and samples sizes of the cell signaling (A) and
behavioral and cardiovascular study (B).
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Figure 5.3 ANA-12 dose dependently reduces phosphorylated TrkB without altering total TrkB. Treatment with ANA-12
produced dose dependent inhibition of defeat-induced TrkB phosphorylation in the CeA (A). Maximal inhibition was
demonstrated at the 2.5 µg dose. Analysis using non-linear regression indicated that the IC50 for ANA-12 was approximately
0.6 µg (dotted line; B). Notably, these effects were not due to differences in total TrkB (C).

Figure 5.4 Representative image of the imageJ manipulation utilized to determine ANA12 drug spread.
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Figure 5.5 Comparison of phosphorylated and total Bio-Plex cell signaling targets. Side by side comparison of
phosphorylated Akt (A), ERK (B), and MAPK (C) indicitated a different EC50 value for each of these targets (dotted line).
Similar effects were also noted for total Akt (D), ERK (E) and MAPK (F).
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Figure 5.6 Ferret odor-induced plasma Cort concentrations (A) and freezing behaviors (B)
in low and high responder rats. Following statistical separation, rats classified as “low
responders” exhibited significantly lower ferret odor-induced plasma Cort concentrations
compared with high responders. Analysis of freezing behavior indicated behavioral
responses during ferret odor begin to diverge starting at the 3rd minute of exposure. Similar
to plasma cort, rats assigned to the low responder group demonstrated lower freezing
behaviors across minutes 3-5 compared with high responder rats. ***p<0.001 vs high
responder rats
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Figure 5.7. Social defeat and ANA-12 treatment differentially affect phosphorylation of
TrkB (A-B), Akt (C), MAPK (D), ERK1/2 (E), and CREB (F). Social defeat in vehicletreated rats was associated with a significant enhancement of phosphorylated TrkB in the
CeA. This was associated with an overall increase in phosphorylated MAPK, ERK1/2, and
CREB that was exaggerated in rats demonstrating a passive coping phenotype. While
ANA-12 treatment in socially defeat rats largely blocked these effects, ANA-12 in nonstress controls was associated with a robust and selective enhancement of Akt. ap<0.05 vs
all other stress and treatment groups; *p<0.05, **p<0.01 vs vehicle controls; #p<0.05 vs.
vehicle passive coping group
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Figure 5.8. ANA-12 treatment inhibits the emergence of an active coping phenotype during social defeat. Vehicle-treated rats
predicted to exhibit active coping during defeat demonstrated enhanced defeat latencies (A) and greater upright postures on
day 1 (B) and day 5 of defeat (C) compared to vehicle-treated rats predicted to exhibit passive coping behaviors. Inhibition of
CeA TrkB with ANA-12 signficantly reduced defeat latency and upright postures on both day 1 and day 5. **p<0.01 vs vehicle
active coping rats
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Figure 5.9. Social defeat and ANA-12 treatment differentially affected MAP and HR
on day 1 of defeat. During the 1st social defeat exposure, vehicle-treated active coping
rats demonstrated significantly greater MAP compared with both control and passive
coping groups (A). Treatment with ANA-12 did not alter pressor responses in control
rats (B) and only modestly reduced these effects in active coping rats (C). In contrast,
ANA-12 treatment facilitated pressor responses in passive coping rats (D). Unlike
MAP, HR on day 1 was enhanced to a similar extent in vehicle-treated active and
passive coping rats (E). While ANA-12 did not alter tachycardic responses in control
(F) and passive coping groups (H), treatment significantly blunted HR in active coping
rats (G). ap<0.05 vehicle active coping vs. vehicle control; #p<0.05 vehicle passive
coping vs. vehicle controls; *p<0.05 vs. stress matched vehicle-treated group
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Figure 5.10. ANA-12 facilitates pressor and tachycardic responses selectively in
passive coping rats on day 5 of defeat. The 5th social defeat exposure in vehicle-treated
rats induced similar enhancements in MAP between passive and active coping rats
(A). Treatment with ANA-12 did not alter pressor responses in control (B) or active
coping rats (C) but selectively facilitated pressor responses in passive coping rats (D).
Similar effects were seen in HR on day 5. Social defeat induced similar tachycardia
between active and passive coping groups (E). Unlike MAP, HR was significantly
blunted in ANA-12 treated controls (F) and facilitated in passive coping rats (H). HR
in ANA-12 treated active coping rats did not change (G). ap<0.05 vehicle active
coping vs. vehicle control; #p<0.05 vehicle passive coping vs. vehicle controls;
*p<0.05 vs. stress matched vehicle-treated group
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Figure 5.11. ANA-12 completely inhibits social defeat-induced arrhythmias. Blood
pressure (top panel) and ECG traces (bottom panel) were evaluated for normal sinus
rhythm (A), PVCs (B), and bigeminal beats (C). In response to the 1st social defeat
exposure, active coping vehicle-treated rats exhibited an enhancement an arrhythmic
burden (D) that was associated with an increase in PVCs (E). Defeat on day 1 did not
produce bigeminal beats (F). While arrhythmic events on day 1 were modest, exposure
on day 5 produced robust enhancement of arrhythmic burden that was significantly
pronounced in passive coping vehicle-treated rats (G). This increase in arrhythmic
burden was directly associated with enhancement of defeat-induced PVCs (H) and
bigeminal beats (I). Notably, treatment with ANA-12 completely inhibited the
arrhythmogenic effects of stress in active and passive coping rats. *p<0.05, **p<0.01,
***p<0.001; ****p<0.0001 vs vehicle-treated controls; #p<0.05 vs stress matched
vehicle-treated rats.
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Figure 5.12. ANA-12 treatment inhibits the emergence of depressive-like behavior
but does not affect anxiety-like behaviors following social defeat. Social defeat in
vehicle-treated passive and active coping rats resulted a significant reduction of
sucrose preference (A). Treatment with ANA-12 inhibited the emergence of this
depressive-like behavior in both active and passive coping groups. Exposure to
social defeat further induced the emergence of anxiety-like behaviors in the EPM
as evidenced by reduced time in open arms (B) and reduced percentage of open arm
entries (C). These effects seemed to be more pronounced in rats demonstrating
passive coping during defeat. Treatment with ANA-12 did not improve anxietylike behaviors and seemed to further reduce the percentage of open arm entries.
Comparison of closed arm time between stress and treatment groups indicated that
this measure remained largely unchanged (D). *p<0.05 vs. vehicle-treated control.
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Chapter 6
Bringing it all together: The past, present, and future
As outlined in Chapter 1, the primary goal of the work described in this dissertation
was to elucidate mechanisms underlying stress-induced depressive like behaviors as it
pertains to inflammation. Currently, there are a number of different hypotheses regarding
the specific mechanisms underlying stress-induced behavioral dysfunction. Many of these
hypotheses have largely focused on alterations in one specific neurotransmitter or
neuromodulatory system such as glutamate, GABA, BDNF, 5-HT, CRF, and NE.
However, this is a very narrow view of the complex dysregulation that occurs following
stress exposure and suggests that many of these systems function exclusively and
independently from one another. In reality, it is known that these systems overlap and work
in concert. The most direct evidence for this assumption stems from the broad off target
effects produced following treatment with anti-depressant therapies. For example, selective
serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs) and
tricyclics (TCAs) have all been shown to positively impact BDNF (Balu et al., 2008),
glutamate (Musazzi et al., 2010; Musazzi et al., 2013), and GABA (Bhagwagar et al.,
2004). Notably, these effects occur as a direct result of drug treatment rather than resulting
as a secondary consequence of mood improvement. While it is likely that each one of these
discrete systems contribute to the complex neuronal and behavioral dysfunction that results
from stress, it is highly unlikely that stress preferentially and selectively disrupts just one
of these systems.
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In contrast to these very narrow hypotheses, inflammation represents a broad
approach to studying stress-induced behavioral dysfunction. As outlined in Chapters 3 and
4, exposure to stress produces a global shift of inflammatory processes in the periphery and
the brain. These effects are indiscriminate occurring across a number of cytokine families
and are not isolated to pro- or anti-inflammatory subtypes. Notably, these stress-induced
inflammatory effects are enduring (Voorhees et al., 2013; Wohleb et al., 2013; Wood et
al., 2015; Finnell et al., 2017b; Finnell et al., 2017a; Finnell et al., 2018) and findings from
Chapters 3 and 4 further demonstrate that these systems in the periphery and the brain are
significantly sensitized. Sensitization of microglia and macrophages are dependent upon
shifts in cellular metabolism, epigenetic regulation, and transcription (Cheng et al., 2014;
Saeed et al., 2014; Neher and Cunningham, 2019). This molecular process in microglia and
peripheral inflammatory cell types is suggestive of inflammatory reprogramming of innate
immune memory.
Immune memory is a major consequence of adaptive immune responses. In terms
of disease or infection, immunological memory describes the cellular process which allows
the immune system to respond more rapidly and effectively to previously encountered
pathogens (Dominguez-Andres and Netea, 2019). This process forms the basis for the
efficacy of vaccines. Although it was originally thought that these processes required the
persistent presence of a specific antigen, it has recently been reported that shifts in
metabolism and transcription induced by antigen detection are stored and passed on by
progenitor cells (Christ et al., 2018; Kaufmann et al., 2018; Mitroulis et al., 2018). In this
way immune cell adaptations can be maintained for months (Dominguez-Andres and
Netea, 2019) or years (Janeway et al., 2001). Importantly, recent findings in mice have
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suggested that sustained immune memory is also present in microglia and may last for up
to 6 months (Wendeln et al., 2018). As it pertains to stress and microglia, it is currently
unclear how long these adaptations remain. However, given the slow microglial turnover
rate (28% per year) and an average lifecycle of 4.2 years (Réu et al., 2017), it is very
probable that these cellular effects last well beyond the cessation of stress.
Notably, findings in Chapter 4 of this document directly implicates LC-derived NE
in peripheral and central sensitization. In the periphery, NE is well known to exert
proinflammatory effects by directly stimulating cytokine release (Flierl et al., 2009; Li et
al., 2015) and promoting immune cell sensitization (Spengler et al., 1990; Kavelaars et al.,
1997; Grisanti et al., 2010). In agreement with these previous reports, data in Chapter 4
demonstrated that LC derived NE was directly associated with social defeat-induced
peripheral inflammation. In contrast, loss of LC-NE seemed to disinhibit inflammatory
responses in the brain resulting in robust neuroinflammatory tone within the central
amygdala (CeA). This disinhibition of neuroinflammation following withdrawal of NE
seems to be isolated to brain regions that are predominantly innervated by the LC. Region
specificity of stress-induced neuroinflammation has frequently been reported throughout
the brain. For example, in the prefrontal cortex (de Pablos et al., 2006) and ventral
hippocampus (Pearson-Leary et al., 2017) stress exposure significantly enhances
neuroinflammation. In contrast, findings from the dorsal hippocampus suggest that this
region is largely immune to the inflammatory inducing effect of stress (Pearson-Leary et
al., 2017). Importantly, the prefrontal cortex and the ventral hippocampus receive dense
projections from the LC (Oleskevich et al., 1989; Zhang et al., 2013) while LC projections
to the dorsal hippocampus are minimal (Oleskevich et al., 1989). Taken together, these
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data support a role for LC derived NE in the production of region-specific inflammatory
responses following stress exposure. However, future studies will need to be conducted to
verify this claim.
Although more work needs to be completed in order to fully characterize the
involvement of the LC-NE system in region specific inflammatory responses following
stress, inflammation in the brain is known to affect nearly every major neurotransmitter
and neuromodulatory system (Miller et al., 2013; Finnell and Wood, 2018). Microglia have
been directly and indirectly tied to these effects. For example, microglial cytokine release
can indirectly alter 5-HT and NE systems by enhancing IDO (Robinson et al., 2005) and
MAOs (Dhabal et al., 2018). More direct effects have been demonstrated by studying M1
type pro-inflammatory microglia. Specifically, it has been shown that stimulated M1 type
microglia have the capacity to directly release glutamate (Barger et al., 2007) and its coagonist D-serine (Wu et al., 2004). In this way, microglia can enhance glutamate within
the synaptic cleft and resulting in the activation of neurons. In addition, microglia have
been shown to induce remodeling of synaptic terminals often resulting in elongation and
thinning of dendritic spines. These effects have been linked to enhanced expression of
metalloprotease-9 (Stelzhammer et al., 2015) and kB kinase (Christoffel et al., 2012;
Christoffel et al., 2015) and inhibition of BDNF (Xie et al., 2017). However, inflammation
and resulting effects on neurotransmitter systems are highly region and stimulus dependent.
In the context of the amygdala, inflammation has been shown to enhance resting activity
(Inagaki et al., 2012) and signaling via ERK (Carrasquillo and Gereau, 2007), a major
signaling cascade induced by BDNF.
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In the CeA, the MAPK/ERK signaling cascade has been shown to enhance neuronal
excitability (Stamboulian et al., 2010), activation (Kidambi et al., 2010; Shan et al., 2015),
and directly regulate the acquisition and expression of fear related behavioral responses
(Rodrigues et al., 2004; Di Benedetto et al., 2009; Maldonado et al., 2014). In agreement
with these data, findings from Chapter 5 determined that the expression of defensive
behaviors and cardiovascular abnormalities during defeat were directly associated with
functional enhancement in CeA TrkB phosphorylation and preferential signaling through
MAPK/ERK. Interestingly, these effects were not associated with enhanced BDNF at this
time point. While the study described in Chapter 5 did not directly assess inflammation,
findings from Chapter 4 suggest that exposure to 5 consecutive days of social defeat
robustly enhances inflammatory tone within the CeA. One potential mechanism underlying
stress-induced TrkB activation in the absence of BDNF is through alterations in protein
tyrosine phosphatases (PTPs). PTPs are a large class of protein kinases that function to
dephosphorylate and thus inhibit TrkB. These proteins are sensitive to inflammation are
robustly inhibited by cytokines (Grinnell et al., 2012; Seo et al., 2013; Duan et al., 2014).
While PTPs are widely expressed throughout the brain and have long been studied in the
periphery, the central effects of these compounds are still largely unknown. Moreover, only
one study has assessed the effects of stress on PTPs (Dabrowska et al., 2013). This paucity
of information regarding PTPs in the brain has largely stemmed from the lack of effective
molecular tools. Studies assessing PTPs in the periphery rely on western blots. However,
the antibodies currently available do not provide good detection in brain homogenates
limiting their application.
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While there is clearly more work to be done to further clarify the effects of stressinduced inflammation, contribution of LC-NE, and putative inflammatory sensitive
neuronal mechanisms involved in the emergence of behavioral dysfunction, equal attention
should be paid to these effects in females. This is of particular importance as women are
twice as likely to develop depression and anxiety compared with men (Kessler et al., 1993;
Hankin et al., 1998). Moreover, ovarian hormones are intricately involved in the regulation
of a number of physiological systems including inflammation (Villa et al., 2016). While
these effects are well established, the paucity of information regarding the effects of social
stress in females has largely been attributable to inherent difficulties in conducting
traditional social stress models in female populations. For example, use of social defeat in
females either requires the use of a different species (highly territorial Syrian hamsters or
California mice), use of lactating female residents, or genetic modification of male
residents to induce abnormal aggression (Huhman et al., 2003; Trainor et al., 2010; Trainor
et al., 2011; Jacobson-Pick et al., 2013; Ver Hoeve et al., 2013; Shimamoto et al., 2015;
Duque-Wilckens et al., 2017; Takahashi et al., 2017). However, a new social stress model
has recently emerged that is a modification of the traditional social defeat paradigm. In this
model, a rat is placed behind a partition and is forced to observe the repeated defeat of a
paired male conspecific. We have recently shown that this witness stress model can be
effectively utilized with females and results in significant behavioral, cardiovascular, and
neuroinflammatory disruptions in the CeA that mimic findings in susceptible males
exposed to social defeat (Finnell et al., 2018). Notably, witness stress in females produced
strikingly robust cardiovascular and behavioral profiles during defeat that exceeded those
described in Chapter 5 of this document. Based on the putative role of the CeA in during
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defeat behavior and cardiovascular function, these data suggest that CeA micro circuitry
may be differentially regulated between males and females.
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